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 3. Abbreviations 
 
 
 
AC   articular cartilage 
ACTRI   activin receptor type I 
ADAM   a disintegrin and  
  metalloproteinase 
ADAMTS   a disintegrin and  
  metalloproteinase with  
  trombospondin motifs 
AdMIDAS   adjacent to MIDAS 
ADP    adenosine diphosphate 
AGEs    advanced glycation products 
Akt    RAC-alpha serine/threonine-
  protein kinase 
APC    adenomatous polyposis coli 
Arp2/3   actin related protein 2/3 
  complex 
BBS4    Bardet-Biedl Syndrome protein 
  4 
BMP    bone morphogenetic protein 
BMPR   BMP receptor 
BrdU    Bromodeoxyuridine 
CaMKII   calmodulin-dependent protein 
  kinase CII 
Cbfa1    core-binding factor alpha A 
CD    campomelic dysplasia 
CD44    cluster designation 44 
Cdc42    cell division cycle 42 
CE    convergent extension 
Cho    chondrodysplasia 
CILP    cartilage intermediate layer 
protein 
Cmd    cartilage matrix deficiency 
COMP   cartilage oligomeric matrix 
  protein 
Cre    cyclization recombinase 
DAG    diacylglycerol 
DGO    Diego 
Dsh/Dvl   Dishevelled 
EB1    microtubule plus-end binding 
  protein 1 
ECM    extracellular matrix 
EGF    epidermal growth factor  
ERK    extracellular signal-regulated 
  kinase 
FAK    focal adhesion kinase 
FGF    fibroblast growth factor 
FGFR    fibroblast growth factor  
  receptor 
FMI    Flamingo 
FN  fibronectin 
FNf   Fibronectin fragment 
Fzd    Frizzled 
GAP    GTP-ase activating protein 
GDF    growth and differentiation 
  factor 
GDP    guanosine diphosphate 
GDI    GDP dissociation inhibitor 
GEF    guanine nucleotide exchange 
factor 
GFR    growth factor receptor 
Gli   glioma-associated oncogene 
homolog 
GPCRs   G proteins coupled receptors 
GSK3β   glycogen synthase kinase 3β 
GTP    guanosine triphosphate 
ICAMs   intercellular adhesion 
molecules 
IFT    intraflagellar transport 
Ift88   intraflagellar transport protein 
88 
Ig    immunoglobulin 
IGF-1    insulin growth factor-1 
Ihh    Indian hedgehog 
ILK    integrin linked kinase 
IPP    ILK-PINCH-Parvin 
IP3    inositol triphosphate 
IT-AFM  indentation type atomic force 
microscopy 
JAK    Janus kinase 
JNK    c-jun N-terminal kinase 
kDa    kiloDaltons 
Kif3a    kinesin family member 3A 
LAP    latency-associated peptide 
LEF lymphoid enhancer-binding 
factor 
LGN    leucine, glycine, asparagine 
LRP   lipoprotein receptor-related 
proteins 
LTBP    latent TGFβ binding protein 
MAPK mitogen-activated protein 
kinase 
MEK    MAP kinase-ERK kinase 
MFGE8   milk fat globule-EGF factor 8 
MIDAS   metal-ion-dependent adhesion 
site 
mInsc    mouse Inscuteable 
MLC    myosin light chain 
MMP    matrix metalloproteinase 
N-CAM   neural cell adhesion molecule 
Nck2   noncatalytic region of tyrosine 
kinase, adaptor protein 2 
NRK    normal rat kidney cells 
Numa nuclear/mitotic apparatus 
protein 
OA    osteoarthritis 
Par6    partitioning defective 6 
Pax1    paired box gene 1 
PCP   planar cell polarity 
PC1    policystin-1 
pFAK    phosphoFAK 
PI3-K    phosphatidylinositol 3-kinase 
PINCH  Particularly interesting new 
Cys-His protein 
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PK   Prickle 
PKC   protein kinase C 
PKCζ   protein kinase C ζ 
PKD   polycystic kidney disease 
PLC   phospholipase C 
PPR   PTH/PTHrP receptor 
Prx1   paired related homeobox 1 
PSI   plexin, semaphorins, and 
  integrins 
PtdIns   phosphatidylinositol 
PtdIns-4,5-P2   PtdIns4,5-bisphosphate 
PTHrP   parathyroid hormone related 
  peptide 
Ptc-1   Patched-1 
PYK2   pyruvate kinase 2 
Rac1   ras-related C3 botulinum toxin 
  substrate 1 
Rap1   RAS-related protein-1 
Rap-L  Rap1 ligand 
Ras   rat sarcoma viral oncogene 
  homolog 
RGD   arginine, glycine, aspartate 
RhoA   ras homolog gene family, 
  member A 
RIAM   Rap1-interacting adaptor 
  molecule 
ROS   reactive oxygen species 
ROCK   Rho-associated protein kinase 
Ror2  receptor tyrosine kinase-like 
  orphan receptor 2 
Runx   runt-related transcription factor 
Smad   Similar to mothers against 
  decapentaplegic 
Smo   Smoothened 
Sox   Sry-related high-mobility group 
  box 
Src   Rous sarcoma oncogene 
Sry   sex determining region Y 
STAN   starry night 
STAT   signal transducer and activator 
  of transcription 
STBM   Strabismus 
SyMBS  synergistic metal ion binding 
  site 
TCF   T cell-specific transcription 
  factor 
TGF-β   transforming growth factor β 
TUNEL  Terminal deoxynucleotidyl 
  transferase dUTP nick end 
  labeling 
VANG   vanGogh 
VCAMs  vascular cell-adhesion  
  molecules 
VEGF   vascular endothelial growth 
  factor 
WASp   Wiscott-Aldrich Syndrome 
  protein 
Wnt   wingless-type MMTV  
  integration site family member 
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 4. Summary 
  
 Integrins are heterodimeric cell surface receptors that provide a connection between 
the actin cytoskeleton and extracellular matrix (ECM). In addition, ECM-bound integrins 
activate signaling pathways that control various aspects of cell behavior including cell shape, 
migration, proliferation and differentiation. Genetic deletion of individual integrin subunits 
has shown that they play a vital role in the development of organisms. In this work, we 
examined the role of β1 integrin in cartilage function. 
 In the process of endochondral ossification, long bones of the body are formed by 
replacement of a previously formed cartilage template. The columnar growth plate cartilage is 
a highly specialized and organized structure which sustains the elongation of the bone in early 
life. Lack of β1 integrin on chondrocytes leads to severe chondrodysplasia and perinatal 
lethality. The mutant chondrocytes in the growth plate are round, display adhesion defects and 
do not adopt the normal columnar arrangement. Recently β1 integrin was shown to regulate 
mitotic spindle orientation and the establishment of apical-basal polarity in epithelial cells. 
This polarity creates asymmetrically distributed cortical cues which dictate the orientation of 
the mitotic spindle and therefore the cell division plane. The reduced cellularity and loss of 
the columnar organization of β1 integrin-null chondrocytes led us to hypothesize that the loss 
of β1 integrin had detrimental effects on cell division and subsequent migratory events in 
these cells (Paper I). Histological analysis of growth plate chondrocytes in vivo demonstrated 
that spindle positioning depends on the elongated cell shape and does not requires cortical 
cues. Late mitotic spindles are aligning parallel to the long axis of the cell and perpendicular 
to the longitudinal direction of the bone growth, while the cleavage plane is oriented at right 
angle of the late spindle axis. This cell shape anisotropy is analogous to polarity and is 
essential for the subsequent migration of the cells to form longitudinal columns. In the 
absence of β1 integrin the chondrocytes lose their discoid shape (and therefore polarity) 
leading to arbitrary spindle orientations. This results in a randomized cleavage plane and 
subsequent inability to form columns. The dependence of cell shape to orient the mitotic 
spindle was recapitulated in vitro with isolated primary chondrocytes. Taken together, these 
data indicate that the disorganized columnar structure in the β1 integrin-deficient growth plate 
is a consequence of the loss of cell anisotropy due to adhesion abnormalities, which leads to 
mitotic orientation defects. We conclude that β1 integrin is essential for regulating the cell 
shape, which in turn dictates the division plane in the growth plate chondrocytes. 
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 Next, we studied the role of β1 integrin in the function of adult articular cartilage 
(AC), by deleting β1 integrin from the limb bud osteochondral progenitors, and therefore 
from chondrocytes of the joints of the long bones (Paper III). Previous studies deleted β1 
integrin from all chondrocytes, which caused the mice to die around birth due to defects in 
vital skeletal structures; restricting the deletion to the long bones spared the animals and 
permitted the examination of adult articular cartilage. The limbs of such animals showed 
characteristics of dwarfism and the columnar organization in the growth plate was lost. Joint 
defects accompanied by structural changes in the articular cartilage were detected in mutant 
animals. The shape and proliferation of mutant chondrocytes were altered in knee joint AC. 
The composition of the ECM surrounding mutant chondrocytes was altered, indicating that 
the differentiation of mutant chondrocytes did not proceed normally, and the ECM that was 
deposited was disorganized. Each of these changes is characteristics of ostearthritis, but 
surprinsigly we were unable to detect accelerated cartilage erosion. As an explanation of this 
unexpected finding, we noticed normal activity of matrix metalloproteinases and 
aggrecanases accompanied by normal metabolism of the major cartilage structural proteins, 
collagen II and aggrecan. Our observations suggest that the loss of β1 integrin on AC 
chondrocytes may contribute to arthritis but alone is not sufficient for a bona fide arthritis 
phenotype since cartilage surface erosions are absent in the deficient mice. 
 The progression of arthritis is characterized by increasing erosion of the AC surface. 
Diagnosis is possible only after major pathological modifications have occured in the 
cartilage. To enable the examination of the AC surface in early osteoarthritic events we made 
significant contributions to the development of a technique to examine the topography and 
stiffness characteristics of AC using indentation-type atomic force microscopy (IT-AFM) 
(paper IV). As a proof of principle in this study we used AC from both patients and mice 
deficient in collagen-IX expression, which serves as a classical model for progressive 
arthritis. This study demonstrated that nano scaled IT-AFM can resolve individual collagen 
fibrils and can reliably measure elastic properties in normal and diseased AC. Wild type 
cartilage displays increased bundling of collagen fibrils and a gradual increase in stiffness 
with age. The thickness of collagen fibrils was accelerated and increased in the absence of 
collagen-IX, concomitant with an increase in AC stiffness until six months of age, after which 
stiffness gradually decreased owing to degeneration of the collagen matrix. Therefore, we 
could show that IT-AFM is a valid technique to quantitatively compare the physical qualities 
of AC cartilage, and detect and monitor the progression of arthritis long before other 
techniques are effective. 
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 5. Introduction 
 5.1. The integrin family of adhesion receptors  
 
The assembly of cells and extracellular matrix (ECM) molecules into tissues is 
mediated by adhesion molecules which can either form cell-cell interactions or can anchor 
cells to the ECM 1. Integrins are a major class of cell adhesion receptors in metazoan cells, 
present from sponges to mammals 2, 3. They are heterodimeric transmembrane proteins which 
interact either with ECM molecules or with cellular counter-receptors, and they connect to the 
cytoskeleton via adaptor proteins, thus forming a structural link between the extracellular 
space and the intracellular milieu 3, 4. Integrins are dual function receptors, acting both as 
adhesion and signaling receptors which enable cells to both bind and respond to the 
extracellular matrix chemically and mechanically. They control cell shape and polarity as well 
as essential cellular processes such as proliferation and differentiation, survival, apoptosis and 
cell migration 5. 
 5.1.1. Integrins and their ligands 
 
Integrins can bind three major classes of ECM ligands: collagens, laminins and 
molecules which have exposed RGD (arginine, glycine, aspartate) motifs such as fibronectin, 
vitronectin, tenascin, osteopontin and thrombospondin 6, 7. Besides interactions with the major 
ECM ligands, leukocyte-specific integrins establish cell-cell contacts with endothelial cells by 
interacting with cellular counter-receptors such as intercellular adhesion molecules (ICAMs) 
and vascular cell-adhesion molecules (VCAMs)8 (Fig. 1). Additional ligands known to 
interact with integrins are: milk fat globule-EGF factor 8 (MFGE8) and complement factor 
(iC3b)9, which are involved in phagocytosis of apoptotic cells and pathogens, respectively; 
the latency-associated peptide (LAP) of transforming growth factor β (TGF-β) which 
regulates TGF-β signaling 10, some of the ADAM (a disintegrin and metalloproteinase) family 
members and MMP-2 (matrix metalloproteinase-2) which participate in ECM remodelling 
during cell adhesion and migration 11. 
18 different α subunits and 8 different β subunits have been described in mammals, 
that combine to form at least 24 distinct αβ heterodimers with different ligand binding 
specificities 3 (Fig.1). There is significant overlap in binding, as the same ligand is often 
recognised by many different integrins, and a given integrin can often recognize more than 
one ECM molecule 6. The complexity of the integrin family is further increased by the 
1 
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presence of splicing isoforms. Different tissues express only a specific isoform and some 
tissues can switch during development between different isoforms. Although many isoforms 
have redundant functions some seem to have vital functions for cell physiology. For example 
the A isoform of β1 integrin (β1A) is expressed in all tissues except muscle and heart which 
express the β1D isoform. Genetically modified mice that express the β1D isoform exclusively 
die early during embryonic development whereas substitution of β1D with β1A causes only 
small abnormalities in the muscles, suggesting that β1D is dispensable for mouse 
development and cannot compensate for loss of β1A 2. 
 
Fig.1 Mammalian family of integrin heterodimers3. Based on the binding specificity given by the two 
subunits of the heterodimer the integrin family can be subdivided into different subfamilies. Some 
integrins are specific for certain cell types such as the leukocyte-specific integrins, and many cell types 
express more than one type of integrin 3. 
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 5.1.2. Integrin structure 
 
Integrins are type I transmembrane glycoproteins composed of non-covalently 
associated α and β subunits. Each subunit consists of a large extracellular domain (80-150 
kDa), a single transmembrane alpha helix and, except for the β4 subunit which has an 
unusually large cytoplasmic domain of 1072 residues, a short cytoplasmic domain of 10-70 
amino acids 12. Electron microscopy and biophysical data revealed a 'head on a stalk' 
arrangement of the two subunits, whereby their extracellular domains organize into a head 
sitting on two legs 13, 14. The crystal structure of the αvβ3 extracellular domains was the first 
high resolution data to reveal the organization of both subunits 3, 15. More recently the αIIbβ3 
structure has provided even greater resolution and gave some insight into the integrin 
activation mechanism 14. The extracellular domain of the α subunit contains an N-terminal β 
propeller domain followed by an Ig-like (thigh) and two β sandwich domains (calf1 and 
calf2). Half of the known α subunits (the collagen-binding and leukocytes-specific integrins) 
contain an I/A domain inserted into the larger β propeller domain and in these integrins this 
domain participates in ligand binding 3, 12, 16. The β subunit’s extracellular domain is 
organized in a βI/A domain, which is inserted into an immunoglobulin (Ig)-like “hybrid” 
domain preceded by an N-terminal 54-residue PSI (plexin, semaphorins, and integrins) 
domain, four tandem cysteine-rich EGF-like repeats and a β-tail domain (Fig.2). The PSI 
domain is disulfide bonded to the distal I-EGF domain 3, 17. 
The β propeller of the α subunit together with the βΙ/A and the “hybrid” domains of 
the β subunit comprise the head region. The interface between the propeller and the βI/A 
domain forms the ligand-binding pocket. Integrin-ligand binding is dependent on divalent 
cations. The βI/A domain contains three metal binding sites essential for ligand binding: a 
central Mg²+ binding site called MIDAS (metal-ion-dependent adhesion site) and two 
flanking Ca²+ sites one called SyMBS (synergistic metal ion binding site) and the other 
AdMIDAS (adjacent to MIDAS)14. 
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Fig.2 Diagram of integrin heterodimer  
(adapted from 12 and 18). The ligand-
interacting head is formed of the propeller of 
the α subunit and the hybrid and βΙ/A 
domains of the β subunit. The "switchblade 
model" of activation postulates that during 
activation the inactive bent integrins unfold at 
the bending region (dotted line) to expose 
the ligand binding site. 
 
 
 
 5.1.3. Integrin signaling 
 
Integrins are unusual among transmembrane receptors because they can signal across 
the membrane in both directions. The ECM-binding activity of the integrins can be modulated 
upon an intracellular signaling event (inside-out signaling) and, upon binding ECM, integrins 
can transmit signals into the cell (outside-in signaling) 3, 5 
Inside-out signaling. Integrins that are expressed on the cell surface in an inactive 
conformation, unable to bind to the ECM or cellular counter-receptors, are activated by a 
series of events referred to as inside-out signaling. Upon induction by intracellular stimuli, 
activated cytoplasmic ligands such as talin and kindlins interact with the integrin tails to 
transmit information to the extracellular ligand-binding domain via the transmembrane 
domain and legs 12, 19. Inside-out signaling has best been studied in circulating blood cells 
such as platelets, leukocytes and lymphocytes. Integrin activation in these cells occurs only in 
certain physiological situations such as thrombus formation, during hemostasis, or 
extravasation through the blood vessel walls and migration to the site of inflammation 20-22. 
Several agonists can activate αIIbβ3 in platelets: immobilized stimuli such as von 
Willebrand factor and collagen; soluble molecules released locally such as thrombin; and 
molecules produced by the platelets themselves, ADP and thromboxane A2. These stimuli act 
either through receptors coupled to heterotrimeric G proteins (GPCRs) or through receptors 
not directly coupled to G proteins such as the collagen receptor GPVI. Two important 
enzymes are activated downstream of GPCRs: phosphatidylinositol 3-kinase (PI3-kinase) and 
phospholipase C (PLC). PI3-kinase products, phosphatidylinositol (PtdIns)-3,4-bisphosphate 
(PtdIns-3,4-P2) and PtdIns-3,4,5-P3, recruit proteins with pleckstrin homology domains to the 
4 
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cell membrane. PLC cleaves phosphatidylinositol to produce the secondary messengers 
inositol triphosphate (IP3), which increases cytoplasmic [Ca²+], and diacylglycerol (DAG), 
which activates protein kinase C and CDGI (a Ca²+ and DAG-dependent guanine nucleotide 
exchange factor (Cal-DAG-GEF) for the ras-like small GTPases Rap1) 20. Activated Rap1 
binds to its effector RIAM which in turn binds to talin 23. This ternary complex is targeted to 
the plasma membrane where talin can bind to integrin β2- and β3-tails and together with the 
actions of kindlins switch these integrins into the high affinity state 21, 24-26. 
Additional signaling pathways have been shown to activate integrins in lymphocytes 
(Fig.3). Chemokine-activated GPCRs signal through the same signaling cascades as described 
for platelets, including activation of PI3K and the small GTPases Rap1 and RhoA. 
Furthermore, activation of T cell antigen receptor upon antigen binding was proposed to 
increase integrin activation in a phospholipase C-gamma1- and Rap1-dependent manner 22. 
Also, cross-linking of selectins and binding to ICAM-1 in neutrophils leads to integrin 
activation through a protein kinase C-dependent pathway. 21 
The above pathways ultimately result in the activation of talin, which is proposed to 
disrupt interactions between the cytoplasmic α and β integrin tails, including a proposed salt 
bridge between an Asp residue within the β-tail HDRK motif and an Arg residue in the 
GFFKR motif within the α-tail, by binding to membrane-proximal residues in the β integrin 
tail 27 (see Fig. 4 for the position of the putative salt bridge). In addition to talin, the kindlin 
family of proteins has been recently shown to have a vital role in integrin activation 24, 26, 28. 
However, in contrast to talin, nothing is known about how kindlins become activated. Talin 
and kindlin binding to integrin tails induces a conformational change that is propagated 
through the transmembrane domains to the 
 
 
 
Fig.3 Signaling pathways leading to integrin 
activation in lymphocytes 22. Activation of 
receptors such as GPCRs or TCR leads to talin 
recruitment to the integrin tails which results in 
activation of the integrins from within.  
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Fig.4 Sequences of the transmembrane and cytoplasmic tails of the αIIb and β3 subunits. The salt 
bridge forms between the positively charged R (+) and the negatively charged D (-) residues. The 
binding sites are shown for a few of the proteins known to interact with β integrin tail. 12 
 
extracellular domains of the integrins. The integrin heterodimer can then switch to an active 
conformation by unbending the “legs” at the knee or “genu” between the α thigh and calf1 
and between the I-EGF domains 1 and 2 of the β leg. Thus the integrin can transit from a low 
affinity bent conformation to a high affinity extended conformation. Details of the structural 
changes during integrin activation are still controversial. Two main competing models have 
emerged from independent studies. First, the switchblade model states that the separation of 
the cytoplasmic tails and TM domains of the inactive bent integrin causes the knee extension 
and opening of the ligand binding pocket (Fig 5A). Second, the deadbolt model does not 
require unbending but, upon a change in the tilt of the transmembrane domains following 
inside-out signaling, a conformational change occurs within the head domain to reveal the 
ligand binding site (Fig. 5B) 12, 14, 17, 18. 
Through still unclear mechanisms, integrins that are in a high affinity state and bound 
to ligand initiate clustering and the recruitment and activation of other integrin molecules thus 
strengthening the interaction with ECM17 and leading to activation of intracellular signaling 
pathways by the so called outside-in signaling discussed below. 
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Fig.5 Models of integrin activation. A. In the switchblade model, the inactive heterodimer extends in an 
inactive primed state which consequently opens the ligand binding site. B. In the deadbolt model, a 
conformational change of the transmembrane domain is propagated to the extracellular domain to 
expose the ligand binding site while still in a bent conformation. The two controversial models have 
been described for αvβ3 and αIIbβ3 integrins. Probably each integrin heterodimer has a unique 
repertoire of conformational changes. 17 12 14 
 
 
Outside-in signaling. The cytoplasmic tails of the integrins are devoid of enzymatic activity; 
instead they function as docking sites for many adaptor proteins (Fig. 4). Following integrin 
activation a series of molecules are recruited and assembled into a signaling platform on 
integrin tails, leading to an increase in tyrosine phosphorylation of specific substrates and an 
increase in the concentration of lipid second messengers such as PtdIns-4,5-P2 and PtdIns-
3,4,5-P3. Molecules associated with the integrin tails contribute subsequently both to 
cytoskeletal rearrangements needed during spreading, migration and cell polarity, and to 
initiation of intracellular signals which ultimately result in gene expression changes that 
promote cell survival, proliferation and differentiation (Fig. 6)29. 
The integrin-actin linkage is established by several molecules in a complex but well 
controlled network. The integrin-binding molecules talin, α-actinin, and filamin have been 
described to connect directly to the cytoskeleton by interacting with actin. Both talin and α-
actinin can also indirectly regulate the cytoskeleton in a PtdIns-4,5-P2-dependent manner 
through an interaction with another actin-binding protein, vinculin. Filamins associate with 
integrins and are able to link actin filaments in orthogonal networks or parallel bundles. 29, 30 
Other integrin-binding proteins such as integrin linked kinase (ILK), paxillin, FAK 
and kindlins are linked to the actin cytoskeleton indirectly 29. ILK associates with integrin 
tails when it is a part of a tripartite complex containing parvin and PINCH (known as the 
7 
Introduction 
ILK-PINCH-parvin or IPP complex) 31. Parvins link ILK to actin filaments either directly or 
indirectly through paxillin and vinculin. PINCH, on the other hand, can also modulate actin 
polymerization through WASp (Wiscott-Aldrich Syndrome protein) via an interaction with 
the adaptor Nck2 30. 
One of the important downstream effects of integrin activation is the recruitment of 
the small Rho GTPases and their regulators to the plasma membrane. Many of the mentioned 
molecules, such as parvin, paxillin, FAK, and filamin act on Rho GTPases. Rho GTPases are 
major actin regulators which cycle between an active GTP-bound and an inactive GDP-bound 
conformation. This cycling is regulated by guanine nucleotide exchange factors (GEFs), 
GTPase-activating proteins (GAPs) and guanine nucleotide-dissociation inhibitors (GDIs) 32. 
The three major Rho GTPases involved in integrin-regulated actin remodelling are Cdc42, 
Rac1 and RhoA. Cdc42 is involved in filopodia formation and Rac1 has been shown to 
promote lamellipodial protrusion during cell migration 33. Both act through the activation of 
the actin nucleator Arp2/3 which initiates de novo actin polymerization or branching of pre-
existing actin filaments. RhoA is a major regulator of cell contractility and it has been shown 
to promote stress fiber formation by activating formins and ROCK kinase which in turn 
phosphorylates myosin light chain (MLC) thus inducing acto-myosin contraction 29. 
Integrin signaling affects multiple signal transduction pathways through the Src-FAK 
complex which is localized at adhesion sites by binding β integrin cytoplasmic tails and 
locally produced phosphoinositides 29. The Src-FAK complex activates the Ras-MEK-MAPK 
signaling cascade, a major pathway through which integrins can regulate cell cycle, 
proliferation and gene expression. ERK activation downstream of integrin signaling promotes 
cell proliferation through activation of cyclin D expression and subsequent cell cycle entry 5. 
Survival and differentiation are also regulated by controlling Akt and Gsk3β downstream of 
PI3K signalling, probably in an IPP-dependent manner. The src-homology adaptor Nck2 has 
been shown to interact both with growth factor receptors (GFRs) and the IPP complex thereby 
connecting integrin and GFRs signaling. Thus many of the signaling pathways downstream of 
integrins are also downstream of GFRs, and a significant amount of crosstalk exists between 
these two signaling hubs 29. 
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Fig.6 Outside-in signaling29. Integrins respond to diverse stimuli and activate a wide variety of 
intracellular signaling cascades to induce multiple cellular effects in the so called outside-in signaling 
pathways. Cooperation with other receptors such as GFRs ensures an integrated response to 
extracellular signals.  
 
 
 5.1.4. Integrins in mouse development 
 
In vivo studies using mouse genetics have significantly increased the understanding of 
integrin biology. The most important subfamily of integrins is the ubiquitously expressed 
subfamily of β1 integrins due to its association with more than half of the α subunits. Genetic 
ablation of β1 integrin leads to the loss of all β1-containing heterodimers (α1β1-α11β1, αvβ1) 
and results in peri-implantation lethality characterized by an inner cell mass (ICM) failure 34, 
35. α5, α4 and αv integrin knockouts show the next severe phenotypes characterized also by 
embryonic lethality but at different developmental stages: α5 knockout (ko) embryos die 
between embryonic day 9.5 (E9.5) and E10 due to extraembryonic and embryonic vascular 
defects 36; α4 deletion leads to death between day E11 and E14 as the result of defective 
choriallantois fusion and abnormal cardiac development 37; 80% of the αv ko embryos die 
between E10 and E12 because of a placental defect whereas the remaining 20% die at birth 
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due to cleft palate and massive hemorrhages 38. Deletion of α3, α6, α8, β4, or β8 results in 
perinatal lethality due to various phenotypes. For example the α3 ko mice shows skin 
blistering, kidney, lung and cerebral cortex defects 39-41; α8 ko mice have small or absent 
kidneys as well as inner ear abnormalities 42, 43. Other integrin ko mice show organ-specific 
defects but are viable and fertile. For example, deletion of the β7 subunit leads to impaired T 
cell migration to Peyer’s patches and reduced lymphocyte number associated with the gut 
epithelia 44. Mice lacking β3 or αIIb have defective blood clot formation due to impaired 
platelet aggregation 45, 46. 
To understand the specific role of essential integrins in specialized organs such as 
skin, hematopoietic system, bone, cartilage or blood vessels, conditional knock-out strategies 
are of valuable use since they overcome the problem of early embryonic lethality. The skin-
specific ablation of β1 integrin expression results in severe blistering, abnormal basement 
membrane organization, epidermal proliferation and hair follicle morphogenesis46, 47. The use 
of chimeric mice to study the role of β1 in the hematopoietic system revealed that β1 integrin 
is required for colonization of hematopoietic organs by the hematopoietic stem cells but it is 
not essential for their differentiation48, 49. More recently the inactivation of β1 integrin 
specifically in the pericytes of the blood vessel walls results in perinatal lethality due to blood 
vessel aneurysms and hemorrhages demonstrating a vital role for β1 mediated adhesion in 
maintaining vessel wall integrity50. Deletion of β1 integrin in chondrocytes will be discussed 
in detail in the chapter 5.2.4.4. All together these in vivo studies show that integrins play 
important structural as well as signaling roles in development and maintenance of tissue 
integrity. In the next subchapter, I will summarize our current knowledge about the role of 
integrins in mitotic spindle positioning and tissue polarity.  
 
 5.1.5. β1 Integrin controls orientation of the spindle machinery 
and cell polarity 
 
The orientation of the mitotic spindle determines the plane of cell division and defines 
the relative location of daughter cells, which in turn regulates cell fate decisions that are 
important for tissue morphogenesis. β1 integrin has been recently shown to regulate mitotic 
spindle orientation both in vivo and in vitro. In normal skin, basal keratinocytes display 
apical-basal polarity and cell division is oriented perpendicular (with high percentage) or 
parallel (with low percentage) to the basement membrane at the time when the epidermis 
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begins to stratify during embryogenesis. Deletion of β1 integrin from basal keratinocytes 
leads to the loss of normal apical localization of PKCζ and the polarity complex 
Par6/LGN/mInsc-Numa-dynactin, which consequently results in random spindle orientation51. 
β1 integrin ablation in the basal cells of the mammary gland epithelium alters the orientation 
of the cell division axis leading to dislocation of stem-cell progeny into the luminal epithelial 
compartment 52. In Drosophila, β1 integrin regulates the proper orientation of the mitotic 
spindle of follicular cells, thus ensuring that the two daughter cells remain attached to the 
basement membrane during formation of the ovarian epithelium 53.  
In vitro, cell-ECM interactions mediated by integrins determine the shape of the cell in 
interphase and create cortical cues, which are maintained during mitosis. These cortical cues 
are used by the dividing cells to establish the cell division axis independent of the cell shape 
during mitosis 54. Recently, Toyoshima and Nishida have demonstrated that both in HeLa and 
normal rat kidney cells (NRK) cells, β1 integrin-mediated adhesion orients the mitotic spindle 
parallel to the substratum. This process is independent of cell geometry and involves EB1 and 
myosin X as well as intact astral microtubules 55. Moreover, changing PtdnIns-3,4,5-P3 
distribution by inhibiting the PI3K pathway, which is downstream of integrin signaling, 
results in spindle misorientation 56. Thus, by regulating mitotic spindle orientation, integrin-
mediated adhesion establishes the location and fate of the daughter cells also in these two 
dimensional culture systems.  
 Many morphogenetic events during embryogenesis depend upon choreographed, 
polarized cell migration to form specific structures. Convergent extension (CE) represents 
such a series of polarized cell movements, which result in tissue narrowing along one axis and 
lengthening along a second, perpendicularly oriented axis. CE is particularly important during 
gastrulation, neurulation, body axis elongation and organogenesis in both vertebrate and 
invertebrate embryos. One of the cellular mechanisms of convergent extension is mediolateral 
intercalation. First, the dispersed cells extend lamellipodial protrusions in random 
orientations, then lamellipodia become stable and polarized in the mediolateral axis. These 
polarized protrusions attach to the mediolateral neighbouring cells and exert traction forces, 
pulling the cells between one another (Fig.7) 57. In Xenopus embryos, integrin-ECM 
interactions modulate cadherin-mediated cell-cell adhesion required for CE. Expression of a 
dominant negative form of β1 integrin (HAβ1) in gastrulating embryos leads to disruption of 
cell-intercalation and CE resulting in delayed blastopore closure and shortened antero-
posterior axes. This phenotype is most likely due to the impaired modulation of cadherin-
mediated cell adhesion during intercalation 58. When α5β1 integrin binding to fibronectin is 
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disrupted in Xenopus, the mediolateral protrusions become randomized leading to convergent 
thickening instead of convergent extension 59. Thus integrin-mediated adhesion and signalling 
are central players in tissue morphogenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.7 Mediolateral intercalation during convergent extension 60. The initially non-polarized cells extend 
medial-lateral polarized protrusions and start migrating in a medial-lateral direction. This series of 
movements result in narrowing in one direction and elongation in a perpendicular direction. 
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 5.2. Skeletal development 
 
 The vertebrate skeleton is formed from more than 250 different elements and plays 
essential roles in body support and protection, in locomotion, in blood cell production, and in 
mineral and energy storage 61. The skeleton is composed of cartilage and bone and its main 
parts are derived from three different embryonic compartments: the craniofacial skeleton is 
formed from cranial neural crest cells; the axial skeleton (vertebral column and the rib cage) 
arises from the paraxial mesoderm; and the apendicular skeleton (limbs) is the product of the 
lateral plate mesoderm 62. Cells from these lineages migrate to the locations of presumptive 
skeletal elements and aggregate to form characteristic mesenchymal condensations that 
prefigure the future bone 63. The mesenchymal cells, depending on the function and location 
of the bone, can undergo two developmental fates: either they differentiate directly into bone 
producing osteoblasts during the process of intramembranous ossification by which facial and 
cranial bones are formed; or the progenitors differentiate into chondrocytes that lay down 
initial cartilaginous templates which are subsequently replaced by bone except in the joint 
regions. This latter process, called endochondral ossification (or endochondral bone 
formation) represents the main focus of this chapter 64, 65. 
 
 5.2.1. Endochondral ossification 
 
Endochondral ossification (EO) is a complex, multistep process by which more than 
95% of the vertebrate skeleton including the vertebrae, ribs, and limbs is formed 66. The 
morphogenetic sequence of EO can be divided into five consecutive and partially overlapping 
stages (Fig. 8 and 9): 
1. Commitment of mesenchymal cells: When mesenchymal cells migrate to the site of 
future skeletal elements they become committed to differentiate into chondrocytes. This 
commitment is caused by the soluble morphogen Sonic hedgehog, which induces nearby cells 
to express the Pax1 transcription factor. Pax1 initiates a cascade that is dependent on external 
paracrine factors and internal transcription factors 63, 67. 
2. Mesenchymal condensation and chondrogenic differentiation: The previously 
dispersed, committed mesenchymal progenitors first proliferate then withdraw from the cell 
cycle and begin to aggregate into tightly packed clusters or nodules followed by  
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Fig.8 Condensation and differentiation of limb bud mesenchyme into cartilaginous tissue. 
Mesenchymal cells from lateral plate mesoderm migrate to the site of bone formation. Once there they 
start to divide and aggregate toward the center without dispersing. Later they differentiate into 
cartilage (blue). These processes are tightly controlled by transcription factors, morphogens, cell 
adhesion and ECM molecules. (adapted from 63) 
 
differentiation into chondrocytes (Fig.8). At the same time, cells surrounding the 
condensations elongate and form the perichondrium which prevents further recruitment of 
mesenchymal cells. The condensation process is a result of complex epithelial-mesenchymal 
interactions tightly regulated by growth and transcription factors and is recognised by the 
expression of a characteristic set of cell adhesion and ECM molecules including N-cadherin, 
N-CAM, fibronectin, and tenascin-c (Fig. 8)63. When pre-chondrocytes emerge in the centre 
of skeletal aggregates as a consequence of combinatorial signaling, they switch their 
expression pattern and start to express early cartilage markers such as collagen II and 
hyaluronan 68. 
3. Chondrocyte proliferation: During the third phase (Fig. 9), the chondrocytes rapidly 
proliferate and deposit the typical cartilaginous matrix containing collagen fibrils, 
proteoglycans, hyaluronan and non-collagenous glycoproteins. The major proteoglycan 
component is aggrecan, which is bound to hyaluronan via the link protein, and forms huge 
aggregates in the matrix. The aggregates swell due to the hydrated nature of the 
proteoglycans, and are reinforced by the tense collagen network. The cartilage fibrils consist 
of mainly collagen II and collagen IX and XI as minor components. At the periphery of the 
cartilage template, cells from the inner layer of the perichondrium constantly differentiate into 
chondrocytes contributing to the lateral growth of the template. The coordinated cell growth 
and matrix deposition in both lateral and proximal-distal directions continue to enlarge and 
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shape the anlage, which is moulded into a central shaft (diaphysis) and club-shaped 
expansions at the ends (epiphyses) 65. 
4. Chondrocyte hypertrophy and mineralization: In the fourth phase, chondrocytes in 
the central region of the avascular template stop dividing, increase their cell volume and 
differentiate into hypertrophic chondrocytes that express collagen X and vascular endothelial 
growth factor (VEGF), an angiogenesis promoting factor which can induce mesodermal 
mesenchymal cells to differentiate into blood vessels. Subsequently, hypertrophic 
chondrocytes undergo a terminal step of differentiation. The expression of collagen X is 
downregulated while the expression of matrix metalloproteinase-13 (MMP13), alkaline 
phosphatase and osteopontin is upregulated, inducing the mineralization of the cartilage 
matrix. Finally, the terminally differentiated hypertrophic chondrocytes die by apoptosis. At 
the time that chondrocyte hypertrophy is first initiated, perichondrial mesenchymal cells 
flanking the hypertophic core, differentiate into osteoblasts by intramembranous ossification 
to produce the periosteal bone collar 69.  
5. Vascular invasion and ossification: In the fifth phase, the blood vessels from the 
bone collar invade the hypertrophic core to initiate the formation of the primary ossification 
center 70. Vascular invasion delivers chondroclasts that resorb the ECM surrounding the 
hypertrophic chondrocytes and brings osteoblasts that lay down trabecular bone on the 
remnants of cartilage matrix 69, 71. As the bone enlarges, chondrocytes stop proliferating and 
become hypertrophic at the epiphyses leading to the establishment of secondary ossification 
centres. At the surface of the epiphyses, the cartilage is not replaced by bone, remains intact 
and persists as articular cartilage throughout life. In long bones, chondrocytes between the 
primary and secondary ossification centres form the growth plate that ensures the longitudinal 
elongation of the bone. 
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Fig.9 Endochondral ossification. Bone formation occurs during multiple steps when cartilage anlage is 
replaced by bone. Initially the cells in the center of the anlage undergo hypertrophy which attracts 
blood vessels. At this step a first ossification center establishes. Later the secondary ossification 
center recapitulates this process in the epiphysis. 
 
 
 5.2.2. The growth plate – the functional unit of endochondral 
ossification 
 
Growth plate cartilage is a well-organized and specialized tissue primarily responsible 
for the proximal-distal elongation of the long bones during endochondral ossification. In 
human, the growth plate is gradually resolved after the end of puberty, while in other 
vertebrates (e.g. mice) it exists as a senescent plate between the physes throughout the adult 
life. During the active elongation period, growth plate chondrocytes undergo a temporally 
tightly controlled differentiation process accompanied by the establishment of cellular 
polarity that generates the unique spatial structure of the tissue. Chondrocytes in the growth 
plate are organized into horizontal zones, which reflect their metabolically and 
transcriptionally distinct stages in the differentiation program, and into vertical columns that 
in most vertebrates direct the elongation process (Fig.10). The narrow reserve zone (also 
known as the resting zone) is situated furthest from the ossification front and is composed of 
small, isotropic chondrocytes that are irregularly dispersed in the matrix. They divide very 
rarely and are believed to serve as stem cell-like precursors for chondrocytes in the underlying 
proliferative zone. Chondrocytes in the proliferative zone become flattened with their long 
axis oriented perpendicular to the direction of the longitudinal growth and undergo a clonal 
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expansion resulting in a characteristic columnar structure with the cells lying on top of one 
another. Kinetic studies revealed that cells only in the upper half of the zone are mitotically 
active, whereas chondrocytes in the lower proliferative zone undergo a maturation process. In 
addition to the rapid proliferation, chondrocytes in the upper zone synthesize the bulk of 
cartilage matrix mainly composed of collagen II and aggrecan. In the prehypertophic zone, 
chondrocytes begin to increase their size and express specific markers such as Indian 
hedgehog (Ihh) and parathyroid hormone-related peptide receptor. Most cells in this zone still 
deposit collagen II and aggrecan together with the hypertrophic marker collagen X. In the 
hypertrophic zone, all cells cease dividing, enlarge and become ovoid in shape. Hypertrophic 
chondrocytes stop expressing collagen II and deposit collagen X instead. The fates of 
terminally differentiated chondrocytes are controversial: while generally believed that cells at 
the cartilage-bone border die by apoptosis/necrosis, another theory suggests that hypertrophic 
chondrocytes may transdifferentiate into osteoblasts 65, 72-74. 
In summary, proximal-distal elongation of the long bone is achieved by the 
combination of the activity and special arrangement of growth plate chondrocytes. Matrix 
production, cell proliferation and hypertrophy as well as the columnar alignment are the major 
factors that ensure growth. Although all these aspects contribute to the efficient elongation of 
the bone, there are important differences among vertebrates. In birds, chondrocyte 
proliferation is the major contributing factor for longitudinal elongation, while in mammals 
proximo-distal elongation mostly depend on the rate of hypertrophic differentiation 75. 
Interestingly, in the bullfrog Rana catesbeiana, where growth plate columns are not present, 
bone extension is based on periosteal growth 76.  
 
 
Fig.10 Growth plate 
architecture. Left: 
schematic diagram of the 
cellular organization of the 
growth plate. Right: 
mouse growth plate. The 
different horizontal zones 
correspond to different 
maturation stages of the 
chondrocytes. 
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 5.2.3. Mechanism of column formation 
 
According to the general view, early chondrocytes (chondroblasts) in the presumptive 
growth plate region are initially small and round (isotropic) and they elongate medial-laterally 
after the formation of the hypertrophic core 72, 77. In contrast, Holmes and Trelstad have 
reported that the Golgi-nucleus axis of cells in the initial prechondrogenic/cartilaginous 
aggregates is oriented predominantly toward the proximal-distal axis of the growth suggesting 
that the polarity and coordinated alignment of a group of cells are established very early 
during cartilage development 78. In the 1970s, several hypotheses emerged to explain 
chondrocyte polarity and orientation in the cartilaginous templates. In the mechanical model 
79, chondroblasts situated in the cylinder-like growth plate region extensively secrete matrix 
which exert pressure on the cells themselves. According to this theory, the expansion of the 
cylinder is greater in a radial direction than along the long axis, therefore the newly 
synthesized matrix will flatten the cells at right angles to the long axis. Further explanations 
for the switch between nonoriented-oriented cellular behaviors include changes in surface 
properties of the aggregating cells 80, alterations in the diffusible environment of the 
condensations 81 and the synthesis of local morphogens by limb mesenchymal cells 82. 
Once the initial chondrocyte polarity is established, the flattened (anisotropic) 
chondrocytes in the proliferative zone are arranged into columns oriented parallel to the 
longitudinal axis of the growing bone. The cells are close together implying their recent 
division and align their long axis perpendicular to the direction of the bone growth. Each cell 
is surrounded by a pericellular matrix which may merge with that of a neighboring cell. All of 
the chondrocytes within a clonal column together with a common surrounding territorial 
matrix form a chondron, the functional unit of the growth plate. Matrix between chondrons is 
called interterritorial matrix and histochemically resembles the territorial matrix. However in 
this region the collagen fibers orient in the direction of growth and organize into septa 
separating the individual columns. 
An attempt to understand the process of column formation was made as early as 1930 
by the American anatomist Dodds who observed that the rows are formed by directional 
divisions of discoid cells 83. He stated that the long axis and the mitotic figures of the discoid 
chondrocytes are always arranged perpendicular to the direction of the bone growth. 
Consequently, the plane of cell division cuts orthogonal to these axes and parallel with the 
longitudinal orientation of the columns. Thus, following cytokinesis the two daughter cells lie 
side by side having a semicircular shape. Later, they adopt different wedge-shaped stages 
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which allow the cells to expand and glide over each other, finally achieving their flattened 
shape in the same vertical row 83. Subsequently, AW Ham performed light microscopic 
studies on rabbit growth plates and identified additional cell division planes; however, 
diagonally or perpendicularly oriented chondrocyte divisions were much less abundant than 
the parallel ones described by Dodds 84. More recently, the laboratory of Jeffrey Baron used 
transplantation experiments to ectopically place the resting zone perpendicular alongside the 
proliferative zone in the rabbit growth plate 85. It was observed that the ectopic resting zone 
induced a 90° rotation in the orientation of the proliferative zone columns and inhibited 
hypertrophic differentiation. The authors, therefore, proposed that the resting zone may 
secrete a growth plate orienting soluble factor and a morphogen that inhibits terminal 
differentiation. According to their hypothesis, these factors, at least partially, are responsible 
for the columnar and zonal arrangement of growth plate chondrocytes. 
In summary, three levels of structural organization can be observed in the growth 
plate: (1) flattening of the proliferative chondrocytes (cell anisotropy/polarity); (2) their 
alignment at a right axis to the proximal-distal direction of the growth (tissue/planar cell 
polarity); and (3) their columnar stacking along the long axis. Despite the importance of these 
processes in longitudinal growth, the exact mechanisms responsible for growth plate polarity 
remain unknown. However, mouse genetics revealed a plethora of intrinsic and extrinsic 
factors that, in addition to other functions, influence cartilage polarity. In the next chapter, 
these factors will be discussed in detail. 
 
 5.2.4. Regulation of growth plate morphogenesis 
5.2.4.1. Transcription and diffusible factors 
 
The Sox transcription factors. Several molecules are central for cartilage development 
and among them the Sry-related high-mobility group box (Sox) transcription factor Sox9 has 
essential roles to specify the commitment and differentiation of mesenchymal cells toward the 
chondrogenic lineage. In 1994, researchers have identified the human genetic disease 
campomelic dysplasia (CD) as caused by heterozygous mutations in the SOX9 gene leading to 
hypoplasia of all endochondral elements 86. Heterozygous mice, in which a Sox9 allele was 
inactivated, die at birth and show a phenotype similar to human CD 87. During 
embryogenesis, Sox9 is expressed in chondroprogenitors and chondrocytes, except 
hypertrophic chondrocytes, largely overlapping with the expression of collagen II (Col2a1). It 
has been shown that Sox9 binds to regulatory elements of Col2a1, Col11a2, and Aggrecan 
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and together with Sox5 and Sox6, two other members of the Sox family, activate transcription 
of these genes 88-90. Inactivation of both Sox9 alleles in mouse limb-buds prior mesenchymal 
condensation by using the Prx1cre transgene resulted in the complete absence of appendicular 
skeletal elements due to the lack of mesenchymal aggregations, indicating that Sox9 is a 
master gene that controls mesenchyme-chondrocyte transition 91. When Sox 9 was ablated 
after mesenchymal condensation by the Cola1cre transgene, Sox9fl/fl-Col2cre mice developed 
severe chondrodysplasia characterized by impaired proliferation and maturation of 
chondrocytes as well as the diminished expression of the Sox9 downstream targets Sox5 and 
Sox6 91. Gain of function mutants, in which Sox9 was overexpressed in chondrocytes 
(Col2a1/Sox9 knock in), displayed severe inhibition of cell proliferation resulting from 
downregulated cyclin D expression mediated via crosstalk between Sox9 and the Wnt 
canonical pathway (see below) 92. Thus, genetic approaches have clearly identified Sox 9 as 
pivotal factor acting in a dose dependent manner at all stages of endochondral bone 
formation. In addition to its multiple roles in chondrogenesis, Sox9 levels influence polarity 
of the growth plate. In Sox9fl/fl-Col2cre mice, small groups of flattened proliferative 
chondrocytes were found, however they did not organized into orderly columns 91. In 
Col2a1/Sox9 knock in mice, the proliferative chondrocytes were isotropic and lacked an 
apparent orientation in the growth plate region 92.  
The Runx transcription factors. While Sox9 is essential for mesenchymal 
condensation and chondrogenic differentiation, the Runt domain transcriptional activator 
Runx2 (previously Cbfa1) determines the commitment of mesenchymal progenitors to the 
osteoblastic lineage. Mice with targeted inactivation of Runx2 die around birth and, due to the 
complete arrest in osteoblast differentiation, are devoid of bone 93, 94. Mice with heterozygous 
Runx2 mutation are viable and develop a phenotype similar to human cleidocranial dysplasia, 
a skeletal disorder characterized by open fontanelles and short stature 95. Runx2 is expressed, 
in addition to the multipotent mesenchymal cells, in prehypertrophic/hypertrophic 
chondrocytes 96 and plays an important role in chondrocyte maturation. Runx2-/- mice display 
arrest in hypertrophic differentiation in the proximal skeletal limb elements (femur, humerus), 
whereas hypertrophic differentiation is delayed only in the distal elements (e.g. tibia, radius) 
96 97. In contrast, Runx2 overexpression in transgenic mice leads to accelerated hypertrophy of 
normal growth plate chondrocytes, further demonstrating the essential role of Runx2 in 
chondrocyte terminal differentiation 98, 99. It has been shown that Runx2 directly regulates the 
expression of MMP-13, osteocalcin, osteopontin and osteonectin, which are characteristic 
markers for chondrocyte hypertrophy and bone formation 93, 100 (reviewd in 72, 101). 
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Importantly, Runx2-deficiency in the humerus/femur leads to reduced proliferation and the 
lack of growth plate polarity since chondrocytes exhibit a rounded shape and do not organize 
into columns. These defects are extended to the entire limb skeleton in the Runx2/Runx3 
double knockout mice, suggesting the cooperative action of Runx family members on 
chondrocyte proliferation, maturation and organization 102. The regulatory roles of 
Runx2/Runx3 in growth plate chondrocytes are probably mediated, directly or indirectly, via 
the induction of Ihh expression (see below) in prehypertrophic chondrocytes 102, 103. 
The Ihh/PTHrP signaling pathway. Indian hedgehog (Ihh) is a secreted peptide from 
the hedgehog family which co-ordinates chondrocyte proliferation and the onset of 
hypertrophic differentiation by acting either directly on chondrocytes or in a negative 
feedback loop together with the parathyroid hormone related peptide (PTHrP) (Fig. 11) 101. 
During endochondral ossification Ihh is first expressed in the centre of the aggregated 
cartilage templates, later its expression becomes largely restricted to the transitional zone 
between proliferative and hypertrophic chondrocytes (prehypertrophic zone). The secreted Ihh 
acts on both neighboring and distant cells by activating gene transcription via the hedgehog 
signaling system composed of the transmembrane proteins Patched-1 (Ptc1), Smoothened 
(Smo) and the downstream target Gli proteins 104. In the absence of Ihh, Ptc1 keeps Smo in an 
inactive state which allows the Gli transcription factors to be processed to their repressor 
form. Upon binding Ihh, Ptc1 loses its repressive role on Smo leading to the processing of 
Gli1, Gli2 and Gli3 which, depending on the cellular context, act as either transcriptional 
activators or inhibitors 105. Cyclin D1 promotes cell cycle progression through the G1/S phase 
and it has been shown to be expressed at a low level in the cartilage of both Ihh and Smo 
knockout mice indicating that cyclin D1 expression might be mediated directly by Ihh 
signaling 106, 107. Ihh can also directly promote osteoblast differentiation in the perichondrium 
during endochondral ossification 106 as shown by the lack of bone collar in the long bones of 
Ihh-/- mice or in mice in which Smo was conditionally ablated in perichondrial cells 108. In 
addition to the direct effects on proliferation and osteoblastgenesis, the major role of Ihh in 
the developing cartilage is the regulation of the rate of hypertrophic chondrocyte 
differentiation through the stimulation of PTHrP.  
During embryonic development, PTHrP is expressed by perichondrial cells and by 
chondrocytes at the ends of the growing cartilage (periarticular chondrocytes) 109. Its main 
function is to keep the chondrocytes in a proliferative state by diffusing away from the place 
of synthesis and activating PTH/PTHrP receptor (PPR), which is expressed at a low level on  
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Fig.11 Ihh/PTHrP signaling. Ihh is expressed by 
the prehypertrophic chondrocytes (blue cells) and 
upregulates PTHrP expression in the periarticular 
chondrocytes (red cells). PTHrP diffuses back to the 
growth plate and stimulates chondrocyte proliferation 
through interaction with its receptor expressed on the 
proliferative and prehypertrophic chondrocytes (cells 
with red contour). Thus PTHrP slows down chondrocyte 
hypertrophy. In addition, Ihh directly stimulates 
chondrocyte proliferation in the growth plate (horizontal 
arrow), osteoblast differentiation in the perichondrium 
(lateral arrow) and may act independently of PTHrP on 
chondrocyte hypertrophy mediated by BMP and Wnt 
signalling (diagonal arrow). 
 
 
proliferative chondrocytes and at a higher level in prehypertrophic chondrocytes, partially 
overlapping with Ihh expression. The prehypertrophic and hypertrophic chondrocytes which 
are far away from the PTHrP source stop proliferating and start secreting Ihh. Ihh signals back 
and activates PTHrP expression in the periarticular region, which in turn stimulates 
chondrocyte proliferation and inhibits hypertrophy by delaying their differentiation 110. Ihh 
induces PTHrP expression either directly or indirectly through intermediate molecules such as 
the members of the transforming growth factor-β superfamily (TGFβs) and bone 
morphogenetic proteins (BMPs)(Fig.11) 104.  
Several in vivo studies have demonstrated the essential role of Ihh/PTHrP crosstalk in 
coordinating chondrocyte proliferation and hypertrophic differentiation. Ihh-/- mice have 
reduced cartilage elements which are prematurely calcified and do not undergo ossification. 
These mice die at birth due to an insufficiently developed rib cage which causes respiratory 
distress. Growth plate chondrocytes do not organize into columns, they have reduced 
proliferation rate and undergo premature differentiation resulting in an extended hypertrophic 
zone. These defects are accompanied by the abolished expression of PTHrP in periarticular 
chondrocytes. Similarly, genetic inactivation of PTHrP or PPR in mouse cartilage leads to 
reduced chondrocyte proliferation and premature hypertrophic differentiation demonstrating 
the inhibitory role of the PTHrP/PPR pathway on chondrocyte hypertrophy. Collectively, 
these results imply that the Ihh/PTHrP negative feedback loop determines where 
chondrocytes become hypertrophic 107, 109, 111-113. Interestingly, a more recent study 
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demonstrated that overexpressing Ihh in the cartilage of PTHrP-/- embryos accelerates 
hypertrophic differentiation through BMP and canonical Wnt signaling suggesting that Ihh 
could signal independently of PTHrP to promote hypertrophy 114. Furthermore, upregulation 
of Ihh signaling in PPR-mosaic mice accelerated the differentiation of periarticular 
chondrocytes to columnar chondrocytes leading to the elongation of the stacks 115. Hence, Ihh 
signaling also regulates the columnar cell mass independently of PTHrP.  
FGF signaling. Many genetic studies have shown that fibroblast growth factor (FGF) 
signaling is crucial for chondrocyte proliferation and differentiation during endochondral 
bone formation (Fig.12). Several of the 22 FGF ligands and the 4 FGF receptor (FGFR) 
tyrosine kinase molecules are expressed during different stages of endochondral ossification. 
Among them, signaling via FGFR3 is the best studied and understood 116. In human, 
activating mutations in the FGFR3 gene lead to different grades of achondroplasia-like 
dwarfism phenotypes correlating with the degree of FGFR3 signaling activation 117, 118. 
Conversely, deletion of FGFR3 in mice leads to skeletal overgrowth due to increased 
chondrocyte proliferation and reduced hypertrophy 119, 120. Altogether the existing data 
demonstrates that the main function of FGFR3 signaling is to limit chondrocyte proliferation 
and differentiation. These effects are mediated either through direct signaling in chondrocytes 
or indirectly by modulating the Ihh/PTHrP/BMP cascades. FGFR3 inhibits chondrocyte 
proliferation mainly by activating the Janus kinase-signal transducer and activator of 
transcription-1 (JAK-STAT1) pathway. This activation results in the nuclear translocation of 
STAT1 and STAT3, which induces the expression of cell cycle inhibitors such as p21 121. 
Deletion of FGF18 in mice leads to a similar phenotype to that of FGFR3 inactivation, thus 
identifying FGF18 as one of the important ligands for FGF signaling in chondrocytes 122, 123. 
However, other FGFs such as FGF2 and FGF9 have been also reported to be involved in 
skeletal development. FGF9 is expressed in the apical ectodermal ridge in the limb bud and 
lack of its expression in mice leads to a shortening of the proximal skeletal elements. FGF9 
seems to promote chondrocyte hypertrophy at early stages and to regulate vascular invasion in 
the growth plate as well as bone formation 124. Mice lacking FGF2 show only a mild decrease 
in mineral bone density without any morphological defects in their skeleton. The expression 
of other FGFs might compensate for its absence 125. 
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Fig.12 FGFs in cartilage 121. FGF and FGFRs expression through different zones of cartilage GP (R-
reserve, P-proliferative, PH-prehypertrophic H-hypertrophic) FGF18 is one of the most important 
ligands of the FGF receptors. It is expressed in the perichondrium and may signal to FGFreceptors in 
both chondrocytes and osteocytes. Activated FGFR3 inhibits chondrocyte proliferation and 
hypertrophy.  
 
BMPs and TGFβs. Bone morphogenetic proteins (BMPs) together with the 
transforming growth factors β (TGFβs) form the TGFβ superfamily of secreted signaling 
molecules. Based on sequence similarities, BMPs are grouped into several classes including 
the growth and differentiation factor (GDF) subfamily126.  
The role of BMPs in bone development became obvious when they were identified as 
inducers of ectopic endochondral bone formation at implantation sites under the skin or in 
muscle 127. BMPs act through two major types of membrane-bound serine/threonine kinase 
receptors: the type-I and type-II receptors 128. After ligand binding, the active receptors form 
heterotetrameric molecules consisting of two type I and two type II receptors. Type II 
receptors phosphorylate type I receptors, which transmit the signal by phosphorylating the 
receptor-regulated Smad (R-Smad) 1, R-Smad5 and R-Smad8 129, 130. Three type I receptors 
are able to transduce the signal: BMP receptor types IA (BMPRIA), IB (BMPRIB) and 
activin receptor type I (ACTRI). Upon release from the receptors, phosphorylated R-Smads 
recruit and bind Smad 4 forming a heteromeric complex, which translocates to the nucleus 
and together with other factors activates target gene expression. For example, in cooperation 
with Runx2, Smad1 and Smad5 activate type X collagen expression in hypertrophic 
chondrocytes 131, 132. The Ihh promoter contains several Smad binding elements and its 
expression seems to be directly controlled by BMPs 133. Further studies have revealed that 
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BMPs regulate the appearance and shape of mesenchymal condensations and are involved in 
skeletal patterning. Many BMPs have overlapping expression patterns, for example, BMP-2, -
3, -4 and-5 are expressed in perichondrium, BMP-2 and -6 are expressed in hypertrophic 
chondrocytes and BMP-7 is expressed both in proliferating chondrocytes and perichondrium. 
Thus, dissecting the roles of individual BMP molecules in skeletal development is difficult 
due to functional redundancy. Indeed, loss of function mutations of BMP-5, -6, -7 and GDF-5 
produce relatively mild skeletal malformations 126, 134. To overcome the problem of 
compensation, Noggin, a secreted antagonist of BMPs that is expressed in early cartilaginous 
condensations, was manipulated in vertebrate embryos. Both knockout and misexpression 
experiments revealed that Noggin inhibits cartilage condensation and is required for joint 
specification through GDF-5 135, 136. Further supporting the essential roles of BMPs in 
cartilage development, mice lacking both BMPRIA and BMPRIB during chondrogenic 
differentiation display only a few rudimentary skeletal elements, in which chondrocytes never 
organize into a columnar growth plate 137. In addition, Noggin null mice have skeletal 
overgrowth and increased chondrocyte proliferation rate 135, whereas noggin overexpression 
leads to reduced chondrocyte proliferation and growth plate size indicating that BMP 
signaling acts at several steps of endochondral ossification. Additional studies have shown 
that BMPs likely oppose the effects of FGFs and synergize with the Ihh/PTHrP pathway on 
chondrocyte proliferation and differentiation 138, 139.  
TGFβs are synthesized and assembled into an inactive complex with latency-
associated peptide (LAP) and latent TGFβ binding protein (LTBP). This complex is deposited 
into the ECM and, upon proteolytic cleavage or pH changes TGFβ is released and can bind to 
its receptors. Similar to BMPs, TGFβs act through heterotetrameric receptors which activate 
the downstream targets Smads 2 and 3. Active Smads interact with the common Smad4 
forming a complex which is translocated to the nucleus to activate gene transcription 140. 
TGFβs are expressed in prehypertrophic and hypertrophic chondrocytes, in the 
perichondrium, in osteoclasts and in osteoblasts but their role in growth plate function is not 
yet clear 141, 142. Explant culture experiments demonstrated the importance of TGFβ2 in the 
perichondrium to mediate Ihh regulation of PTHrP 143, and the expression of a dominant 
negative type II receptor causes postnatal defects of the growth plate characterized by 
increased collagen X and Ihh expression in the hypertrophic chondrocytes 144. However, 
TGFβ2 knockout mice have a much milder skeletal phenotype than Ihh-/- or PTHrP-/- mice, 
indicating that TGFβ2 is only moderately involved in the regulation of the Ihh/PTHrP loop in 
vivo 145.  
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Wnt signaling pathways. Wnt signaling is another fundamental regulatory system used 
by chondrocytes (Fig. 13). The Wnt signaling network comprises the Wnt secreted ligand 
molecules, specific receptors, antagonists and a large number of intracellular effectors. Three 
major branches are activated downstream of Wnt receptors at the level of Dishevelled 
(Dsh/Dvl): the canonical signaling and two non-canonical pathways. The central line of the 
canonical Wnt cascade is the regulation of the stability of its core component, β-catenin, 
through a cytoplasmic destruction complex which includes Axin, adenomatous polyposis coli 
(APC), and glycogen synthase kinase 3β (GSK-3β). In the absence of Wnt signals, β-catenin 
is captured and N-terminally phosphorylated by the destruction complex, ubiquitinated and 
targeted to the proteosome. Upon Wnt binding to the receptor complex composed of members 
of the Frizzled (Fzd) family of seven transmembrane receptors, serpentine receptors and low 
density lipoprotein receptor-related proteins (LRPs), the activated signaling molecule Dvl 
inhibits the Axin/APC/GSK-3β complex which is disassembled through the binding of Axin 
to phosphorylated LRP5/6. Consequently, the free cytoplasmic β-catenin can translocate to 
the nucleus where it regulates target gene expression through the interaction with the T cell-
specific transcription factor/ lymphoid enhancer-binding factor (TCF/LEF) family of 
transcription factors (reviewed in 146-148). 
The non-canonical pathways are β-catenin independent. Upon activation, the signal 
can diverge into the Wnt/Ca2+ pathway and the planar cell polarity (PCP) pathway. In the 
Wnt/Ca²+ pathway, Wnt binding to Fzd/LRP stimulates intracellular Ca²+ release, which leads 
to the regulation of cell adhesion via the activation of protein kinase C (PKC) and 
calmodulin-dependent protein kinase C (CaMKII) 149, 150. In the PCP pathway, Fzd activates 
the JNK cascade that directs cytoskeletal asymmetry and polarization of cells within a tissue 
plane. Beside the Fzd receptors and the regulator Dvl, the core molecules of the PCP pathway 
include Flamingo (FMI, STAN), Strabismus (STBM, VANG), Diego (DGO) and Prickle 
(PK) which are recruited to the membrane and antagonistically regulate Dvl activity: upon 
signaling, the Fz-Dvl-DGO complex promotes Dvl activation, whereas the STBM-PK 
complex limits Dvl activation. Some of the molecules which are activated downstream of Dvl 
are inturned, fuzzy, Rac1, RhoA, and Rho kinase. In vertebrates, PCP signaling plays 
important roles in morphogenetic processes such as convergent-extension movements or the 
alignment of stereocilia bundles in the organ of Corti 151. 
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Fig.13 Canonincal and noncanonical Wnt signaling pathways 152. Wnt ligands binding to their 
receptors can activate the β-catenin-dependent canonical pathways or the β-catenin-independent non-
canonical, PCP or Ca pathways. 
 
Several recent experiments using conditional loss- and gain-of-function mutations of 
β-catenin in mice explored the important role of canonical Wnt signaling in skeletogenesis. 
Deletion of β-catenin in skeletal progenitors by Prx1cre or Dermo-cre results in arrested 
osteoblast maturation, increased chondrogenesis and ectopic cartilage formation 153-155, while 
gain-of-function mutations of β-catenin in osteo-chondroprogenitors leads to a block in 
chondrogenesis 154. In vitro, β-catenin-deficiency increases the expression of Sox9 and 
induces precocious chondrogenic differentiation in micromass culture, whereas β-catenin 
activation mutations reduce Sox9 level and suppress chondrogenesis 154. These data indicate 
that the canonical Wnt/ β-catenin pathway negatively regulates chondrocyte differentiation 
from mesenchymal progenitor cells. Furthermore, mice with stabilized β-catenin in 
chondrocytes display reduced proliferation and delayed hypertrophic differentiation 
accompanied by the loss of growth plate polarity. These defects phenocopy the abnormalities 
of mice overexpressing Sox9 in chondrocytes suggesting direct genetic interaction between 
the two signaling systems 92. Furthermore, it has also been shown that β-catenin binds to the 
C-terminal transactivation domain of Sox9, and this interaction controls the relative levels of 
both Sox9 and β-catenin, which in turn regulates chondrocyte differentiation and survival 92. 
Finally, it has been demonstrated that β-catenin signaling acts downstream from Ihh during 
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osteoblast differentiation, while β-catenin acts upstream of Ihh to inhibit chondrocyte 
apoptosis 156.  
In contrast to the Wnt/β-catenin pathway, the roles of noncanonical cascades in 
skeletogenesis are less well defined. Wnt5a is a representative of the noncanonical pathways-
activating Wnts and its dysfunction leads to dysregulated convergent extension during 
vertebrate gastrulation 157. In the developing limb, Wnt5a inhibits the canonical pathway by 
promoting β-catenin degradation 158. It was shown that Ror2, an alternative Wnt receptor, is 
required for Wnt5a effects on both the noncanonical and canonical signaling pathways 159, 160. 
Mice lacking or overexpressing Wnt5a in chondrocytes exhibited defects in chondrocyte 
proliferation, differentiation and growth plate polarity 161. Ror2-deficient mice display similar 
skeletal phenotypes 160, 162 indicating the importance of noncanonical Wnt/frizzled signaling 
in growth plate morphogenesis. Corroborating evidence has come from a recent study in 
which the members of the noncanonical Fzd pathway were manipulated in retroviral-infected 
embryonic chick legs 163. Disruption of the noncanonical pathway by overexpressing a 
truncated form of Fzd7, which blocks frizzled signaling, resulted in chondrocyte 
misorientation in the proliferative zone, whereas the expression of constitutively active 
CamKII led to chondrocyte rounding.  
These data collectively show that canonical/noncanonical Wnt pathways have both positive 
and negative regulatory effects on cartilage development. However, further studies are 
required to fully understand the roles of Wnt signaling network during skeletogenesis 150, 152. 
 
5.2.4.2. The primary cilium and endochondral bone formation 
 
Cilia (or flagella) are specialized organelles that project from the surface of most 
eukaryotic cells. They originate from the plasma membrane-associated basal body during 
interphase and are made of microtubule-based axoneme surrounded by a bilayer lipid 
membrane. Axoneme are generated through the process of intraflagellar transport (IFT), a 
bidirectional transport system mediating the movements of large protein complexes (IFT 
particles). The anterograde transport directs structural components from the cell body to the 
axoneme driven by kinesin-2 motors, whereas the retrograde transport returns proteins from 
the cilium driven by a dynein motor. Cilia can be classified as “motile” characterized by an 
axoneme consisting of nine doublets of microtubules arranged around a central microtubule 
pair (9+2), or as "non-motile” or primary cilia, which lack the central microtubule pair (9+0). 
Primary cilia function as cellular antennae that sense a broad range of chemical and 
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mechanical signals important for smell, sight and mechanoreception. Defects in their normal 
structure and function are associated with congenital human syndromes with multiple defects 
in kidney, retina and skeleton. The mechanical function of the cilium was studied mostly in 
kidney cells. It has been shown that cilia on renal cells play a role in transmitting mechanical 
signals by sensing fluid shear stress and responding with changes in the concentration of 
cytosolic Ca²+. Defective Ca²+ channel proteins policystin-1 and -2, which are localized in the 
cilium membrane fail to transmit essential signals for normal renal cell polarity, growth and 
differentiation, and mutations in either genes (PC1 or PC2) cause polycystic kidney disease 
164, 165. 
The chondrocyte has an immotile cilium, which was proposed to bend in response to 
mechanical forces transmitted through the cartilage ECM 166. Confocal microscopy studies 
suggest that cilia on columnar chondrocytes originate from the center of the cell between 
Golgi and nucleus 166. Mathematical studies have attempted to describe a certain pattern in 
cilium orientation in different types of cartilage 167, however strictly polarized cilia alignment 
was not verified experimentally. 
The importance of primary cilia in transmitting chemical signals was revealed 
relatively recently in mice lacking components of IFT. The defects all converged onto 
abnormal hedgehog signaling, suggesting that cilia coordinate Hh functions in mammals 168, 
169. Indeed, several components of Hh signaling including the Smo/Ptc1 complex and Gli 
proteins are localized to the cilia 170. In the absence of Shh or Ihh, Smo is localized on 
intracellular vesicles and its function is repressed by Ptc1. At the same time, transcriptional 
repressor forms of Gli proteins move from the cilium into the nucleus and silence Hh 
transcription. In the presence of Hh proteins, Ptc1 leaves the cilia allowing the accumulation 
of active Smo in the cilium, which in turn activates gene transcription through the 
transcriptional activator forms of Gli proteins 171. 
The strong connection between cilia function and Ihh signaling during endochondral 
bone formation is reflected in the skeletal phenotype of mice with mutations in IFT 
components. Mice with a conditional ablation of Ift88 (intraflagellar transport protein 
88/Tg737/polaris), a core component of IFT particles, or Kif3a (a subunit of heterotrimeric 
kinesin 2 motors involved in anterograde transport) show several abnormalities during 
endochondral ossification depending on the time of deletion. When IFT88 or Kif3a were 
deleted in the osteo-chondroprogenitors of early limb bud, mice had short bones associated 
with accelerated hypertrophic differentiation, delay of vascular invasion and the lack of bone 
collar 172. In addition, Ptc1 and Gli expression was reduced both in the perichondrium and in 
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the chondrocytes indicating disrupted Ihh signaling. When deletion of Ift88 and Kif3a was 
restricted to chondrocytes by using the chondrocyte-specific Col2a1cre transgenic line, the 
embryonic development of long bones was surprisingly normal but starting from postnatal 
day 7, the mutant growth plates showed signs of degeneration. By postnatal days 10, the 
columnar organization of the proliferative zone was severely altered characterized by 
chondrocyte rounding and column misorientation, which was accompanied by altered pFAK 
localization and an abnormal actin cytoskeleton. The observed defects were apparently 
independent of Ihh signaling suggesting an additional function of the cilia in maintaining the 
columnar organization after birth 173. Cilia were proposed to interact with the ECM through 
β1 integrins, which have been localized to the cilia in chondrocytes 174. These findings 
corroborated in vitro studies showing defects in adhesion and spreading of renal epithelial 
cells lacking ciliary proteins, raising the possibility of a link between primary cilia and 
integrin mediated adhesion 166.  
 Besides the role in hedgehog signaling, several studies have attributed a role for cilia 
in the planar cell polarity pathway. Two proteins which are known to be essential for 
ciliogenesis, inversin and Bardet-Biedl Syndrome protein 4 (BBS4) were implicated in PCP 
signaling 175, 176. Worth noting, the inactivation of two PCP effectors encoded by the Inturned 
and Fuzzy genes leads to defective ciliogenesis in the amphibian Xenopus laevis. As a 
consequence, the mutant embryos exhibited a phenotype which reflects a failure of hedgehog 
signaling due to lack of primary cilia. Importantly, the PCP-dependent convergent extension 
movements of cells of the Meckel’s cartilage were disrupted resulting in the loss of columnar 
structures. This observation was consistent with the phenotype caused by the dominant-
negative PCP-specific mutants dishevelled and Frizzled 8 177. It seems that both Inturned and 
Fuzzy control the assembly of an apical actin network that is essential for normal orientation 
of ciliary microtubules. However, the exact mechanisms involved in PCP/ciliogenesis 
crosstalk are not completely understood. 
 
5.2.4.3. The impact of ECM proteins on cartilage development 
 
Cartilage is characterized by an elaborated and complex ECM, which is secreted by a 
relatively low number of chondrocytes. The ECM contains collagens, proteoglycans, and non-
collagenous glycoproteins that are organized into specific marcromolecular assemblies 
providing the tissue with its specific mechanical properties such as mechanical strength and 
elasticity. Furthermore, the cartilage ECM gives a physical framework for chondrocytes and 
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serves as storage source of growth factors and morphogens. Several lines of evidence suggest 
that collagen fibrils and proteoglycan aggregates contribute essentially to the establishment 
and maintenance of normal growth plate structure. The homotrimeric collagen II accounts for 
about 95% of the total collagen content in hyaline cartilage. Mutations in the COL2A1 gene 
encoding collagen II leads to various hereditary skeletal disorders in human with severity 
ranging from moderate to lethal. Mice lacking collagen II die at birth and develop a 
cartilaginous skeleton without significant endochondral bone formation 178. Although, the 
chondrocytes deposit collagen I instead of collagen II, the collagen fibrils are sparse and not 
organized into a network 178. Interestingly, Col2a1-null proliferative zone chondrocytes are 
flattened and oriented properly in early (E13-E14) cartilage templates (A. Aszodi unpublished 
information). At later stages, however, the chondrocytes become disoriented and never 
organize into columns 178. Similarly, the naturally occurring cho/cho mice, harbouring a 
premature stop codon at the N-terminal region of the α1(XI) chain of collagen XI, die at birth 
due to breathing difficulties and display a reduced number of abnormally thick fibrils in the 
cartilage matrix leading to a severely disorganized growth plate with no columns 179. Mice 
with a targeted inactivation of the Col9a1 gene encoding the α1 chain of collagen IX are 
viable but develop degenerative changes of the articular cartilage 180. Although growth plate 
abnormalities were not reported in the original publication, recent studies indicate age-
dependent disorganization of the proliferative zone 181 182; (A. Aszodi unpublished). While the 
initial elongation and alignment of chondrocytes is normal in Col9a1-/- embryos, newborn 
mice exhibit rounded and misoriented cells that become normalized again in 8-weeks old 
animals. Taken together, these mice imply that the collagen network is not required for the 
establishment of early growth plate polarity, but they are necessary for its stabilization and for 
columnar alignment of chondrocytes.  
 The lack of functional aggrecan in the spontaneous mutant cmd/cmd mouse strain 
leads to perinatal lethality owing to cleft palate and severe impairment of endochondral bone 
formation characterized by compression of the cartilage ECM, disorganization of the growth 
plate and alterations in the expression pattern of cartilage specific genes 183, 184. The binding 
of aggrecan to hyaluronan is stabilized by the link protein, a glycoprotein showing structural 
similarities to the G1 domain of aggrecan. Link protein knockout mice display similar but 
milder chondrodysplasia than cmd mice. Newborn mutants have abnormal growth plate with a 
proliferative zone lacking columnar structures and intermingled prehypertrophic and 
hypertrophic zones 185. Perlecan is a heparan-sulfate proteoglycan which is present in the 
growth plate as well as in the articular cartilage. Perlecan null mice die at two stages: at E 
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10.5-12.5 due to basement membrane defects and perinatally due to respiratory failure caused 
by severe chondrodysplasia. The growth plate of the mutants is disorganized associated with 
impaired chondrocyte proliferation, differentiation and endochondral bone formation 186, 187. 
 
5.2.4.4. Integrin expression and function during endochondral ossification 
 
The ECM receptors on chondrocytes include integrins, syndecans and hyaluronan 
receptor, CD44. The integrins expressed on growth plate or articular cartilage chondrocytes 
are the collagen receptors α1β1, α2β1 and α10β1; the RGD receptors α5β1, αvβ3 and αvβ5; 
and the laminin receptor α6β1. The roles of integrins in cartilage development were first 
studied in culture systems. In high density micromass culture, which recapitulates several 
steps of chondrogenesis, β1 integrin blocking antibodies were shown to prevent the formation 
of cartilaginous nodules implying that integrins may be important for the transition from 
mesenchymal cells to chondrocytes 188. In chicken sternal organ culture, blocking β1 integrin 
resulted in reduced growth, increased apoptosis and abnormal organization of the actin 
cytoskeleton 189.  
A major breakthrough in understanding the roles of β1 integrin during skeletogenesis 
came from a genetic study of mice in which β1 integrin was deleted in chondrocytes using the 
Col2a1cre transgene 190. β1 integrin-deficient mice develop severe chondrodysplasia leading 
to perinatal lethality of most mutant animals. The major phenotypes of the β1fl/fl-Col2a1cre 
mice can be summarized as follows: 
1) Destroyed growth plate polarity. The columnar arrangement of proliferative 
chondrocytes was completely missing in the mutants accompanied by cell rounding. The 
defects in chondrocyte shape and rotational movements are probably the consequence of loss 
of adhesion to collagen II, to laminin and, partially, to fibronectin. 
2) Abnormal actin cytoskeleton. The role of β1 integrin in actin network remodelling 
was demonstrated by the inability of mutant chondrocytes to spread and form proper stress 
fibers when cultured in vitro. In addition, β1-deficient chondrocytes in vivo displayed a 
punctuated cortical actin network, while control cells had an even cortical actin distribution.  
3) Cytokinesis defect. Mutant cartilage contained increased number of chondrocytes in 
the G2/M phase of the cell cycle which were frequently binucleated indicating a defect in 
cytokinesis. During cell division, both adhesion-generated pulling forces and actomyosin ring 
constriction at the cleavage furrow are required to separate the two daughter cells. Thus 
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reduced adhesion and the abnormal actin network observed in the β1-null cells might account 
for defective cytokinesis of chondrocytes. Interestingly, a very recent study suggests that 
Rab21-mediated trafficking of integrins to and from the cleavage furrow is necessary for 
normal cell division providing adhesive and signaling cues during telophase 191. 
4) Reduced chondrocyte proliferation and increased apoptosis. BrdU incorporation 
assay and cyclin D expression analysis demonstrated progressive proliferation defects, 
whereas TUNEL assay showed a slightly increased apoptotic rate in the mutant cartilage. A 
significant portion of β1-null chondrocytes exhibited impaired G1/S transition probably 
caused by increased Fgfr3 expression, which in turn increased the nuclear translocation of 
Stat1/Stat5 and elevated the expression levels of cell cycle inhibitors p16 and p21. 
5) Abnormal collagen matrix assembly. Electron microscopy of mutant limb cartilage 
specimens showed a reduced density of collagen fibrils in the proliferative and hypertrophic 
zones compared with that of controls. Moreover, collagen fibrils assembled in bundles of 
variable diameter, implying that β1 integrins control collagen fibrillogenesis. 
6) Cartilage differentiation: β1-deficient growth plates have decreased hypertrophic 
but increased prehypertrophic zones as shown by Collagen X, Ihh and PTHrP localization. 
The underlaying mechanisms of the differentiation defect are not completely understood but 
β1-matrix interactions may directly control hypertrophic differentiation or the disorganized 
matrix network could affect diffusion of soluble morphogens important for this process.  
Collectively, these findings clearly demonstrate that β1 integrin-mediated adhesion 
plays crucial roles in cartilage morphology and function regulating chondrocyte proliferation, 
survival, differentiation, cytokinesis and ECM assembly. The importance of integrins in 
endochondral bone formation was further demonstrated by two additional genetic studies. 
Mice deficient in the major collagen-binding integrin α10β1 are viable but develop 
progressive growth retardation 192. α10-null mice exhibit defects in chondrocyte/growth plate 
polarity, cell proliferation and survival as well as in collagen fibril distribution resembling the 
abnormalities of the β1fl/fl-Col2a1cre mice, however, the defects are milder suggesting a 
partial redundancy among the various β1 integrin heterodimers expressed on chondrocytes. 
Integrin-linked kinase (ILK) is associated with the cytoplasmic domain of β1/β3 integrins. 
Cartilage-specific deletion of ILK also results in “β1 null-like” abnormalities suggesting that 
integrin signaling through ILK may contribute to the skeletal phenotype of β1fl/fl-Col2a1cre 
mice 193.  
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 5.3. The articular cartilage 
 
Diarthroidal joints ensure load transmission within skeletal structures and coordinate 
their movement. Diarthroidal joints unite different types of tissues to exert their specific 
functions: the opposing bones are covered with articular cartilage and are separated by a joint 
cavity enclosed in a capsule linking the skeletal elements. The capsule is lined by a synovial 
membrane (synovium) that secretes synovial fluid which lubricates and provides nutrition to 
the joint’s components. Most capsules are strengthened by tendons and ligaments which can 
be arranged around the capsule or can be found inside the joint like the cruciate ligaments of 
the knee joint 194. 
 Below, a brief overview of the normal and diseased articular cartilage will be 
presented. More detailed information can be found in our recent review presented as Paper II. 
 
 5.3.1. Morphology of the normal articular cartilage 
 
Articular cartilage (AC) is a specialized, type of hyaline cartilage, which covers the 
ends of the long bones and persists for the entire life of the organism 195. It functions as a load 
bearing tissue and can resist shearing forces and friction 196. AC is characterized by a high 
degree of anisotropy and is divided into four zones with distinct organization of the matrix 
and cells: the superficial (tangential), intermediate (transitional), deep (radial) and calcified 
zone (Fig. 15). The superficial zone is the thin, outermost layer of cartilage facing the joint 
cavity. It contains densely packed collagen fibrils arranged parallel to the surface and a layer 
of flat cells, which elongate in the same direction as the fibrils. The chondrocytes of this zone 
synthesize less aggrecan but more small proteoglycans such as biglycan and decorin. The 
intermediate zone contains individual spherical cells and a relatively disorganized collagen 
network. This zone stains intensively with cationic dyes due to its high chondroitin sulphate 
concentration. In the deep zone the chondrocytes tend to organize into chondrons oriented 
perpendicular to the surface resembling the columns of the growth plate. The extracellular 
matrix is rich in proteoglycans and the collagen fibrils form radial bundles which extend into 
the calcified zone. The calcified zone is a physical and mechanical barrier between cartilage 
and subchondral bone and its main function is to anchor the cartilage to the bone. It consists 
of mineralized matrix containing collagen X and hypertrophic chondrocytes and is separated 
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from the noncalcified upper zones by a tidemark, which represents the mineralization front 194, 
196, 197. 
 The specific biomechanical function of the articular cartilage is confined to the 
structure and organization of the matrix molecules produced by a sparse population of cells. 
The structural scaffold, which confers strength and resilience, is composed of a fibrillar 
network of collagens, mainly collagens II and XI and the associated collagens IX and VI 198. 
The collagen network entraps proteoglycans (e.g. aggrecan) rich in polyanionic 
glycosaminoglycan chains, which creates an osmotic pressure that draws water into the tissue 
and expands the collagen network 199. Several noncollagenous proteins such as fibronectin, 
cartilage oligomeric matrix protein protein (COMP), decorin, biglycan, matrilins, 
fibromodulin, cartilage intermediate layer protein (CILP), chondroadherin and others are 
required for the proper assembly of this complex network (Fig.15). The correct balance 
between tensile strength and osmotic pressure conferred by the collagen and proteoglycans, 
respectively, are essential for AC physiology. Therefore the continuous and tightly controlled 
metabolism of the matrix is the main task of the chondrocytes, which can respond to direct 
biomechanical perturbations by secreting various matrix remodelling and signaling molecules 
200. 
 Proteolysis of the ECM is a normal feature of cartilage remodelling and several 
enzymes are implicated in this process including metalloproteinases (MMPs) and 
aggrecanases. In cartilage, MMP-13 is the major collagenase, which is able to degrade the 
native collagen triple helix, whereas MMP-2 and -9 (gelatinases) further degrade the 
predigested collagen fragments. MMP-3 (or stromelysin) together with ADAMTS (a 
disintegrin and metalloproteinase with trombospondin motifs) -4 and -5 are the major 
aggrecan degrading enzymes in AC. An imbalance in the anabolic and catabolic activities of 
the cartilage leads to various pathological conditions, including osteoarthritis 201. 
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Fig.15. Articular cartilage organization and the principal components of the ECM 202. AC is composed 
of chondrocytes and ECM organized into distinct morphological and functional zones. Three classes of 
proteins exist in AC ECM: collagens (mostly type II collagen); proteoglycans (primarily aggrecan); and 
other noncollagenous proteins (including link protein, fibronectin, cartilage oligomeric matrix protein) 
and the smaller proteoglycans (biglycan, decorin and fibromodulin) 
 
 5.3.2. Osteoarthritic articular cartilage 
 
Osteoarthritis (OA) is a common, age-associated disease that causes significant 
functional impairment, pain, inflammation, stiffness and loss of mobility in the elderly. It is 
characterized by degeneration of AC, which in more advanced cases is accompanied by 
limited intra-articular inflammation with synovitis (inflammation of the synovial membrane) 
and in the worst cases by cartilage erosion and exposure of subchondral bone 203, 204 (Fig. 16). 
There are several factors involved in OA aetiology: aging, genetic factors, obesity, gender and 
biomechanical stress 203, 204. These factors alone or in combination can initiate the disease 
through the activation of stress induced pathways, cytoskeletal changes and, in case of aging, 
production of reactive oxygen species (ROS) and accumulation of advanced glycation 
products (AGEs) 204. Although the articular cartilage is thought to be the central tissue for the 
initiation and the progression of OA, the other elements of the joints (synovial membrane, 
ligaments and tendons, and subchondral bone) contribute equally to the disease process 205. 
The first, morphological indication of pathological changes is the appearance of small 
lesions in the superficial zone of AC associated with increased denaturation and loss of type II 
collagen fibrils. As a consequence of the damaged collagen network, the entrapped 
proteoglycans such as aggrecan, decorin and biglycan are depleted from the matrix, ultimately 
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leading to biomechanical and functional impairment of the AC. However, the exact order in 
which an ECM component (collagen network or proteoglycans) is degraded is still 
controversial. The initial damage is causeing an increase in MMP activity, which amplifies 
further ECM degradation. The chondrocytes sense AC destruction through their numerous 
ECM receptors and attempt to repair the lesion by increasing their anabolic and catabolic 
activities. The change in their metabolic status is accompanied by a change in the repertoire of 
gene expression: growth factors such as insulin growth factor-1 (IGF-1), proinflammatory 
cytokines (interleukin-1, -6, tumor necrosis factor-α), and nitric oxide synthase are 
upregulated in osteoarthritic cartilage. Furthermore, ECM molecules atypical for AC such as 
collagen I and III are synthesized by the chondrocytes during the progression of OA. In 
addition, ECM degradation products (fibronectin and collagen fragments) further stimulate 
the chondrocytes to produce MMPs through cell surface receptor signalling (see below). 
Despite the increase in anabolic activity, the metabolic balance favours catabolism and the 
attempt by chondrocytes to repair the cartilage is unsuccessful, leading to further cartilage 
damage 204, 206-208. In the calcified zone, a series of additional pathological changes occur: 
tidemark duplication and the presence of fibrous cartilage that often advances into the non-
calcified regions. The changes described above cause the softening of the cartilage and 
wearing and tearing produce deeper lesions in the cartilage and eventually complete AC 
erosion 209. Although OA is not an inflammatory disease, the synovium often becomes 
inflamed as a result of cartilage breakdown. Synovitis is usually confined to areas close to the 
cartilage and can further accelerate cartilage damage in OA by producing proinflammatory 
cytokines capable of inducing MMPs expression 204. 
As the cartilage breaks down, changes occur in the underlying bone, which thickens to 
form bony outgrowths, or osteophytes, that usually appear at margins of the joint. It is still 
controversial if these structures are beneficial or harmful: they may help to stabilize the joint 
or they may cause more pain and damage to the innervated neighbouring tissues (synovium, 
joint capsule, ligaments and meniscus). Osteophytes are formed through a process which 
recapitulates endochondral ossification under the control of TGFβ and bFGF signaling. In 
advanced stages of OA, necrosis of the bone occurs which lead to presences of the cysts in 
subarticular bone 204, 209. 
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Fig.16. Normal and osteoarthritic cartilage 209. Fibrillated cartilage, bony outgrowth, subchondral 
sclerosis as well as synovial inflammation are common features of osteoarthritis. 
 
 
 5.3.3. The role of β1 integrin in articular cartilage functions 
 
Integrins are the major ECM receptors on AC chondrocytes that are believed to act 
both as signal transducers and as mechanoreceptors responding to physical forces exerted 
through the matrix. Despite their anticipated importance, our knowledge about the actual roles 
of integrin-mediated adhesion and signaling in AC physiology is limited. To date, only a few 
studies have attempted to address this important question. The collagen binding α1β1 integrin 
is expressed at a low level on chondrocytes of the normal AC but its expression is up-
regulated during OA suggesting that α1β1 may be involved in repair processes. Indeed, mice 
lacking the α1 subunit display early onset osteoarthritis characterized by increased MMP-2 
and -3 expression, proteoglycan loss, synovial hyperplasia and reduced cartilage cellularity 
210. 
Numerous reports have shown that fibronectin (FN) and collagen fragments are 
released in arthritic cartilage as a result of increased catabolic activity and these fragments can 
further mediate joint destruction. Treatment of cultured synovial fibroblasts with the central, 
cell-binding 120kDa FN fragment or with blocking antibodies to α5β1 integrin was shown to 
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stimulate expression of MMP-1 and MMP-3211. Similarly, when the 120 kDa FN fragment or 
activating antibodies against α5β1 or α2β1 were added to primary human chondrocytes, the 
expression of MMP-13 was upregulated. Mechanistically, the activation of α5β1 integrin 
induces PKC-delta, which in turn phosphorylates the non-receptor tyrosine kinase PYK2 212, 
resulting in increased MAP kinase signaling and increased phosphorylation of c-jun and 
nuclear factor-κb inhibitor 213. Moreover, treatment with antisense oligonucleotides to α5 
reduced the ability of bovine chondrocytes to degrade proteoglycans in response to 120kDa 
cell-binding, 29kDa heparin binding or 50kDa gelatine binding FN-fragments 214. Beside 
degradation fragments, collagen itself is able to induce MMPs expression upon integrin 
binding. In the chondrogenic cell line MC615, type I collagen stimulates expression of 
MMP13 via the activation of ERK and JNK MAP kinases. In the presence of blocking 
antibodies against the α1 or β1 subunit the induction of MMP13 expression is inhibited 215.  
Taken together, the upregulation of MMPs expression in response to matrix products 
suggests an amplifying effect of integrin-mediated interactions in OA progression. However, 
the contradictory results from in vivo and in vitro experiments call for more detailed analysis 
of integrin signaling during OA. 
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 5.4. Atomic force microscopy (AFM) 
 
The first atomic force microscope (AFM) was developed in 1986 by Binnig. AFM is 
an unconventional microscope because it does not use any lenses to create an image. Instead, 
a sharp stylus at the end of a long cantilever detects the contours of an object as the tip scans 
over the sample. Cantilever deflection is monitored by a fine laser beam that is reflected at 
distal end of the cantilever and whose motion is registered by a position-sensitive photo-diode 
(Fig.17). In high resolution imaging, the force between the tip and the sample is kept constant 
and as small as possible to minimise sample deformation. Thus the AFM senses the sample 
surface height as a function of position producing a quantitative 3D map of the surface from 
the mm to the nm scale. 
Indentation-type (IT) AFM it is used to measure the mechanical properties of a 
sample, for example its compressive stiffness. When AFM is operated in the force mode, the 
specimen is pushed against the tip by the position transducer while monitoring the deflection 
of the cantilever. Depending on the stiffness of the specimen, the indentation of the tip into 
the sample is more or less deep for a given Z-displacement of the position transducer. In this 
way, the stiffness (or dynamic elastic modulus) of the sample can be calculated from a 
“displacement-deflection” curve. The steeper the “displacement-deflection” curve the stiffer 
the sample 216. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.17. Principle of atomic force microscopy (courtesy of Dr. Martin Stolz) 
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 IT-AFM was recently proven to be a valuable tool in evaluating biomechanical 
properties of the cartilage. Normal and enzymatically digested porcine cartilage stiffness was 
measured at both the micrometer and nanometer scale. The micrometer scale measurements 
gave information about elastic modulus of cartilage as a multi-compound biomaterial and 
individual chondrocytes embedded in a compact ECM can be observed. At the nanometer 
scale, AFM operated in the scanning mode were able to resolve individual collagen fibrils and 
the supramolecular organization of cartilage was visualized. In the force mode, the 
compressive stiffness measurements showed a 100 to 500 fold lower elastic modulus 
compared to that of the micrometer scale. Moreover, the enzymatically digested cartilage, 
which mimics osteoarthtritic cartilage, exhibited significant stiffening detectable only at the 
nanometer scale 217. Thus IT-AFM, can principally be used to measure biomechanical 
properties of normal and damaged articular cartilage as well as to detect early molecular 
changes at the cartilage surface associated with cartilage pathologies.  
 
 
41 
Aim of the thesis 
 6. Aim of thesis 
 
Recently, β1 integrins emerged as essential regulators of mitotic spindle orientation in 
polarized epithelial cells. In basal keratinocytes, integrins are involved in the establishment of 
apical-basal polarity and in proper orientation of the division plane. Similarly, in mammary 
gland epithelium as well as in Drosophila follicular cells integrins are required for proper 
orientation of the mitotic spindle and consequently the proper location of the daughter cells. 
In metaphase, cultured cells orient their spindle parallel to a surface coated with β1 integrin 
ligands, and along the cell’s long axis which is established in interphase. However, in 
mesenchymal cells such as chondrocytes the role of β1 integrin in proper orientation of the 
division plane was not previously addressed. Mice lacking β1 integrin in cartilage have a 
disorganized growth plate lacking columns and chondrocytes display adhesion, spreading and 
cytokinesis defects. These data led to the hypothesis that β1 integrin might be involved in 
mitotic spindle orientation and column formation during growth plate development. In the 
first paper, we addressed the role of β1 integrin in mitotic spindle orientation using both 
genetically modified mice, which lack β1 integrin on chondrocytes, as well as wild type and 
β1-deficient chondrocytes cultured on various ECM substrates. 
Next, we were interested in the role of β1 integrin-mediated cell-matrix interactions in 
the functions of adult knee joints. Several studies have attempted to clarify the contribution of 
integrins to articular cartilage morphogenesis and function but the present information is still 
contradictory. In vivo, genetic ablation of the α1 subunit in mice causes age-dependent 
osteoarthritis with early signs of proteoglycan depletion and increased cartilage degradation 
accompanied by MMP-2 and MMP-3 expression. Fibronectin and collagen fragments, present 
in synovial fluid and cartilage of osteoarthritic patients, have been previously suggested to be 
β1 integrin-dependent stimulators of catabolic activities in chondrocytes. To assess the role of 
integrins in knee joint formation, function and articular cartilage metabolism we analyzed the 
phenotype of mice which lack β1 integrins in the limbs. 
Furthermore, we participated in a study aiming to develop a tool for detecting early 
physical changes in cartilage pathologies. Osteoarthritis is a degenerative joint disease found 
mostly in older people. It is characterized by the destruction of articular cartilage starting 
from small injuries at the joint surface followed by progressive cartilage erosion and bone 
damage. Currently, diagnostic methods such as radiography, MRI and macroscopic 
examination detect pathological changes at a more advanced stage of the disease, when 
strategies to prevent further damage are no longer applicable. IT-AFM was previously 
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employed for determining mechanical properties of biomaterials such as pig cartilage and 
gave good results in resolving fine structural details of the cartilage macromolecular structure. 
Therefore, for this study we used nano-scale IT-AFM to detect early osteoarthritic changes in 
normal and diseased samples from both humans and genetically modified mice, which were 
previously described to develop age-dependent OA. 
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 7 Brief summaries of the publications 
 
7.1 PAPER I:  β1 integrin-dependent cell shape governs mitotic spindle 
positioning in growth plate chondrocytes 
Growth plate cartilage is a specialized and polarized structure, which is responsible for 
growth of the long bones during endochondral ossification. It is organized in morphologically 
distinct zones, which reflect the differentiation stages of the chondrocytes. In the proliferative 
zones the chondrocytes are flattened and arrange into stacks. The long axes of the cells are 
oriented perpendicular to the longitudinal axis of the bone. The mechanism of column 
formation was investigated initially by Dodds who proposed that when the flattened cells 
divide the spindle is oriented perpendicular to the proximo-distal (P-D) axis of the bone and 
along the long axis of the cell. Upon division, the two daughter cells initially lie side by side 
and then migrate and rotate on top of one other. In mice with β1 integrin deficient 
chondrocytes, the columnar structure is lost due to cell rounding and impaired intercalation 
movements caused by diminished chondrocytes anchorage to the ECM. Cell division 
orientation is a well known mechanism implicated in tissue morphogenesis. Recently, 
integrins have been described to play a major role in epithelial tissue polarity by determining 
the mitotic spindle orientation and thus the spatial localization of the daughter cells. 
 To understand the role of β1 integrin in growth plate morphogenesis, we mated mice 
carrying β1 floxed alleles with mice expressing a Cre recombinase under the control of either 
the Prx1 or Col2a1 promoters. First, we analyzed the early morphogenetic process of the wild 
type growth plate starting from initial stages of cartilage formation. We observed that 
chondrocyte shape anisotropy and tissue polarity is established very early during 
development. Thus, from E12 the cells become progressively flatter and by E14 short stacks 
containing 2-3 discoid cells are already present in the presumptive growth plate. Spindle 
alignments and division axes were examined in these mice in vivo by fluorescence confocal 
microscopy. At E12, early metaphase spindles were randomly oriented, whereas late ana- and 
telophase spindles showed a tendency to orient along the long axis of the cell and 
perpendicular to the P-D axis of the bone. The tendency toward perpendicular orientation of 
the late spindle increases with developmental stage and consequently with the degree of 
flattening. By late stages of development the metaphase spindles also tend to align parallel to 
the long axis of the cells suggesting that the orientation of elongated chondrocytes determine 
spindle orientation independent of guiding cortical cues. In contrast, β1 integrin-null 
chondrocytes are round and both late and early spindles are misaligned, leading to random 
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cleavage planes. Prx1cre-mediated deletion of β1 integrin leads to mosaicism in the β1fl/f-
lPrx1cre mice and the growth plates of these mice contain both β1 positive and negative cells. 
The rare positive cells are flat, oriented and can form columns demonstrating that β1 controls 
shape and polarity in a cell autonomous manner. In vitro studies have shown that in Hela cells 
that are rounding up during mitosis, β1 integrin controls metaphase spindle orientation 
parallel to the substratum independently of the cellular geometry. To test if this is the case in 
more adhesive cell types, we used wild type and β1-deficient chondrocytes and cultured them 
on collagen, fibronectin or vitronectin. Wild type chondrocytes were able to spread on FN and 
VN and consequently oriented their spindle parallel to the substrate. On collagen, the cells 
were round and they showed a random orientation of the spindle. Similarly, mutant 
chondrocytes spread on vitronectin via αvβ3 and oriented their spindle parallel to the culture 
dish. In contrast, mutant chondrocytes were round on fibronectin and collagen and the 
spindles were randomly aligned. Altogether, our data suggest that geometrical constrains 
established and maintained by β1-mediated adhesion provides a default guiding cue for the 
orientation of the spindle and division apparatus in chondrocytes both in vivo and in vitro. 
 
7.2 PAPER II:  Knock-Out Mice in Osteoarthritis Research 
Various animal models have been used to study the complex etiology and pathological 
features characteristic for osteoarthritis. Of these, genetically modified mice have proved to 
be one of the most powerful tools to dissect the mechanisms involved in OA. Conditional 
targeting additionally increased the number of strains available for OA studies. In this paper, 
we reviewed the mouse strains with naturally occurring mutations as well as transgenic and 
knockout mice which have contributed to our understanding of OA pathology. Important data 
came from mice deficient in proteolytic enzymes and their inhibitors, which demonstrated 
that a proper balance must exist between matrix synthesis and degradation, contradicting the 
solely destructive role previously attributed to MMPs. ECM composition and assembly as 
well as the proper interaction of ECM proteins with cellular receptors are essential for normal 
cartilage function as demonstrated by numerous OA mouse models with ablation in genes 
coding for various matrix molecules or cell surface receptors. Mice which lack or overexpress 
signaling molecules like cytokines and growth factors develop more severe or accelerated AC 
destruction in surgically induced OA models demonstrating that important cellular processes 
are regulated through numerous signaling molecules and alterations in their functions can 
have harmful effects on the joints. 
In conclusion, genetically modified mice are very useful for studying the in vivo 
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molecular pathology of OA and definitely their number will continue to grow in the future. 
 
7.3 PAPER III: β1 integrin-deficiency results in multiple abnormalities of the knee 
joint 
 The aim of this work was to examine the long term consequences of β1 integrin 
deletion in chondrocytes of limb skeleton. A previous study demonstrated that ablation of β1 
integrin in all cartilaginous skeletal elements results in the death of the animals at birth, 
precluding any possibility to study post-natal events such as the maintenance of articular 
cartilage with age. Therefore, we deleted the β1 integrin gene using the cre recombinase under 
the control of the Prx1 promoter, which is expressed in early limb bud mesenchyme. These 
animals were viable at birth and developed skeletal abnormalities restricted to the limbs, as 
expected. Histological analysis of knee joints revealed that from 1 month old mutant mice the 
secondary ossification centers were delayed and the articular cartilage architecture was highly 
disorganized. The superficial zone of AC was expanded and lacked flattened cells, while 
characteristic column-like structure in the radial zone was missing implicating that β1 
integrins are pivotal for structural anisotropy of the AC. The level of disorganization increased 
at later stages: mutant cartilage was thicker and displayed higher calcified/noncalcified ratio 
when compared to the control. Ultrastructural studies revealed an abnormal collagen fibril 
organization and extended pericellular matrix (PM) compartment associated with impaired 
expression of the PM marker collagen VI suggesting a role of β1 integrins in matrix assembly. 
Articular chondrocytes, in contrast to growth plate chondrocytes, arrest their differentiation 
program before hypertrophy. We found that β1-deficient AC chondrocytes deposit the 
hypertrophic marker type X collagen close to the articular surface implying an abnormally 
activated terminal differentiation. The ECM abnormalities were accompanied by decreased 
proliferation and increased binucleation rates of mutant chondrocytes leading to 
hypocellularity of the AC. In addition, the actin cytoskeleton of chondrocytes was disrupted in 
aged mutants at the weight bearing areas of the AC. Despite these features, most of them 
characteristic for diseased AC, the cartilage of mutant animals did not show accelerated or 
more severe erosions compared with control mice indicating that the lack of β1 integrin does 
not affect the progression of osteoarthritic cartilage destruction. Corroborating this 
observation, the catabolic activity of cartilage judged by the expression of MMPs, 
aggrecanases and their degradation products were similar in both genotype groups. MAPK 
signaling is often activated in OA but we could not detect any significant changes in the 
mutant cartilage. In addition, when we stimulated femoral head explants with the central, cell-
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binding fragment of FN, which is known to activate MAPKs, we did not find differences in 
Erk, p38 and JNK phosphorylation between wild type and mutant chondrocytes. These 
findings clearly demonstrate that MAPK activation is efficiently compensated by signaling 
through either β3/β5 integrins or growth factor receptors in β1 integrin-deficient 
chondrocytes. Next, we examined the synovial tissue development. Starting at E16, multiple 
abnormalities were present in the mutant synovium and by 7 months of age fibrosis, invasion 
of the synovial tissue in the joint space accompanied by chondrogenic differentiation were 
obvious. 
All together, our data demonstrate that the lack of β1 in the joints leads to severe 
structural defects in both AC and synovium reminiscent of OA but does not result in 
premature erosion of AC surface. 
 
 
7.4 PAPER IV: Early detection of aging cartilage and osteoarthritis in mice and 
patient samples using atomic force microscopy 
Osteoarthritis is a degenerative joint disease which starts with early perturbation of the 
cartilage ECM supramolecular assembly. Such subtle defects are not detectable by 
conventional diagnosis methods and a more sensitive tool is required for early detection in 
order to halt or reverse the progression of the disease. Previously IT-AFM was used to image 
native surface of porcine articular cartilage and to measure its compressive properties. The 
fine structural details of the cartilage and significant elasticity changes in enzymatically 
digested cartilage could be resolved only with nanometer-sized tips. Therefore in this study 
we compared the biomechanical properties of the cartilage from wild type and collagen IX 
deficient mice as well as from patients at both nanometer and micrometer scales. First, to 
validate the method, we measured the age-dependent changes in the normal cartilage from the 
femoral heads of mice. Using nanometer-sized tips we could detect a progressive thickening 
of collagen fibrils which was not detected by scanning electron microscopy (SEM). Similarly, 
only at the nanometer scale could we measure increased cartilage stiffness with age. Next, we 
used collagen IX-deficient mice to test if nanometer scaled IT-AFM can monitor pathological 
changes in a well-established mouse model for OA. As early as 1 month of age, cartilage fibril 
thickening and increased nanostiffness were observed by IT-AFM, in contrast to SEM or 
normal histology techniques which could not detect these changes, suggesting that 
pathological changes may occur very early during disease progression. Next, we measured the 
changes at 3, 6, and 12 months of age and we noticed an accelerated increase in collagen 
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thickening in the mutant mice when compared to the wild type. In addition both 3 months and 
6 months old mutant mice displayed an increased nanostiffness but similar microstiffness. 
Surprisingly, the 12 months old knock out mice manifested a decrease in stiffness at both 
nano- and micrometer scale suggesting that collagen meshwork is dramatically destroyed 
resulting in softening of the cartilage. These changes where confirmed also by SEM and 
histology. To test the applicability of IT-AFM in clinical practice we analyzed samples from 
osteoarthritic patients of different ages. All the samples were evaluated for OA changes using 
the Outerbridge scoring system. Analysis revealed increased softening of the cartilage with 
increasing OA scores at a given age only at the nanometer scale. Furthermore we could detect 
age-dependent increased nanostiffness in the cartilage from normal patients which are 
different from OA changes. 
 In conclusion, nanoscale IT-AFM can be used to detect subtle topographical and 
biomechanical alterations in the cartilage ECM which occur very early in OA.  
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Abstract 
Recently, members of the β1 integrin family of cell-adhesion receptors have 
emerged as important orienting factors of the mitotic apparatus in epithelial 
tissues. In contrast, the role of β1 integrins for spindle positioning in 
mesenchymal tissues such as the columnar, cartilaginous growth plate in the 
long bones is unknown. Here we show by mouse genetics that β1 integrin 
function is pivotal for flattening and mediolateral orientation of proliferative 
chondrocytes in the growth plate, which in turn dictates spindle alignment 
along the long axis of the cell. The rounded, nonoriented β1-null chondrocytes 
display random spindle and division axes and fail to intercalate into columns. 
We further demonstrate that in vitro, integrin-dependent adhesion defines 
relative spindle orientation to the substratum by modulating chondrocyte 
geometry. Based on the above findings, we propose that cell shape anisotropy 
maintained by β1 integrins provides a default guiding cue for spindle and 
division positioning in chondrocytes. 
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INTRODUCTION 
Endochondral bone formation (Kronenberg, 2003) is the primary mechanism of 
skeletogenesis which begins with the aggregation and chondrogenic differentiation of 
mesenchymal precursors at the sites of future skeletal elements. During 
development, the cartilaginous templates of long bones display club-shaped 
expansions at the ends (epiphyses) separated by a middle shaft. While the epiphysis 
contains rounded cells dispersed in extracellular matrix (ECM), midshaft-resident 
chondrocytes form a polarized structure called the growth plate (GP) (Fig. 1A). At 
birth, GP chondrocytes arrange into longitudinal columns and distinct zones reflecting 
the various stages of differentiation. In the proliferation zone (PZ), cells exhibit high 
mitotic activity, are flattened and oriented along the mediolateral (ML) axis of the GP. 
As stated by Dodds (Dodds, 1930), mitotic figures in the elongated chondrocytes lie 
perpendicular to the proximal-distal (PD) direction of growth, while cell divisions occur 
parallel to the columns (Fig. 1B). This observation is in agreement with Hertwig´s 
laws postulating that 1) the axis of the spindle takes “the direction of the greatest 
protoplasmic masses” and 2) “the plane of division always cuts the axis of the spindle 
perpendicularly” (Hertwig, 1912). In Dodds' model, following cytokinesis the semi-
circular daughter cells adopt a wedge-shape and glide around each other until they 
reach the same vertical plane and become discoid again. Later, chondrocytes 
withdraw from the cell cycle and become hypertrophic. Thus, longitudinal bone 
growth is achieved by proliferation, matrix production and hypertrophy of GP 
chondrocytes. Surprisingly, the mechanisms responsible for the geometrical 
anisotropy and columnar arrangement of proliferative chondrocytes are poorly 
understood, although the roles of ECM mechanics (Gould et al., 1974), secreted 
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morphogens (Abad et al., 2002) and noncanonical frizzled signaling (Li and Dudley, 
2009) have been suggested. 
 The heterodimeric (αβ) integrins are the major class of adhesion molecules 
that control various aspects of cell behavior including shape, migration, proliferation 
and survival (Lo, 2006). We previously reported that β1fl/fl-Col2a1cre mice, in which 
the β1 integrin gene was ablated in chondrocytes, develop severe chondrodysplasia 
and lack GP columns at birth due to cell rounding and impaired cell motility in the PZ 
(Aszodi et al., 2003). Mice lacking the collagen-binding integrin α10β1 or integrin-
linked kinase in cartilage display similar but milder GP abnormalities (Bengtsson et 
al., 2005), (Grashoff et al., 2003). Although these findings clearly demonstrate the 
crucial importance of chondrocyte-ECM interactions in GP organization, the role of 
β1 integrins for spindle orientation in chondrocytes was not addressed. 
 Growing evidence suggests that integrin functions are critical for spindle 
alignment and daughter cell positioning both in vivo and in vitro (Streuli, 2009). In the 
skin, β1 integrins are involved in the establishment of apical polarity of basal 
keratinocytes which in turn determines whether the spindle orients parallel or 
perpendicular to the basement membrane (Lechler and Fuchs, 2005). In mammary 
epithelium, ablation of β1 integrin randomizes the division plane in basal cells 
resulting in the mislocation of stem cell progeny to the luminal compartment (Taddei 
et al., 2008). In Drosophila ovary, signaling via βPS integrins is required for the 
correct spindle orientation in follicular epithelial cells (Fernandez-Minan et al., 2007). 
Furthermore, in vitro studies demonstrated that β1 integrins regulate the angle 
between the mitotic spindle and the substrate plane in cultured, non-polarized 
adherent cells (Toyoshima and Nishida, 2007). HeLa cells plated on fibronectin or 
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collagen orient their metaphase spindle parallel to the substratum, whereas spindle 
axes are misoriented when β1 integrin function is compromised. 
 To assess whether mitotic spindle positioning is affected by β1 integrins in the 
GP we used conditional knock-out mouse strains. Here we show that β1 integrins are 
necessary for establishing GP polarity and for correct orientation of the mitotic 
spindle in chondrocytes both in vivo and in vitro by maintaining their geometrical 
anisotropy. 
 
RESULTS 
Chondrocyte shape change and column formation in the growth plate 
To gain detailed insight into GP morphogenesis, we characterized the cellular 
changes that occur in the PZ during the development of the mouse tibia (Fig. 1C). At 
the aggregation phase (embryonic day 11, E11), mesenchymal cells show no 
obvious orientation relative to the PD axis. Morphometric analysis of tissue 
cryosections revealed that pre-chondrocytes are polygonal and display a shape index 
(SI) of 1.43±0.30. Upon chondrogenic differentiation at E12, presumptive GP 
chondrocytes exhibit moderate flattening (SI=1.93±0.45) and their long axes tend to 
align perpendicular to the PD direction. Thus, chondrocyte shape anisotropy and 
spatial tissue polarity are established very early in cartilage development. At E13, 
proliferative chondrocytes further flatten (SI=3.41±0.60) along the ML axis and largely 
organize into parallel lines. At E14, PZ chondrocytes are slightly more flattened 
(SI=3.58±0.72) and show the first signs of column formation, composed of short 
stacks of 2-3 discoid chondrocytes. At newborn stage, the SI increases to 4.91±1.41 
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indicating the extreme flattening of PZ chondrocytes. In contrast, epiphyseal 
chondrocytes are rounded or ovoid in shape (SI=1.42±0.25). 
 
Spindle position depends on the orientation and shape of chondrocytes  
To monitor spindle alignments and division axes in proliferative chondrocytes, we 
imaged tibial GPs of normal mice. Spindle orientations during metaphase (early 
spindle) and during anaphase-telophase (late spindle) were determined by 
measuring the angle (α°), from 0° (parallel) to 90° (perpendicular) between the PD 
axis and the spindle axis in the xy plane. At E12, early spindles were randomly 
oriented, whereas 57% of the late spindles aligned within 30° of perpendicular to the 
PD axis. In contrast, only 15% of the late spindles were within 30° of a parallel 
orientation (Fig. 2A,B). Early spindles were still randomly aligned at E13, but now 
perpendicularly aligned (60°-90°) late spindles accounted for more than 81% of all 
mitotic figures (Fig. 2D). Consequently, midbodies and cleavage furrows were mostly 
positioned parallel to the PD axis, although diagonal orientations were occasionally 
observed (Fig. 2C). Increasingly stringent perpendicular late spindle orientation was 
observed between E12 and E13, with 15% and 48% of late spindles within 10° of 
perpendicular, respectively (Fig. 2B,D). From E14, perpendicular alignment of late 
spindle became the default orientation. At E18, early spindles displayed a bias 
towards perpendicular orientation with 75% of the spindle angles falling between 60°-
90°, whereas all late spindles were oriented within 20° of perpendicular to the PD 
axis (Fig. 2E,F). Importantly, while 93% of late spindles aligned completely 
perpendicular (80°-90°), only 27.5% of metaphase spindles showed stringently 
perpendicular orientation (Fig. 2F). Next, we examined the relationship between 
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spindle orientation in mitotic cells and long axis orientation of interphase cells relative 
to the PD axis (Fig. 2G). The angles of the long axis during interphase and the 
spindle angles in anaphase/telophase correlated well at all stages (E12, E13 and 
E18) suggesting that the orientation of the elongated chondrocytes within the GP 
determines late spindle orientation and, therefore, the cleavage plane. However, 
such a correlation was not observed between early spindle and interphase long axis 
angles at E12 and E13, and only a partial correlation was found at E18. 
 The above findings led us to modify and extend Dodds´ model (Fig. 2H). 
Following aggregation, differentiated chondrocytes elongate and align their long axis 
either perpendicular or, to a lesser extent, diagonal to the PD axis of growth. 
Between E13-E14, late spindles align parallel to the long axis of the cells according 
to Hertwig´s rule. After cytokinesis, daughter cells of perpendicularly-oriented 
chondrocytes either remain in the same row as the mother cell, contributing to the 
lateral expansion of the cartilaginous template, or undergo a rotational movement of 
90° to initiate a two-cell stack. Column initiation can also be achieved by the division 
and subsequent rotation of diagonally-oriented chondrocytes. At later stages, 
chondrocytes are more flattened and aligned more strictly perpendicular to the PD 
axis. Following cytokinesis, the daughter cells intercalate to expand the columns, 
mature and become hypertrophic to accomplish the longitudinal elongation of the 
tissue. Importantly, Hertwig´s rule can strictly be applied only for late mitotic figures of 
E12-NB proliferative chondrocytes implying that misoriented metaphase spindles 
adjust their orientation to ensure chromosomal segregation along the long axis of the 
flattened cell during anaphase/telophase. Furthermore, this observation argues 
against the existence of cortical cues in GP chondrocytes that could specifically 
guide spindle orientation at the time of mitotic entry. 
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β1 integrins control mitotic spindle positioning in the growth plate 
Our model suggests that chondrocyte geometry and orientation are important 
determinants of spindle and cell division positioning in the GP which may depend on 
integrin-mediated cell adhesion. By immunostaining wild type tibial sections, we 
observed even deposition of the β1 integrin subunit on the surface of interphase, 
mitotic and intercalating proliferative GP chondrocytes (Fig. 3A). To determine the 
impact of β1 integrins on chondrocyte spindle orientation, we imaged the cartilage 
from β1fl/fl-Col2a1cre mice (Aszodi et al., 2003). Because deletion of β1 integrin 
occurs at around E12, a significant amount of β1 integrin was still visible on 
proliferative chondrocytes at E13 that was apparently sufficient for their normal ML 
elongation (Fig. 3B, upper insert). At E14, when little if any, β1 integrin is detected, 
the cells rounded and lost their orientation (Fig. 3B, lower insert). This rapid change 
between E13 and E14 implies that β1 integrins are vitally important to maintain 
chondrocyte shape and tissue polarity in the proliferative zone of the GP. At E18, 
cells of the epiphysis and the PZ were morphologically indistinguishable (Figure 3C) 
(SIepi=1.27±0.14 and SIPZ=1.37±0.20). Moreover, mutant chondrocytes in the PZ 
displayed random orientation of both early and late spindles (Fig. 3D,E), similar to 
what we observed in mutant and wild type epiphyses (Fig. 3F and not shown). These 
data indicate that rounded chondrocyte geometry is accompanied by the randomized 
orientation of the mitotic apparatus. 
 To further examine the role of β1 integrins in GP polarity, we generated β1fl/fl-
Prx1cre mice to achieve deletion of the β1 integrin gene in early limb-bud 
mesenchymal cells. In the hind-limb, the Prx1cre-driven deletion is complete in most, 
but not all mesenchymal progenitors of skeletal lineages at E10.5 leading to mosaic 
expression of β1 integrin during cartilage development. At E13, β1 integrin-positive 
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chondrocytes were flattened and aligned at a right angle to the PD axis, whereas β1-
negative chondrocytes were rounded (Fig. 3G, upper insert). At E14, β1-positive 
chondrocytes intercalated, forming the first 2-cell columns (Figure 3G, lower insert) 
that by E18 had expanded to 6-10 cells (Fig. 3H). β1 integrin-expressing cells in the 
largely β1-deficient GP properly oriented their long axis and aligned the late spindle 
perpendicular to the PD axis (Fig. 3H and not shown). In contrast, β1fl/fl-Prx1cre PZ 
chondrocytes had misoriented spindles comparable to β1fl/fl-Col2a1cre chondrocytes 
(not shown). These findings therefore demonstrate that β1 integrins regulate 
chondrocyte polarity and arrangement in a cell autonomous manner.  
In summary (Fig. 3I), β1-deficiency in the GP leads to chondrocyte rounding, 
randomizes spindle and cleavage plane orientation, and blocks gliding movements 
necessary for column initiation and elongation. 
 
β1 integrins regulate spindle orientation relative to the substrate plane in vitro 
To determine the role of β1 integrins for spindle orientation in vitro, primary 
chondrocytes isolated from wild type and β1fl/fl-Col2a1cre embryos were plated on 
various substrates and imaged in metaphase. On collagen II (Fig. 4A), wild type (wt) 
and mutant (mt) chondrocytes failed to spread and remained round (SIwt=1.02±0.2 
and SImt=1.57±0.2). Control chondrocytes attached to the collagen II-coated surface 
via β1 integrins, while β1fl/fl-Col2a1cre chondrocytes deposited a focal fibronectin 
matrix beneath them and attached to it via β3 integrins (not shown). Surprisingly, 
both control and β1-deficient chondrocytes displayed average spindle angles of 
29.81°±4.13° and 20.92°±3.26°, respectively, and showed no preference to orient 
their metaphase spindle parallel with the substratum (α°= 0° to 10°, Fig. 4A). In 
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contrast, control and mutant chondrocytes spread and flattened well on vitronectin 
via β3 integrins (SIwt=4.11±0.23 and SImt=4.20±0.22). In most cases the spindle was 
aligned parallel to the adhesion plane (Fig. 4B) leading to low average spindle angles 
(α°wt=6.36°±1.22° and α°mt=5.19°±1.33°). On fibronectin, mutant cells which lack the 
major fibronectin receptor α5β1 integrin, spread significantly less and are more 
rounded than control chondrocytes (Fig. 4C). Wild type chondrocytes had a high 
shape index (SI=3.26±0.21), low spindle angle (α°=7.25°±1.40°) and about 80% of 
the spindles were oriented parallel to the substratum, whereas for mutant cells the 
same parameters were 1.73±0.13, 22.66°±3.49° and about 37% (Fig. 4C). To 
manipulate their shape in culture by crowding, wild type cells were plated at high 
density on fibronectin and the shape indexes and spindle orientations were 
compared to those of sparse culture (Fig. 4D). We observed a significant decrease in 
the shape index (3.26±0.21sparse and 2.19±0.07dense, p<0.0001 by t-test) and increase 
in the average spindle angle (7.25°±1.40°sparse and 11.98°±1.41°dense, p<0.05). 
Importantly, only 40% of the wild type metaphase cells oriented their spindle parallel 
to the surface in dense culture. Collectively, our results suggest that geometric 
constraints are the primary determinants of the angle between the spindle axis and 
the substrate plane in cultured chondrocytes; and integrin-mediated anchorage has a 
pivotal role on ligand-selective cellular geometry. Thus, integrins govern spindle 
alignment via cell shape regulation both in vivo and in vitro. 
 
DISCUSSION 
Our findings demonstrate that β1 integrin-based adhesion is essential for several key 
steps of GP morphogenesis. First, β1 integrins are critically required for the 
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establishment of chondrocyte polarity and orientation in the GP upon chondrogenic 
differentiation. The primary mechanism triggering chondrocyte elongation and ML 
orientation is speculative, and may involve mechanical or secreted signals (Gould et 
al., 1974); (Abad et al., 2002). In the forming GP, integrins may act as 
mechanoreceptors or co-receptors for morphogen pathways and orchestrate the 
cellular commands for shape change by providing a physical platform for matrix 
engagement and by organizing the cytoskeleton. It has been recently demonstrated 
that noncanonical frizzled (Fzd) signaling controls chondrocyte orientation in chicken 
GP without significant impact on cell anisotropy (Li and Dudley, 2009). Therefore, it 
seems unlikely that the noncanonical Fzd pathway modulates the expression and/or 
localization of β1 integrins on the cell surface, although a role in polarized matrix 
deposition cannot be excluded. 
Second, β1 integrin-based anchorage to the ECM is needed for proliferative 
chondrocytes to adopt their elongated shape. β1-null mouse basal keratinocytes also 
change their shape, but become elongated rather than rounded (Raghavan et al., 
2000). In contrast, depletion of the β1 equivalent βPS integrin does not significantly 
change the cuboidal shape of follicle cells in Drosophila ovary epithelium 
(Fernandez-Minan et al., 2007). Since collagen II is by far the most abundant 
adhesive ligand in cartilage, it is possible that the loss of β1 integrins in such a “β1-
specific matrix” creates a quasi suspension-like environment leading to chondrocyte 
rounding. Indeed, chondrocytes lacking the major collagen receptor α10β1 integrin 
also show a tendency to become round (Bengtsson et al., 2005). 
Third, β1 integrins control the direction of cytokinesis by maintaining 
chondrocyte shape anisotropy that guides late spindle orientation and chromosome 
segregation along the long axis of the cell. Basal keratinocytes round up when they 
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enter mitosis and align their spindles relative to the basement membrane depending 
on intrinsic polarity cues, cell-cell and β1 integrin-mediated cell-ECM interactions 
(Lechler and Fuchs, 2005). In contrast, chondrocytes are completely surrounded by 
the ECM, do not round up in metaphase and do not show obvious cortical polarity. 
Taking into account the extreme flattening of proliferative chondrocytes, we propose 
that GP cartilage represents a rather unique tissue in which the cells achieve 
symmetrical and oriented cell division by using solely geometric constraints inherent 
to the elongated shape. This concept is further supported by our in vitro analysis 
demonstrating that the metaphase spindle aligns parallel to the substratum in flat 
chondrocytes, whereas the spindle is misoriented in rounded cells. In HeLa cells, 
which exhibit mitotic rounding, depletion of β1-integrin impairs parallel spindle 
alignment by inhibiting the activation of PI3K (Toyoshima et al., 2007). We show here 
that spindle orientation in chondrocytes relies on cell spreading and not on the 
expression of β1 integrin per se. Thus, cell type-specific differences could generate 
distinct mechanisms for spindle alignments in two-dimensional culture systems. 
 Finally, β1 integrins are necessary for ML intercalation of proliferative 
chondrocytes to produce vertical columns (Aszodi et al., 2003). This process is 
similar to convergence extension movements of the dorsal mesoderm in Xenopus 
that also require β1 integrin-ECM interactions (Marsden and DeSimone, 2003); 
(Davidson et al., 2006). However, while in Xenopus the primary driving mechanism of 
motility is the traction generated by cell-cell contacts, in cartilage chondrocyte 
rotation may only depend on matrix adhesion-induced traction forces. 
 In summary, β1 integrins provide adhesive cues for chondrocyte geometry and 
orientation, which in turn orients the mitotic spindle and determines the division axis, 
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and for chondrocyte intercalation to shape the three-dimensional structure of the GP 
during endochondral bone formation. 
 
METHODS 
Mice 
The β1fl/fl-Col2a1cre strain was described previously (Aszodi et al., 2003). β1fl/fl-
Prx1cre mice were generated by crossing mice carrying the floxed β1 alleles with 
transgenic mice expressing the Cre-recombinase under the control of the Prx1 
enhancer (Logan et al., 2002). 
Tissue samples and immunostaining  
Hindlimbs were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline 
(PBS, pH 7.4) at room temperature overnight. Fixed samples were immersed into 
30% sucrose/PBS for 24h, frozen in OCT and cut longitudinally (50 µm) using a 
cryostat. Sections were treated with hyaluronidase (2mg/ml in PBS, 2h, 37°C), 
blocked in 2% BSA, 0.5% Triton X-100 in PBS, and incubated with the following 
primary antibodies: anti-α tubulin (Chemicon MAB1864), anti-pericentrin (Covance 
PRB-432) and anti-β1 integrin (Chemicon MAB 1997). Primary antibodies were 
visualized by the appropriate fluorescently labelled secondary antibodies. Actin was 
stained with phalloidin Alexa 488 (Invitrogen) and the DNA was stained with DAPI 
(Sigma). Tissues were also embedded into paraffin or plastic resin for standard 
immunohistochemistry and histology, respectively. 
Primary chondrocytes and immunocytochemistry 
Rib chondrocytes from E18 mice were isolated and cultured for 36 hours on 
substrate-coated chamber slides as described (Aszodi et al., 2003). For spindle 
analysis, cells were prefixed in 0.5% glutaraldehyde/0.2% TritonX-100 in modified 
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Hank’s balanced salt solution (137mM NaCl; 5mM KCl; 1.1mM Na2HPO4; 0.4mM 
KH2PO4; 2mM MgCl2; 2mM EGTA; 5mM PIPES; 5.5mM glucose; 4mM NaHCO3; 
0.11% MES ; pH 6.5) for 1 min, postfixed in 1% glutaraldehyde for 10 min and were 
sequentially stained with anti-α-tubulin and anti-pericentrin antibodies, with 
fluorescently-labelled secondary antibodies, with phalloidin (1h each) and DAPI. 
Image analyses 
Confocal stacks were built from images acquired every 0.5 microns by confocal 
microscopy (DMIRE2; Leica) with a 63x 1.4 oil objective. From the acquired stacks of 
tissue sections, the long and the short axes of chondrocytes, corresponding to the 
major and minor axes of an ellipse, were measured using the Leica Confocal 
Software (version 2.5) as well as the angle between the spindle axis and the 
proximodistal axis of the cartilage using MetaMorph 6.0. Cell orientation was 
determined by measuring the angle between the long axis of the cell and the 
proximodistal axis of the growth. For in vitro data, the angle values were obtained 
using inverse trigonometric function: α° = tan-1 Z/l (Z is the vertical distance between 
the centrosomes; l is the projection of the linear distance between the centrosomes, 
measured using Leica Confocal Software (modified from (Toyoshima and Nishida, 
2007)). Shape indexes were calculated as follows: the ratio of the long and short 
axes of the cell (in vivo) or the ratio of the length and height of the cell (in vitro). 
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Figure 1. Cell shape and orientation in the normal growth plate. 
(A) Schematic structure of a long bone at birth. Cells in the proliferative zone are 
organized into vertical columns and their long cell axes (red arrows) orient 
perpendicular to the proximal-distal direction of the bone. (B) Drawings showing the 
sequential steps of column formation (after (Dodds, 1930)). (C) Morphogenesis of the 
proliferative zone. Toluidine blue histochemistry showing the gradual flattening, 
orientation and columnar organization of the proliferative cells. Shape indexes (SI) 
were calculated from the ratio of the long (L) and short (S) axes (yellow lines) of the 
cells after double staining tissue cyrosections with actin and DAPI. 
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Figure 2. Mitotic spindle orientation during morphogenesis of the proliferative 
zone. 
(A) Images of tibia at E12 showing the orientation of the mitosis (metaphase, purple; 
anaphase/telophase, yellow) relative to the PD axis. (B) Quantification of early and 
late spindle orientation at E12. (C) Immunofluorescence staining demonstrating the 
orientation of midbodies (circles), telophase spindles (yellow arrows) and cleavage 
furrows (arrowheads) at E13. (D) Quantification of spindle orientation at E13. (E) 
Images showing the spindle axis (arrows) and (F) quantitative analysis of spindle 
alignment at the newborn stage. (G) Plot diagrams of mitotic spindle and cell 
elongation orientation with respect the PD axis. (H) The modified Dodd´s model. 
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Figure 3. β1 integrins regulate chondrocyte shape and spindle orientation in 
the growth plate. 
(A) Immunostaining of β1 integrin expression on the surface of interphase, mitotic 
and intercalating proliferative chondrocytes. (B) Depletion of β1 integrin results in 
rapid shape change and loss of chondrocyte orientation in the GP of β1fl/fl-Col2a1cre 
mice. (C) At E18, β1fl/fl-Col2a1cre epiphyseal and GP chondrocytes are 
indistinguishable by shape and orient both early and late mitotic spindles randomly 
(D, E, F). (G and H) In the mosaic growth plate of β1fl/fl-Prx1cre mice, β1 integrin 
positive cells elongate perpendicular to the PD axis at E13 (G, upper), initiate 
chondrocyte stacks (G, lower) at E14 and form columns at E18 (H). (I) Cartoon, 
summarizing he consequence of β1 integrin deficiency on spindle orientation and GP 
morphogenesis. 
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Figure 4. The angle between the spindle axis and the substrate plane is 
regulated by the shape of cultured chondrocytes. 
(A-D) Wild type (wt) and β1fl/fl-Col2a1cre (mutant, mt) primary chondrocytes were 
cultured on various adhesive surfaces and metaphase spindle angles (α°) were 
plotted as a function of the shape index (SI, bottom graphs). Middle graphs 
demonstrate the distribution of metaphase spindle orientation. Right upper inserts on 
A-C are representative pictures showing the position of centrosomes (pericentrin 
staining) and the shape of the chondrocytes (phalloidin staining). The right upper 
insert on D shows the spreading of control chondrocytes on fibronectin in sparse and 
dense culture. 
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Abstract: Osteoarthritis (OA) is the most common degenerative disorder of the joints with an etiology involving genetic 
and environmental factors. Although various animal models have been used to elucidate the pathogenesis of OA, in the 
past decade gene targeting in mice has become one of the most powerful tools to dissect the molecular mechanisms of the 
disease. The generation of knockout mice has enormously accelerated the identification of the key genetic players in ar-
ticular cartilage homeostasis and made a significant contribution to further our understanding of OA pathology. In this re-
view, we will outline the phenotypes of the currently available mouse strains, carrying either engineered or spontaneous 
gene mutations, which provide insight into the processes of articular cartilage destruction. The analysis of these mice re-
veals a complex interaction among cytokines, proteases, transcription factors, extracellular matrix, cell surface and signal-
ing molecules during the initiation and progression of OA and, in some cases, suggests new therapeutic interventions for 
the disease. 
Keywords: Osteoarthritis, gene targeting, mouse models, extracellular matrix, signaling, proteolysis, cytokines, growth factors. 
INTRODUCTION 
 Osteoarthritis (OA) is a non-systemic degenerative joint 
disease affecting millions of people world-wide and is the 
prevalent cause of disability over 65. Although OA is char-
acterized by the gradual deterioration of the articular carti-
lage, both destructive and repair processes are activated at 
certain phases of the disease, suggesting a highly dynamic 
interplay among catabolic and anabolic molecular cascades. 
Osteoarthritis is generally accepted as a complex disorder 
influenced by both environmental and genetic factors [1]. To 
assess the contribution of genetic factors and to explore the 
pathogenesis of OA, murine models of human skeletal disor-
ders are important tools. These models include mouse strains 
carrying spontaneous mutations and induced mutant strains 
generated by classical transgenesis (transgenic mice) or by 
gene targeting (knockout mice). Since the publication of 
OA-like changes in transgenic and knockout mice with mu-
tations in the collagen IX gene in the mid 1990s [2, 3], gene 
ablation experiments have yielded more than 40 knockout 
mouse strains which have significantly advanced our knowl-
edge of normal and pathobiology of the articular cartilage. 
Genetically modified mice not only provide a deeper insight 
into molecular mechanisms controlling joint development 
and OA pathogenesis, but also identify potential target mole-
cules for therapeutic interventions against OA. In this re-
view, we summarize the currently available knockout and the 
most relevant transgenic and spontaneous mouse models for 
OA research. 
MATRIX TURNOVER AND ECM DEGRADING EN-
ZYMES 
 Articular cartilage (AC) is composed of a structurally 
well organized, interactive set of extracellular matrix (ECM) 
molecules produced by chondrocytes. The two major struc- 
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tural components of the cartilage ECM are the type II colla-
gen fibrils and the proteoglycan (PG) aggrecan. It is gener-
ally accepted that in OA the normal turnover of ECM mole-
cules is disturbed, and the imbalance between anabolic and 
catabolic processes favors proteolytic degradation of aggre-
can (aggrecanolysis) and collagens (collagenolysis), which 
eventually leads to articular cartilage destruction. 
 Several families of proteinases and proteinase inhibitors 
have been implicated in the initiation and progression of OA. 
Matrix metalloproteinases (MMPs) are a family of more than 
20 zinc- and calcium-dependent proteinases that play crucial 
roles in various developmental, repair and pathological proc-
esses facilitating the turnover and breakdown of most ECM 
molecules [4-6]. A second family of MMP-related protein-
ases is composed of the membrane-anchored ADAMs (a 
disintegrin and metalloproteinases) and the secreted 
ADAMTSs (ADAM with thrombospondin motifs). Concern-
ing the cartilage, ADAMTS proteins are particularly impor-
tant because many of them are able to degrade aggrecan (ag-
grecanases) [7]. The activities of both MMPs and 
ADAMTSs are tightly regulated at multiple levels including 
inhibition by tissue inhibitors of metalloproteinases (TIMPs) 
[8]. Recent expression profiling revealed that most MMP, 
ADAMTS and TIMP genes are expressed in both normal and 
osteoarthritic human joints demonstrating the potential im-
portance of these three protein families in OA [9, 10]. Fi-
nally, cysteine proteinases such as cathepsins B, L and K and 
their inhibitor (cystatin C) represent other important mole-
cules that might be involved in AC destruction [11]. 
Aggrecanolysis 
 Proteoglycan depletion is among the first detectable al-
terations in osteoarthritic cartilage, usually preceding colla-
gen degradation. Aggrecan consists of two N-terminal globu-
lar domains (G1 and G2), separated by an interglobular do-
main (IGD); regions substituted with keratan sulfate (KS) 
and chondroitin sulfate (CS) glycosaminoglycan (GAG) side 
chains; and a C-terminal globular domain (G3). Multiple 
cleavage sites for MMPs and aggrecanases have been identi-
fied in aggrecan in vitro and the corresponding degradation 
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fragments can be detected in human OA synovial fluid 
and/or cartilage [12]. Two important cleavage sites associ-
ated with articular cartilage destruction are located in the 
IGD: all MMPs expressed in cartilage cleave predominantly 
between Asn341-Phe342 generating the G1-IPEN341 neoepi-
tope; whereas ADAMTS aggrecanases cleave at Glu373-
Ala374 generating the G1-TEGE373 fragment. Since aggreca-
nase but not MMP inhibitors are able to suppress aggrecan 
loss from human OA cartilage explants [13], most studies 
have focused on the identification of the key aggrecanase 
responsible for destructive aggrecanolysis. 
 ADAMTS-4 and ADAMTS-5, two aggrecanases pos-
sessing high aggrecanolytic activity, are expressed in normal 
and OA cartilage and their contribution to cartilage pathol-
ogy was recently dissected in genetically modified mice [14-
16]. Surprisingly, neither ADAMTS-4 nor ADAMTS-5 
knockout mice exhibit obvious abnormalities indicating that 
these aggrecanases are dispensable for skeletal development. 
In unchallenged mutants, the level of G1-TEGE373 fragment 
in cartilage was reduced suggesting that both proteases con-
tribute to physiological aggrecanolysis in mice.  However, 
inflammatory stimulation of aggrecan breakdown in IL--
treated articular cartilage explants was blocked in 
ADAMTS-5 knockouts but not in ADAMTS-4 mutant mice. 
Similarly, only ADAMTS-5 mutant mice were protected 
from aggrecan loss and articular cartilage erosion in inflam-
matory or surgically induced in vivo models of arthritis. 
Thus, ADAMTS-5 is the sole enzyme responsible for IGD 
cleavage and for the initiation of early aggrecan breakdown, 
however, a recent study showed that some aggrecanolysis 
still occurs at the CS-rich region in the ADAMTS-5 knock-
out mice [17]. Furthermore, cartilage explants from 
ADAMTS-4/ADAMTS-5 double mutant mice release intact 
or G1 domain-containing aggrecan molecules upon retinoic 
acid stimulation demonstrating that aggrecan loss is not nec-
essarily coupled to its proteolytic processing [18]. Neverthe-
less, blocking IGD cleavage by aggrecanase inhibitors might 
be a useful therapeutic strategy to reduce or even reverse 
cartilage destruction. Consistent with this assumption, the 
so-called “Jaffa” mice, in which the aggrecan core protein is 
rendered resistant to aggrecanase-mediated cleavage, are 
partially protected against aggrecan loss and cartilage dam-
age progression in surgically and inflammatory-induced ex-
perimental models of arthritis [19]. 
 Explant culture experiments revealed that MMPs account 
for only a small percentage of total aggrecan catabolism in 
porcine cartilage implying that MMPs are rather involved in 
basal turnover of aggrecan in the pericellular microenvi-
ronment of chondrocytes than in destructive aggrecanolysis 
[20]. In line with the in vitro data, the so-called “Chloe” 
mice with a mutation resistant to MMP-driven cleavage of 
aggrecan IGD show normal skeletal development [21] and 
have no protection against cartilage deterioration in induced 
models of arthritis [19]. Among the MMPs capable of de-
grading aggrecan, MMP3 was studied in knockout mice in 
detail. MMP3 can degrade, in addition to aggrecan, various 
cartilage ECM components; and is able to activate procolla-
genases and progelatinases [4]. The incidence of spontane-
ous OA was recently compared between Mmp3-null and wild 
type mice [22]. While mild OA-like changes were similar in 
knockout and control 1-year-old mice, the exposure of G1-
IPEN341 and the deterioration of the AC were significantly 
less prominent in MMP3-deficient mice at 2 years of age. In 
inflammatory arthritis models, Mmp3-null mice showed 
normal PG depletion, but did not expose type II collagen-
cleavage neoepitopes [23, 24]. Since the findings were ac-
companied by a lack of significant cartilage destruction, the 
major function of MMP3 in these arthritis models seems to 
be the initiation of collagenase-mediated cartilage break-
down by activating procollagenases. In contrast, in a surgi-
cally-induced knee joint instability model Mmp3-null mice 
exhibited accelerated OA changes with increased G1-
IPEN341 and collagenase-cleavage neoepitope staining 
around the lesion sites [25]. These data imply that MMP3 
could be replaced by functionally related MMPs to acceler-
ate OA in some arthritis models, and that MMP3-regulated 
matrix turnover is important to maintain normal cartilage 
homeostasis. 
Collagenolysis 
 The cleavage of the triple helical domain of type II colla-
gen fibrils by collagenases occurs in both normal and ar-
thritic cartilage. All three collagenases (MMP1, MMP8 and 
MMP13) cleave at the Gly906-Leu907 site of each -chain 
resulting in the generation of characteristic three-quarter and 
one-quarter collagen fragments. At the cleavage site, neoepi-
topes are exposed which can be detected by specific antibod-
ies (C2C or C1,2C) either in the cartilage itself or in body 
fluids. In addition to collagenases, MMP2 and the mem-
brane-bound MMP14 (MT1-MMP) also cleave native fibril-
lar collagens. In OA cartilage excessive collagen fragmenta-
tion is believed to increase the expression of proteolytic en-
zymes leading to further degradation of matrix proteins and 
subsequent cartilage resorption [26, 27]. 
 A transgenic mouse line overexpressing constitutively 
active human MMP13 in postnatal joint cartilage exhibits 
deteriorated AC at 5 months of age accompanied by in-
creased C1,2C immunostaining in the pericellular matrix 
[28]. Loss of Safranin O staining in the AC was also ob-
served demonstrating that the disintegrated collagen network 
cannot retain proteoglycans in the tissue. In addition, 
MMP13 transgenic mice exhibit strong collagen X expres-
sion above the tidemark in the non-calcified upper and mid-
dle zones suggesting that MMP13 overexpression is linked 
to the reactivation of the normally suppressed differentiation 
program of AC chondrocytes. Interestingly, mice heterozy-
gous for Runx2, a runt-related transcription factor which 
may activate both MMP13 and collagen X transcription, 
show decreased AC degradation along with reduced MMP13 
and collagen X expression in a surgically induced OA model 
[29]. Whether MMP13 is a valuable target for OA treatment 
is still a question, since articular cartilage was not studied in 
Mmp13-null mice [30]. 
 The emerging view that MMPs are not simply destructive 
but rather constructive enzymes of the cellular microenvi-
ronment [5, 6] is further illustrated by the phenotype of the 
Mmp2
-/- and Mmp14-/- mice. MMP2-deficiency leads to mul-
tiple defects including disrupted long bone and craniofacial 
development [31]. Arthritic changes of the tibia and femur 
are visible at 3 months of age and are accompanied by the 
invasion of fibrous tissue and inflammatory cells into the 
joints. Ablation of the Mmp14 gene results in a similar skele-
tal phenotype and severe, generalized soft tissue fibroses 
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leading to lethality at 1-3 months of age [32]. Although the 
pathomechanism of arthritis in Mmp14-/- mice was not ad-
dressed specifically, it has been suggested that inappropriate 
remodeling caused by impaired pericellular collagenolysis at 
the AC-soft tissue interfaces induces AC destruction. On the 
other hand, MMP14 is a critical activator of other proteases 
and the conversion of pro-MMP2 to active MMP2 was 
strongly reduced in Mmp14-null mice [33]. This raises the 
possibility that the common skeletal pathology observed in 
the two mutant strains are ascribed, at least partially, to di-
minished MMP2 function. 
Timp3 and Cathepsin K in Articular Cartilage 
 The balance between MMPs and their endogenous inhibi-
tors TIMPs are critical to prevent excessive ECM degrada-
tion in connective tissues. Among the four TIMPs, TIMP3 is 
uniquely sequestered in the matrix and effectively inhibits, in 
addition to MMPs, several members of the ADAM and 
ADAMTS families predicting its role in cartilage homeosta-
sis [8]. Indeed, Timp3-/- mice exhibit mild, age-dependent 
AC degradation characterized by reduced Safranin O stain-
ing [34]. Consistent with the inhibitory potential of TIMP3, 
knockout mice show elevated levels of both aggrecan and 
type II collagen cleavage products in the AC. Interestingly, 
the exposure of the G1-IPEN341 is more prominent than the 
exposure of G1-TEGE373 implying that TIMP3 modulates 
proteoglycan turnover primarily via the inhibition of MMPs 
and not aggrecanases. 
 In addition to the pivotal role of MMPs in cartilage de-
struction accumulating evidence has suggested that cathepsin 
K, a lysosomal cysteine proteinase that is able to degrade 
both aggrecan and fibrillar collagens, is also involved in de-
generative cartilage diseases. In normal mice which develop 
mild OA spontaneously at 9 months of age, cathepsin K is 
upregulated in close vicinity of the cartilage lesions [35]. 
Transgenic mice overexpressing cathepsin K under its en-
dogenous promoter display progressive synovitis accompa-
nied by severe destruction of the articular cartilage and sub-
chondral bone [36]. In cathepsin-K-deficient mice (Ctsk-/-), 
which develop osteopetrosis due to impaired bone resorp-
tion, joints were not investigated [37]. Worth noting, how-
ever, is that in the null mice a compensation mechanism is 
activated resulting in the transcriptional upregulation of sev-
eral MMPs (including MMP13) and the elevation of colla-
gens I and II degradation products [38, 39]. 
CYTOKINES AND GROWTH FACTOR SIGNALING 
 The permanent communication of chondrocytes with 
their environment is essentially mediated by soluble growth 
factors and cytokines. They interact with specific cell surface 
receptors and control gene expression in order to maintain a 
balanced ratio between the anabolic and catabolic activities 
of chondrocytes. To understand the role of cytokine/growth 
factor-mediated signaling in cartilage biology and OA pa-
thology several models of genetically modified mice have 
been established. 
Cytokines and Cartilage Homeostasis 
 Although OA is not defined as a classical inflammatory 
arthropathy, there is strong evidence for the involvement of 
catabolic inflammatory cytokines in the evolution of the dis-
ease [40]. IL-1 cytokines are probably the most well studied 
pro-inflammatory cytokines that play important roles in OA 
[41, 42]. Upon binding to type I IL-1 receptor on chondro-
cytes, IL-1 activates NF-B and mitogen-activated protein 
kinase (MAPK) signaling pathways and stimulates the ex-
pression of inducible nitric oxide synthase (iNOS), various 
cytokines and chemokines, and matrix degrading enzymes 
such as MMPs and aggecanases. Knockout mice lacking 
either IL-1, ICE (IL-1-converting enzyme) or iNOS de-
velop accelerated OA [25] after knee surgery. This unex-
pected observation suggests that the primary role of IL-1 is 
to maintain a balanced metabolism in the AC and IL-1-
deficiency might up-regulate the expression of other cata-
bolic enzymes in the knockout mice. 
 IL-6 is a multifunctional cytokine that mediates joint 
inflammation, but it also induces the expression of protein-
ase inhibitors in chondrocytes [43, 44] implicating IL-6 as a 
protective factor against cartilage destruction. This assump-
tion was supported in a study with IL-6-deficient mice. Ag-
ing IL-6-/- male mice exhibit severe cartilage erosion, sub-
chondral sclerosis, reduced PG synthesis and bone mineral 
density with higher incidence than IL-6-/- females or wild 
type mice [45]. In the STR/ort mouse strain, which develop 
spontaneous OA-like changes more severely in males than in 
females, young females display increased expression of IL-6 
and the chondroprotective IL-4 and TGF- [46]. It was hy-
pothetized that in IL-6-/- females the upregulation of IL-
4/TGF- may compensate for the loss of IL-6, ameliorating 
OA pathology [45]. 
Growth Factors 
 It is generally accepted that growth factors including the 
members of the transforming growth factor (TGF)- super-
family, insulin-like growth factor (IGF)-I and fibroblasts 
growth factors (FGFs) play pivotal roles in AC biology ow-
ing to their ability to modulate chondrocyte differentiation, 
proliferation and metabolism [42, 47, 48]. IGF-I modulates 
cartilage homeostasis by promoting PG synthesis and chon-
drocyte survival, and by opposing the catabolic effects of IL-
1 and TNF-. IGF-I is produced primarily by growth hor-
mone (GH) stimulation and transgenic mice over-expressing 
bovine GH develop arthritic joints exhibiting AC lesions and 
osteophyte formation [49, 50]. The tissue degradation corre-
lated with a high TNF- level, and decreased proliferation 
and increased apoptosis of the chondrocytes [50]. 
 Numerous in vitro studies have shown that mammalian 
TGF- isoforms potently induce chondrocyte PG and colla-
gen II biosynthesis and, at the same time, suppress the ex-
pression of IL-1-regulated genes [51, 52]. Although many 
findings imply that TGF- could be used for treatment of 
OA, repeated injection of TGF- into mouse knee joints re-
sulted in osteophyte formation and cartilage lesions suggest-
ing a role for excessive TGF- in OA development [53]. 
Transgenic mice expressing a dominant negative form of the 
human TGF- type II receptor (TGFRIIDN) develop pro-
gressive joint degeneration characterized by PG depletion, 
synovial hyperplasia, ectopic hypertrophy and osteophyte 
formation [54]. Targeted disruption of exon 8 of the Smad3 
(Smad3ex8/ex8) gene encoding a receptor-activated SMAD 
which transduces TGF- signals into the nucleus, leads to a 
similar phenotype as seen in TGFRIIDN transgenics [55]. A 
recent microarray analysis of Smad3ex8/ex8 articular chondro-
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cytes indicated the enhanced expression of MMPs as well as 
alterations in the expression of genes responsible for protein 
synthesis, cellular respiration and growth factor signaling, 
implying that Smad3-deficiency interferes with several cellu-
lar mechanisms which might contribute to the development 
of OA [56]. LTBP (latent TGF- binding protein)-3 is a 
structural component of the ECM which modulates TGF- 
availability [57]. Mice lacking LTBP-3 have impaired mem-
branous ossification and develop progressive osteosclerosis 
and OA associated with ectopic hypertrophic chondrocyte 
differentiation in the superficial zone of the AC [58]. Collec-
tively, these mouse models demonstrate that TGF-/Smad-3 
signaling is necessary to repress articular chondrocyte differ-
entiation and to maintain normal articular cartilage function.  
 Bone morphogenetic proteins (BMPs), members of the 
TGF- superfamily, are critically involved in the control of 
multiple aspects of embryogenesis including bone and carti-
lage formation [47, 59]. The physiological role of BMP sig-
naling in the maintenance of AC was recently addressed by 
conditional targeting of the gene encoding BMP receptor 1a 
(BMPR1A) [60]. Since Bmpr1a-/- mice die during early em-
bryogenesis, the floxed Bmpr1a allele was deleted by ex-
pressing Cre recombinase under the control of the joint-
specific Gdf-5 (growth differentiation factor-5) regulatory 
regions. Young Gdf5-Cre/Bmpr1afl/fl mice showed defective 
joint development in the ankle, whereas most other joints of 
the body developed normally. This initially mild phenotype, 
however, was followed by severe OA-like changes in adult 
digit and knee joints characterized by PG loss and progres-
sive destruction of the AC. Interestingly, the expression of 
the Agn and Col2a1 genes was also reduced by the mutant 
articular chondrocytes but, in contrast to mice with defective 
TGF- signaling, the articular cartilage showed no signs of 
hypertrophic differentiation. These findings reveal that 
BMPR1A function is required for 1) the formation of spe-
cific joints and 2) for the maintenance of adult articular carti-
lage by stimulating the expression of key ECM molecules. 
BMP and TGF- signaling pathways therefore play partially 
distinct roles in OA pathogenesis. 
 While the importance of FGF/FGF receptor signaling in 
limb patterning and skeletal development is well appreciated 
[61], the role of FGFs in AC was only recently addressed 
using mice lacking FGF receptor 3 (FGFR-3). Fgfr-3-/- mice 
develop skeletal overgrowth [62], osteopenia [63] and early-
onset osteoarthritis [64]. The OA phenotype is characterized 
by enhanced expression of MMP13 and increased exposure 
of MMPs-generated aggrecan and collagen II cleavage prod-
ucts accompanied by PG loss and alteration of the biome-
chanical properties of the articular cartilage. In addition, col-
lagen X is expressed above the tidemark in the mutant AC 
suggesting that FGFR-3 is not only a critical regulator of AC 
metabolism but it is also required to suppress terminal dif-
ferentiation of articular chondrocytes. 
 Mitogen-inducible gene 6 (Mig-6) is an immediate early 
response gene that can be activated by growth factors [65]. 
Mig-6
-/-
 mice develop severe joint defects and most mice die 
around 6 month of age due to tempomandibular (TM) joint 
ankylosis [66]. The phenotype includes early-onset degrada-
tion of the AC, synovial hyperplasia, subchondral cyst and 
osteophyte formation. It was suggested that following me-
chanical stress Mig-6 suppresses the stimulatory effects of 
growth factors on the proliferation and differentiation of 
mesenchymal progenitors required for joint renewal. Conse-
quently, the ablation of Mig-6 leads to overproliferation of 
these cells causing bony outgrowths and joint deformities. 
MATRIX INTEGRITY AND SIGNALING 
 The composition and structural organization of the matrix 
varies throughout the articular cartilage to fulfill specific 
mechanical demands [67]. In addition to the structural role, 
the matrix provides an instructive environment from which 
extracellular information is transduced to chondrocytes via 
cell surface receptors. The heterodimeric () integrins are 
the major class of adhesion molecules that mediate chondro-
cyte-ECM interactions. Articular cartilage chondrocytes 
primarily express 1-subunit-containing integrins including 
receptors for fibrillar collagens (11, 21 and 101) and 
fibronectin (51). It has been suggested that ECM degrada-
tion products of the AC stimulate MMP13 synthesis through 
integrin-mediated activation of Erk, p38 and JNK, members 
of the MAPK family [68, 69]. Type II collagen fibrils also 
bind to and activate the tyrosine kinase receptor discoidin 
domain receptor 2 (DDR2), which in turn induces MMP13 
expression in human OA cartilage [70, 71]. 
The Fibrillar Collagen Network and Collagen Receptors 
 Collagen fibrils of the cartilage are heterotypic consisting 
of the abundant type II and the quantitatively minor type IX 
and XI collagens. Mutations in these collagens lead to a 
range of heritable disorders primarily affecting the cartilagi-
nous skeleton [72]. In general, the consequence of mutations 
in the genes encoding collagen IX (COL9A1, COL9A2 and 
COL9A3) are the mildest leading to multiple epiphyseal 
chondrodysplasia (MED), a heterogenous group of skeletal 
dysplasias characterized by moderately short stature and 
early onset osteoarthritis. Some collagen II (COL2A1) and 
collagen XI (COL11A1 and COL11A2) mutations result in 
Stickler syndrome, a phenotypically and genetically variable 
disorder associated with ocular defects and OA of the hip 
and knee joints [73]. 
 Mice with collagen II deficiency in the cartilage matrix 
as a consequence of engineered (Col2a1-/-) or spontaneous 
mutations (dmm/dmm; disproportionate micromelia) and 
transgenic mice expressing high levels of a deleted version 
of the murine Col2a1 gene (Del1+/+) exhibit severe dwarfism 
and die at birth from respiratory failure [74]. In contrast, 
heterozygous animals survive and develop variable degrees 
of OA. In the Del1+/- mice, OA-like lesions appear at 3 
months of age that gradually progress in older mice [75]. 
Severe AC damage develops slightly slower in dmm/+ mice 
[76]. Whereas Del1+/- and dmm/+ mice show early-onset OA, 
Col2a1
+/- develop a milder phenotype characterized by a 
higher prevalence of OA in aged mice in association with a 
softened articular cartilage [77, 78]. In the Del1+/- mice the 
onset of cartilage destruction coincides with the upregulation 
of cathepsin K in chondrocytes, suggesting the involvement 
of this cysteine protease in the development of OA [35]. 
 The heterotrimeric (123) collagen IX and collagen 
XI molecules are associated with the fibrillar surface or bur-
ied in the core of the fibers, respectively. Homozygous 
cho/cho (chondrodysplasia) mice harboring a Col11a1 gene 
with a naturally mutated premature stop codon develop lethal 
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chondrodysplasia [79], whereas cho/+ mice show a normal 
skeleton at birth but exhibit age-dependent OA-like changes 
of the knee and TM joints [80-82]. Homozygous transgenic 
mice expressing a truncated version of the 1(IX) chain or 
Col9a1
-/- mice lacking the triple-helical collagen IX mole-
cules survive and develop early-onset OA [2, 3, 82, 83]. A 
possible molecular mechanism underlying the OA-like phe-
notype of the Col9a1-/- and cho/+ mice was proposed in a 
series of recent publications [80-84]. As the result of the 
structural disorganization of the collagen network, mechani-
cal stress first elevates pericellular PG synthesis and chon-
drocyte proliferation leading to the formation of cell clusters 
in the mutant AC by 3 months of age. This repair step is fol-
lowed by the overproduction of MMP13, PG depletion and 
collagen degradation by 6 months of age, and severe carti-
lage erosion over the age of 9-12 months. The key event in 
the progression of OA is the increasing contacts between 
type II collagen fibrils and the chondrocyte surface receptor 
DDR2. The enhanced activation of DDR2 up-regulates the 
expression of MMP13 as well as the expression of DDR2 
itself in the articular cartilage. In vitro experiments with 
mouse chondrocytes revealed that the interaction between 
native type II collagen and the collagen binding discoidin 
domain of DDR2 is a prerequisite for the ERK/p38-mediated 
induction of MMP13 expression. In vivo, the MMP13-
mediated degradation of the collagen fibrils and fibronectin 
may further stimulate MMP13 production via activation of 
the integrin receptors 21 and 51, respectively, resulting 
in the progressive destruction of the articular cartilage [84]. 
 Chondrocyte integrins act as mechanoreceptors and 
transduce signals from the pericellular matrix into intracellu-
lar pathways regulating cartilage homeostasis [85]. Despite 
the numerous integrin knockouts described in the literature, 
the in vivo role of integrins in OA pathogenesis is largely 
unknown. Most mutant lines lacking a particular integrin 
subunit develop a normal skeleton without reported AC ab-
normalities [86], whereas the cartilage-specific deletion of 
the 1 subunit-containing integrins results in severe chon-
drodysplasia and high mortality rate at birth [87]. To date 
only 1 integrin-deficiency has been linked to pathological 
abnormalities of the knee articular cartilage [88]. 1-null 
mice show precocious PG loss, synovial hyperplasia and 
cartilage erosion associated with increased MMP2 and 
MMP3 expression. The mutant AC is also characterized by 
hypocellularity and increased cell death. Interestingly, a 
similar, accelerated development of knee OA was observed 
in mice lacking the membrane-anchored ADAM15 [89]. 
ADAM15 possesses multiple pericellular functions including 
the modulation of outside-in signaling of integrins. Alto-
gether, these data implicate collagen-binding integrins as 
critically involved in the regulation of AC remodeling and 
chondrocyte survival in response to ECM stimuli. 
Proteoglycans 
 Aggrecan is the most abundant proteoglycan of the ar-
ticular cartilage and association of aggrecan gene (AGC1) 
polymorphism with various forms of OA has been demon-
strated [90, 91]. More recently, a frameshift mutation in exon 
12 of AGC1 was identified in patients with autosomal domi-
nant spondyloepiphyseal dysplasia type Kiberley (SEDK) 
characterized by mild short stature and early onset OA [92]. 
In the cmd (cartilage matrix deficiency) mice, a spontaneous 
mutation leads to a premature stop codon in exon 6 and to 
the absence of mature aggrecan in the matrix [93]. Homozy-
gous mutants exhibit severe chondrodysplasia and die at 
birth due to respiratory failure. Heterozygous mice (cmd/+) 
survive and develop mild dwarfism and age-dependent spi-
nal abnormalities [94]. In contrast to SEDK, no OA-like 
changes were reported in these mice [95]. A possible expla-
nation for this discrepancy is that the SEDK AGC1 mutation 
predicts the formation of a relatively large truncated protein, 
which may be retained in the endoplasmatic reticulum (ER), 
impairing chondrocyte function in the articular cartilage. 
 The small leucine-rich proteoglycans (SLRPs) play piv-
otal roles in connective tissues interacting with various ma-
trix macromolecules and growth factors, thereby modulating 
both ECM organization and cellular metabolism [96]. Mice 
lacking SLRPs exhibit a broad range of phenotypes primarily 
affecting collagen fibrillogenesis in tissues rich in type I col-
lagen such as skin, bone, tendon and cornea [96]. Several 
SLRPs are expressed in the articular cartilage including 
biglycan, fibromodulin and lumican. Mice double deficient 
in biglycan/fibromodulin [97] or lumican/fibromodulin [98] 
develop premature knee OA characterized by severe erosion 
of the articular cartilage at 3-6 months of age. The corre-
sponding single knockout mice, except lumican-null, also 
exhibit OA which is milder and occurs later than in the dou-
ble mutants [97-99]. The cause of OA pathology in these 
mice is unclear but it could be secondary to structural and 
functional defects in tendons and/or ligaments. Bigly-
can/fibromodulin double knockout mice also develop TM 
joint OA with significantly later onset and slower progres-
sion than knee OA [100]. Biglycan/fibromodulin double 
knockout mice also develop TM joint OA with significantly 
later onset and slower progression than knee OA [100]. The 
overt TM joint OA is preceded by reduced chondrocyte pro-
liferation suggesting that misregulated cell growth could be 
an important factor in this type of OA. Knockout mouse 
models demonstrate that SLRPs are involved in the control 
of cell growth in various tissues via the modulation of 
TGFb/BMP availability [101], therefore it is possible that 
biglycan and/or fibromodulin deficiency impairs chondro-
cyte proliferation by disturbing growth factor signaling. 
 Perlecan (HSPG2) is a large secreted proteoglycan abun-
dant in basement membranes (BMs) and cartilage. The levels 
of perlecan protein and mRNA were found to be increased in 
late stage OA samples from human knee joints which might 
suggest that perlecan is involved in repair processes acti-
vated around the defect areas [102]. The importance of per-
lecan in skeletogenesis is illustrated by the severe chondro-
dysplasia developed in human and mice lacking functional 
perlecan. Patients with dyssegmental dysplasia of the Sil-
verman-Handmaker type (DDSH) and perlecan-null (Hspg2-/-) 
mice are characterized by defective endochondral bone for-
mation and embryonic/perinatal lethality [103]. In contrast, 
mutations reducing the level of perlecan lead to the non-
lethal, autosomal-recessive Schartz-Jampel syndrome (SJS) 
characterized by osteochondrodysplasia and myotonia [104]. 
Recently a mouse model of SJS with altered Hspg2 tran-
scription and reduced perlecan matrix deposition was gener-
ated [105]. The hypomorphic mutants (C1532Yneo) mimic 
typical SJS and exhibit rough surface and clefts on the 
humeral head resembling OA. 
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 Proteoglycan 4 (PRG4) is highly abundant in the syno-
vial fluid and on the surface of AC, and is secreted by both 
superficial chondrocytes and synoviocytes. Mutations in 
PRG4 lead to CACP syndrome characterized by precocious 
joint failure demonstrating the essential role of PRG4 in 
maintaining joint integrity [106]. PRG4 levels decrease at 
early OA stages in surgically induced degenerative AC ani-
mal models [107] implicating PRG4 in OA pathology. Mice 
Table 1. Gene Modified Mouse Models Relevant in Osteoarthritis Research 
 
Protein/Gene Model Articular Cartilage Phenotype Ref. 
Proteolytic Enzymes and Related Molecules 
ADAM15 
ADAMTS-1 
ADAMTS-4 
ADAMTS-5 
ADAMTS-4/-5 
Cathepsin K 
Cathepsin K 
MMP2 
MMP3 
 
MMP9 
MMP13 
MMP14 
Runx2 (+/-) 
TIMP3 
 
KO 
KO 
KO 
KO 
KO 
TR 
KO 
KO 
KO 
 
KO 
TR 
KO 
KO 
KO 
 
Accelerated knee OA; modulation of integrin signaling? 
Normal susceptibility to experimentally induced arthritis 
Normal susceptibility to experimentally induced arthritis 
Protection from experimental arthritis; major aggrecanase in OA 
Similar to ADAMTS-5 KO, AC releases intact aggrecan 
Joint destruction associated with sever bone defects 
Osteopetrosis, OA was not investigated 
Age-dependent AC destruction, bone defects 
Decreased susceptibility to spontaneous OA and inflammatory arthritis 
Increased susceptibility to surgically-induced OA 
Spontaneous OA-like changes in young mice 
Accelerated OA, ectopic collagen X expression 
Skeletal defects including AC destruction, impaired MMP2 activation 
Amelioration of surgically induced OA, reduced MMP-13 expression 
Mild OA, increased cleavage of aggrecan and collagen II 
 
[89] 
[119] 
[14-16] 
[14, 16] 
[18, 120] 
[36] 
[37] 
[31] 
[22-24] 
[25] 
[22] 
[28] 
[32, 33] 
[29] 
[34] 
ECM Molecules and Receptors 
1 integrin 
Aggrecan (Cmd/+) 
Aggrecan “Jaffa” 
 
Aggrecan ”Chloe” 
 
Biglycan 
Fibromodulin 
Biglycan/Fibromodulin 
Lumican 
Lumican/Fibromodulin 
Collagen II, 1 (+/-) 
Collagen II, 1 (dmm/+) 
Collagen II, 1 (Del/+) 
Collagen IX, 1 
Collagen IX, 1 
Collagen XI, 1 (cho/+) 
Collagen XI, 2 
Proteoglycan 4 
Matrilin-3 
 
Matrilin-1/Matrilin-3 
Perlecan 
 
KO 
KO 
KI 
 
KI 
 
KO 
KO 
dKO 
KO 
dKO 
KO 
NO 
TR 
KO 
TR 
NO 
KO 
KO 
KO 
KO 
dKO 
KO 
 
Accelerated OA, increased MMP2 and MMP3 expression 
No reported OA-like changes 
Resistant to aggrecanase-mediated IGD cleavage 
Partially protected from experimental arthritis 
Resistant to MMP-mediated IGD cleavage 
Normal susceptibility to experimentally induced arthritis 
OA-like changes, ectopic tendon ossification 
Age-dependent OA-like changes, ectopic tendon ossification 
Early onset OA, ectopic tendon ossification, accelerated TMJ OA 
OA was not reported 
Early onset OA, ectopic tendon ossification 
Higher prevalence of OA in aging mice, softer AC 
Early-onset OA, AC thinning, increased cell density, reduced matrix 
Early-onset OA, up-regulation of cathepsin K 
Early onset OA, up-regulation of DDR2 and MMP13 expression 
Early onset OA 
Early onset OA, up-regulation of DDR2 and MMP13 expression 
Mild abnormalities of the AC, no obvious OA 
Surface changes followed by AC deterioration 
No obvious OA in one study; high OA prevalence at 12 months in 
another study 
Similar incidence of OA in controls and double mutants at 14 months 
OA-like changes on the femoral head  
 
[88] 
[95] 
[19] 
 
[21] 
[19] 
[97] 
[99] 
[97, 100] 
[98] 
[98] 
[77, 78] 
[76] 
[75] 
[3, 82, 83] 
[2] 
[80-82] 
[121] 
[108] 
[113] 
[118] 
[117] 
[105] 
Cytokines and Growth Factors 
Growth hormone 
BMPR1A 
Fgfr3 
IL-1 
IL-6 
ICE 
Ltbp-3 
Mig-6 
iNOS 
Smad3 
TGFRII 
 
TR 
cKO 
KO 
KO 
KO 
KO 
KO 
KO 
KO 
KO 
TR 
 
OA-like changes of the AC, osteophyte formation 
Progressive AC degradation 
Premature OA, increased MMP13 expression 
Acceleration of surgically induced OA 
Age-dependent OA and subchondral sclerosis in males 
Acceleration of surgically induced OA 
Progressive AC degradation, abnormal chondrocyte hypertrophy 
Early-onset OA, osteophyte formation 
Acceleration of surgically induced OA 
Progressive OA, osteophyte formation, increased Col10 expression 
Progressive OA, osteophyte formation, increased Col10 expression  
 
[49, 50] 
[60] 
[64] 
[25] 
[45] 
[25] 
[58] 
[66] 
[25] 
[55] 
[54] 
Note: KO, knock-out; dKO, double knock-out; cKO, conditional knock-out; KI, knock-in; NO, naturally occurring; TG, transgenic. 
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lacking proteoglycan 4 (Prg4-/-) show age-dependent syno-
vial hyperplasia, irregular AC surface with protein deposits, 
loss of the flattened layer of superficial zone chondrocytes 
and subsequent AC deterioration [108]. In addition, the mice 
exhibit abnormal calcification of tendons in the ankle joint. 
Collectively, these data suggest a protective role for proteo-
glycan 4 on AC and provide a novel therapeutic target for 
treatment of OA. 
Glycoproteins Modulating ECM Structure and Function 
 In hyaline cartilage the collagen-aggrecan networks are 
interconnected via molecular associates containing SLRPs 
and non-collagenous glycoproteins such as cartilage oli-
gomeric matrix protein (COMP) and the members of the 
matrilin family [109]. COMP is abundant in both the devel-
oping growth plate and the articular cartilage, and mutations 
in the COMP gene results in MED and pseudoachondrodys-
plasia [110]. Matrilins, especially matrilin-1 and -3, are 
highly expressed during cartilage development and matrilin-
3 mutations are linked to various skeletal disorders including 
a distinct group of MED [109]. COMP, matrilin-1 and matri-
lin-3 levels are upregulated in articular cartilage and/or the 
synovial fluid during joint diseases; they therefore may serve 
as markers for disturbed cartilage metabolism. Mice lacking 
these proteins do not develop chondrodysplasia implying a 
dominant negative pathomechanism behind the human dis-
orders [111-113]. Similarly, no signs of OA were observed 
in COMP- and matrilin-1-deficient mice [111, 112]. The role 
of matrilin-3 in articular cartilage function is more contro-
versial. In humans, the association of matrilin-3 polymor-
phisms with hand osteoarthritis but not with knee os-
teoarthritis was demonstrated [114-116]. Matrilin-3-deficient 
single and double knockout mice (Matn3-/- and Matn1-/-
/Matn3
-/-) generated in our laboratory showed no evidence 
for higher incidence of OA-like changes in the knee joints 
compared with control mice up to 14 months of age [113, 
117]. In contrast, a higher prevalence of severe knee OA at 
one year of age was reported in a second matrilin-3-deficient 
mouse line suggesting that matrilin-3 may protect articular 
cartilage from degradation [118]. The discrepancy between 
these works might be explained by background or gender 
specific differences of the investigated mice and call for fur-
ther, more detailed studies. 
CONCLUSION 
 During the last decade, the number of genetically modi-
fied mice with OA-like changes has dramatically expanded. 
These mouse models are particularly effective to elucidate 
the molecular basis of articular cartilage homeostasis under 
both normal and pathological conditions. The analysis of the 
phenotypic consequences of gene modifications in trans-
genic, knockout and knock-in mice has yielded a wealth of 
information about the complex functional interactions among 
cytokines, growth factors and ECM structural proteins of the 
joints and has provided valuable insight to the pathogenesis 
of cartilage degeneration in osteoarthritis. The genetic mouse 
models not only help to dissect signal transduction pathways 
that regulate the catabolic/anabolic balance in AC, they are 
also useful in identifying OA-candidate genes and to validate 
potential target molecules to treat or prevent OA. There is no 
doubt that gene targeting in mice will continue to be an im-
portant tool of OA research in the future. 
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The lack of β1 integrins on chondrocytes leads 
to severe chondrodysplasia associated with high 
mortality rate around birth. To assess the 
impact of β1 integrin-mediated cell-matrix 
interactions on the function of adult knee joints, 
we conditionally deleted the β1 integrin gene in 
early limb mesenchyme using the Prx1-cre 
transgene. Mutant mice developed short-limbed 
dwarfism and had joint defects owing to β1 
integrin-deficiency in articular regions.   The 
articular cartilage (AC) was structurally 
disorganized accompanied by accelerated 
terminal differentiation, altered shape and 
disrupted actin cytoskeleton of the 
chondrocytes. Defects in chondrocyte 
proliferation, cytokinesis and survival resulted 
in hypocellularity. However, no significant 
differences in cartilage erosion, in the 
expression of matrix-degrading proteases or in 
the exposure of aggrecan and collagen II 
cleavage neoepitopes were observed between 
control and mutant AC. We found no evidence 
for disturbed activation of MAP kinases 
(ERK1/2, p38 and JNK) in vivo. Furthermore, 
fibronectin fragment-stimulated ERK 
activation and MMP-13 expression were 
indistinguishable in control and mutant femoral 
head explants. The mutant synovium was 
hyperplastic and frequently underwent 
chondrogenic differentiation. β1-null 
synoviocytes showed increased proliferation 
and phospho-focal adhesion kinase expression. 
Taken together, deletion of β1 integrins in knee 
joints results in multiple abnormalities 
reminiscent of osteoarthritis, however, it does 
not accelerate AC destruction, perturb cartilage 
metabolism or influence intracellular MAP 
kinase signaling pathways. 
 
Chondrocytes of the articular cartilage (AC) 
secrete a unique set of extracellular matrix (ECM) 
molecules that assemble into interactive associates 
composed of collagens, proteoglycans (PGs) and 
non-collagenous glycoproteins (1). The fibrillar 
collagen meshwork supplies cartilage with its 
tensile strength, while the hydrated 
glycosaminoglycan (GAG) chains of PGs (mainly 
aggrecan) generate an osmotic swelling pressure 
that resists compressive forces. In diarthrodial 
joints, the molecular composition and the physical 
properties of the cartilage are principal 
determinants for the shock absorbing function of 
articular surfaces upon mechanical loading. During 
the development of osteoarthritis (OA), an 
imbalance between anabolic and catabolic 
processes increases the proteolysis of PGs and 
collagens (2, 3), which eventually leads to the 
mechanical weakening of the AC and culminates 
in its progressive destruction. Physiological and 
pathological remodeling of the AC ECM is 
primarily attributed to the activities of matrix 
metalloproteinases (MMPs) and ADAMTS (a 
disintegrin and metalloproteinase with 
thrombospondin-like repeat) proteases (4, 5), and 
is controlled  by the communication between the 
cells and their environment.  
  An increasing amount of evidence 
suggests that interactions between chondrocytes 
and the ECM through the integrin family of 
heterodimeric (αβ) transmembrane receptors play a 
central role in cartilage function (6). Integrins 
connect the pericellular matrix to cytoskeletal and 
intracellular signaling complexes and modulate 
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various cellular functions including survival, 
proliferation, differentiation as well as matrix 
assembly and metabolism (7, 8). Chondrocytes 
express several integrin receptors for cartilage 
matrix ligands such as α1β1, α2β1 and α10β1 (for 
collagen II), α5β1, αvβ3 and αvβ5 (for fibronectin) 
and α6β1 (for laminin) (6, 9).  We have previously 
demonstrated that β1fl/fl-Col2a1cre+ mice, in which 
the floxed β1 integrin gene (β1fl/fl) was deleted 
using the chondrocyte-specific Col2a1cre 
transgene, display severe chondrodysplasia and a 
high mortality rate at birth (10). Homozygous 
mutant mice exhibit multiple growth plate 
abnormalities during endochondral bone formation 
characterized by defects in chondrocyte adhesion, 
shape, proliferation, cytokinesis and actin 
organization. In addition, the cartilage matrix 
shows a sparse, distorted collagen network. 
Similar, but milder abnormalities were found in 
mice lacking the collagen-binding integrin α10β1 
or integrin-linked kinase in cartilage (11, 12). 
Although these works have identified β1 
integrins as essential regulators of growth plate 
development, the role of integrins in joint 
morphogenesis, adult joint function and pathology 
is incompletely understood. In embryonic mouse 
limb culture system, administration of β1 and α5 
blocking antibodies or RGD peptides induced 
ectopic joint formation between proliferating and 
hypertrophic chondrocytes of the growth plate 
suggesting that α5β1 integrin controls the decision 
between cartilage differentiation and joint 
formation during development (13). In adult joints, 
increased immunostaining of β1 integrin was 
reported in osteoarthritic monkey cartilage 
compared to normal cartilage (14) and in human 
OA samples at minimally damaged locations 
compared to areas with more severe lesions (15). 
In another study, the neo-expression of α2, α4 and 
β2 integrins were observed in osteoarthritic human 
femoral head cartilage (16). In vitro experiments 
have suggested that signaling through the 
fibronectin (FN) receptor α5β1 integrin is pivotal 
to prevent cell death of normal and osteoarthritic 
human articular chondrocytes (17). FN fragments 
(FN-fs) present in synovial fluid and cartilage of 
OA patients have been implicated in cartilage 
breakdown (18-21).  Human AC chondrocytes 
treated with  the central, 110-120 kDa cell-binding 
FN-f but not with intact FN were shown to 
increase MMP-13 synthesis through the 
stimulation of α5β1 integrin and the subsequent 
activation of the proline-rich tyrosine kinase-2 and 
mitogen activated protein kinases (MAPKs) ERK-
1/2, JNK and p38  (22, 23). Similarly, an 
adhesion-blocking antibody against α2β1 integrin 
induced the phosphorylation of MAPKs in human 
AC chondrocytes (22).  Treatment of cultured 
rabbit synovial fibroblasts with central FN-fs or 
activating antibodies against α5β1 integrin 
elevated MMP-1 and MMP-3 expression (24). 
While these experiments suggest that blocking 
integrin signaling through α2β1/α5β1 in respond to 
degradation fragments may attenuate OA, mice 
lacking α1β1 integrin are prone to osteoarthritis 
(25). Knee joints of α1-null mice display 
precocious PG loss, cartilage erosion associated 
with increased MMP-2 and MMP-3 expression, 
and synovial hyperplasia. 
 To further explore the role of β1 integrins 
in joint biology, here we report the deletion of the 
floxed β1 integrin gene in embryonic limb-bud 
mesenchymal cells using the Prx1cre transgene 
(26). β1fl/fl-Prx1cre+ mice were born alive with 
short limbs owing to the lack of β1 integrin 
heterodimers on chondrocytes. We found that β1 
integrin-deficiency in knee joints leads to multiple 
abnormalities of the AC and the synovium but it is 
not associated with accelerated AC destruction, 
perturbed AC metabolism and MAPK signaling. 
Our data suggest that β1 integrins are required for 
the proper structural organization of the AC by 
anchoring chondrocytes to the ECM but signaling 
through β1 integrins is less important for normal 
cartilage homeostasis.    
   
EXPERIMENTAL PROCEDURES 
 
Mice and radiography- Conditional β1 integrin 
mutant mice (β1fl/fl-Prx1cre+) were generated by 
intercrossing homozygous floxed (fl) β1 integrin 
females (27) with males double heterozygous for 
the β1 integrin (β1fl/+) and Prx1cre transgenic 
alleles (26). β1fl/+-Prx1cre+ and β1fl/+-Prx1cre- 
mice were phenotypically indistinguishable, 
therefore both genotypes were used as controls. 
For X-ray analysis, 16-month-old mice were 
euthanized and radiographs were taken with a 
sealed X-ray cabinet (Faxitron, model 43855A) at 
35 kV, 2 mA and 2 seconds of exposure time. 
Histology, OA grading and X-gal staining- 
Control and β1fl/fl-Prx1cre+ mice were euthanized 
and knee joints were harvested at various time 
points. For histology, samples were fixed in 4% 
paraformaldehyde (PFA) in phosphate buffered 
saline (PBS, pH 7.4), decalcified in 10% EDTA-
 2
PBS and processed for paraffin embedding. 
Approximately 300 consecutive, 6-µm-thick 
sagittal sections were collected from each 
specimen, and every 10th section was stained with 
Hematoxylin-Eosin (HE) for general histology or 
Safranin O-Fast green (SO) to monitor PG 
depletion. To asses osteoarthritis-like changes of 
the articular cartilage, we used a scoring system as 
follows: I. Cartilage erosion (0-5): 0-smooth 
cartilage surface; 1-surface irregularities; 2-cleft to 
transition zone; 3-cleft to radial zone; 4-cleft to 
calcified zone; 5-exposure of subchondral bone. II. 
Cellularity (0-3): 0-normal; 1-hypercellularity; 2-
clustering; 3-hypocellularity. III. Tidemark 
integrity (0-1): 0-normal; 1-loss of tidemark. IV. 
GAG content in the pericellular matrix (PM) (0 to 
2): 0-normal SO staining intensity; 1-focally 
increased intensity; 2-increased intensity 
throughout the cartilage. V. GAG content in the 
interterritorial matrix (ITM) (0 to 3): 0-normal SO 
staining intensity; 1-reduced staining; 2-focal 
patchy loss of staining; 3-50% of cartilage without 
staining. VI. Osteophyte formation (0-2): 0-none; 
1-formation of cartilage; 2-formation of bone. 
Total scale (0-16) and OA severity: 0-1, normal; 
2-5 mild OA; 6-11 moderate OA; 12-16, severe 
OA. 
Picrosirius red and X-gal staining were 
performed as described elsewhere (28, 29). 
Ultrastructural analysis-Knee joints 
including the subchondral bone were isolated and 
the tibial and femoral sides were separated under a 
stereomicroscope. Specimens were fixed in 2% 
glutaraldehyde in 0.1 M sodium cacodylate buffer 
(pH 7.4) for 3 days and processed for electron 
microscopy as previously described (30). 
Analysis of the actin cytoskeleton- Tibiae 
were freshly dissected and ~80 µm thick sagittal 
sections were obtained using a vibratome 
(Microm). Sections were then fixed in 4% 
PFA/PBS for 2 hours at room temperature, 
permeabilized with 0.1%Triton X-100 and stained 
with phalloidin Alexa488 (Invitrogen) to visualize 
the actin cytoskeleton and with DAPI (Sigma) to 
visualize the nucleus. 
Cell proliferation and apoptosis- To 
assess chondrocyte proliferation, PCNA 
(proliferating cell nuclear antigen) 
immunostaining was performed on tissue sections. 
To determine the labeling index, the percentage of 
immunoreactive nuclei per 100 cells, the numbers 
of brown-colored nuclei were counted. To detect 
apoptotic cells, TUNEL assay was used as 
described in (10). 
RT-PCR- To examine the mRNA levels of matrix 
degrading enzymes, tibiae were harvested from 4-
month-old control and β1fl/fl-Col2a1cre+ mice. 
Vibratome sections (100 µm) were cut and the 
articular cartilages were dissected using a sharp 
blade and a stereomicroscope. Cartilage pieces 
were pooled and total RNA was isolated using the 
RNeasy Lipid Tissue Mini Kit (Qiagen). The 
cDNA was synthesized using the SuperScript III 
RNaseH- Reverse Transcriptase (Invitrogene). For 
semiquantitative RT-PCR the following primers 
were used: Mmp2forward: 5´-GACAAGTGGTCC-
GCGTAAAG and Mmp2reverse: 5´-CATCTGCAT-
TGCCACCCATG; Mmp3forward: 5´-CCTACTTCT-
TTGTAGAGGAC and  Mmp3reverse: 5´- GTCAA-
ATTCCAACTGCGAAG; Mmp8forward: 5´-GTAA-
ACTGTAGAGTCGATGC and Mmp8reverse: 5´-
CATAGGGTGCGTGCAAGGAC; Mmp9forward: 
5´-CGAGTGGACGCGACCGTAG-TTGG and  
Mmp9reverse: 5´-CAGGCTTAGAGCCACGACCA-
TACAG; Mmp13forward: 5´-GTGTGGAGTTATG-
ATGATGT and  Mmp13reverse: 5´-TGCGATTAC-
TCCAGATACTG; Gapdhforward: 5´- TCGTGGAT-
CTGACGTGCCGCCTG and Gapdhreverse: 5´-
ACCCTGTTGCTGTAGCCGTAT.  
Immunohistochemistry (IHC) and ELISA 
assays-Knee joints were fixed in 4% PFA/PBS, 
decalcified and processed either for paraffin or 
cryo embedding. To enhance antibody penetration, 
both paraffin and cryo-sections were treated with 
bovine testicular hyaluronidase (2 mg/ml in PBS) 
at 37°C for 30 min. When needed, antigen 
retrieval was performed by incubating the sections 
either in 0.1M citrate buffer (pH 6.0) at 95°C for 
20 min or in 6M guanidine hydrochloride for 15 
min at room temperature. Primary antibodies 
against the following antigens were used: β1 
integrin (Chemicon MAB1997); aggrecan 
(Chemicon AB1031); G1-TEGE (Acris SP5418P);  
G1-PEN and ADAMTS-5 (gifts from Amanda 
Fosang); MMP-1 (Calbiochem IM35L); MMP-2 
(Chemicon AB19167); MMP-3 (Oncogene 
Research Products IM70); MMP-9 (Chemicon 
AB19016); MMP-13 (Chemicon AB8120); C1,2C 
(IBEX #50-1035);  phospho-p38 (#4631), 
phospho-ERK1/ERK2 (#4376), and phospho–JNK 
(#9251) (all obtained from Cell Signaling) and 
phospho-FAK (pY397, Invitrogen #44624G). 
Immunostaining was performed using the 
appropriate Vectastain ABC Elite kit (Vector 
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Laboratories) and 3,3´-diaminobenzidine (Sigma) 
as chromogenic substrate. 
   Commercial ELISA assay kits were used 
to detect the levels of collagen II degradation 
products either in urine samples (CTX-II, which 
measures C-telopeptides fragments; Nordic 
Bioscience 2CAL4000) or in serum samples (C2C, 
which measures the carboxyl-terminal ¾ fragment 
collagen II cleavage neoepitope; IBEX 60-1001-
001). The CPII ELISA kit (IBEX 60-1003-001) 
was used to measure the serum level of collagen II 
C-propeptide, which correlates with collagen II 
biosynthesis. 
Cartilage explant culture- Femoral heads 
were harvested from 4-week-old control and 
mutant mice and cultured in 300 µl serum-free 
DMEM supplemented with streptomycin-
penicillin in 48-well plate for 4 days. Treated 
cartilages received 1µM fibronectin fragment 
(40.1 kDa FNIII7-10RGD) from the beginning of 
the culture. At the end of the culture period the 
femoral heads were fixed in 4% PFA/PBS and 
cryo-embedded. Sections from treated and 
untreated as well as from day 0 samples were 
immunostained for phospho-ERK1/ERK2 and 
MMP-13.    
Statistical analysis- Non-parametric 
Mann-Whitney U test was used to compare the 
median of total OA and cartilage erosion scores. 
All other data were expressed as the mean ± SD 
and significance was assessed using either 
Student´s t test or Mann-Whitney test. 
  
RESULTS 
 
Generation of the β1fl/fl-Prx1cre+ mice. To 
assess the function of β1 integrins in joint biology, 
we deleted the floxed β1 integrin gene in 
embryonic limb-bud mesenchyme by using the 
Prx1cre transgenic line (26). Since the ablation of 
the β1fl allele activates a promoter-less LacZ gene 
(10), we performed X-gal staining to demonstrate 
β-galactosidase (β-gal) activity and monitor the 
deletion of the gene. Forelimb sections of β1fl/fl- 
Prx1cre+ mice at E 18.5 showed β-gal activity in 
tissues of mesenchymal origin including cartilage, 
periosteum/perichondrium, ligaments, tendons, 
synovium and vessels (Fig.1, A-D). While β-gal 
negative chondrocytes were occasionally observed 
in the growth plate, the developing AC contained 
only β-gal positive chondrocytes indicating very 
high deletion efficiency of β1 integrin in this 
region (Fig. 1B). 
β1fl/fl-Prx1cre+ mice recapitulate the 
embryonic skeletal phenotype of β1fl/fl-Col2a1cre+ 
mice (not shown) and survive after birth. 
Immunostaining of control knee joints at 1 month 
showed abundant expression of β1 integrin on AC 
chondrocytes, while little if any expression was 
detected in β1fl/fl-Prx1cre+ AC (Fig. 1E). Similarly, 
β1 integrin was largely absent in the synovium 
(Fig. 1F), meniscus, patella and joint ligaments 
(not shown). Adult mutant mice exhibited 
shortened long bones and abnormal gait which 
were associated with reduced flexibility of the 
knee joints from 7 months.  X-ray analysis of the 
hind-limb at 16 months (Fig. 1G) demonstrated 
misaligned bones, irregular joint surfaces, joint 
space narrowing and the appearance of radio-
dense plaques in the vasculature of β1fl/fl-Prx1cre+ 
mice. The mutant mice were able to walk at all 
stages, however, their mobility was apparently 
reduced from 8 months of age compared to control 
littermates. The frequency of vascular calcification 
increases with age and is associated with high 
mortality rate between 8-12 months of age. 
Histopathological changes of the articular 
cartilage. At birth, the forming AC in control and 
mutant tibiae was unstratified with rounded 
chondrocytes exhibiting a random, isotropic 
distribution pattern (Fig. 2A). At 1 month, control 
tibia showed advanced ossification of the 
epiphysis, while in mutants the secondary 
ossification centre was narrowed and entirely 
composed of chondrocytes (Fig. 2B). Control AC 
displayed structural anisotropy characterized by 
the appearance of flattened chondrocytes in the 
superficial layer and formation of columns in 
deeper regions. In contrast, the mutant AC was 
still isotropic lacking flat cells and column-like 
structures and showed a broad, acellular surface 
area facing the joint cavity (Fig. 2C). After 1 
month of age, endochondral ossification was also 
evident in the mutant epiphyses and the AC 
exhibited several abnormalities including 
thickening (Fig. 2G), disorganized cell 
arrangement with frequent clustering, flattening of 
the tibial plateau and formation of less 
subchondral bone (Fig. 2D). In 1- and 4-month-old 
control and mutant mice the AC surface was 
largely intact with slightly increased roughening in 
mutants (Fig. 2C and not shown). At later stages, 
we found typical signs of cartilage erosion in both 
experimental groups (Fig. 2D). In general, SO 
staining indicated comparable levels of negatively 
charged PGs in control and mutant AC (Fig. 2, E 
 4
and F). At 1 month, the tidemark separating the 
uncalcified and calcified AC was only detectable 
in controls (Fig. 2E). At later stages the tidemark 
appeared in the mutants, however, it was irregular 
and often discontinuous (Fig. 2F). Typically, 
extended pericellular matrix (PM) staining was 
observed in the calcified zone of mutants. 
Furthermore, the length of the uncalcified zones 
with strong SO staining in the interterritorial 
matrix (ITM) is decreased, while the length of the 
calcified zone with less intense staining in the ITM 
is increased in mutants (Fig. 2, E, F and H). 
Quantification of the OA-like 
histopathological changes of the knee joint 
revealed that the total score (the sum of sub-
scores, see Experimental Procedures) is increased 
in each age group (4, 7 and 12 months) of mutants 
compared to controls (Fig. 3A). Separate 
evaluation of cartilage erosion, however, did not 
reveal significant differences in AC destruction 
between control and mutant mice (Fig. 3B). 
Whereas the median score was slightly higher in 
mutants at 4 and 7 months, it moderately 
decreased at 12 months compared with controls.  
Ultrastructural and cytoskeletal abnor-
malities of the mutant articular cartilage. Electron 
microscopy at 4 months revealed abnormalities 
throughout the mutant AC (Fig. 4A). Compared 
with controls, mutant mice displayed an enlarged 
superficial zone with extra layers of disorganized 
collagen fibrils and rounded chondrocytes. In all 
AC zones the PM compartment was expanded, 
most prominently in the lower radial and the 
calcified zones, the chondrocytes were frequently 
binucleated and extended long microvilli into the 
matrix. In the ITM compartment the fibrillar 
network was less organized with a high variation 
of fibril density (not shown), whereas in the PM 
thick collagen bundles occasionally appeared near 
the chondrocyte surface (Fig. 4A). 
  To test the impact of β1 integrin-
deficiency on the actin cytoskeleton of AC 
chondrocytes, we analysed phalloidin-stained 
tissue sections by confocal microscopy. At 4 
months, the actin network was only mildly 
affected in mutants (not shown), however, by 11 
months marked abnormalities of the cytoskeleton 
were observed in chondrocytes located at the 
weight-bearing regions of the tibial plateau (Fig. 
4B). Whereas control chondrocytes in the 
uncalcified zones exhibited a strong and even 
cortical actin staining, mutant chondrocytes 
showed a faint and punctuated actin distribution 
indicating a disrupted actin cytoskeleton in the 
absence of β1 integrins. 
  Chondrocyte proliferation and survival.  
Quantification of AC cellularity in the tibial 
plateau revealed that β1fl/fl-Prx1cre+ mice have 
reduced chondrocyte density (Fig. 5A). 1 month 
old samples showed only a moderate reduction, 
whereas at later stages the mutants showed 
significantly fewer chondrocytes per unit area 
compared with controls. To study the underlying 
mechanism of hypocellularity, chondrocyte 
proliferation and death were investigated. Using 
PCNA immunostaining, we observed a normal 
proliferation rate at day 4, however, at 2 weeks the 
fraction of PCNA-positive cells was reduced by 
about 25% in mutants (Fig. 5B). At 1 and 4 
months of age, the PCNA index was very low and 
comparable in mutant and control samples. A 
closer view at 2 weeks revealed that in controls 
most PCNA-positive cells were located throughout 
the AC including the most superficial layer, 
whereas in mutants PCNA-labelled chondrocytes 
were more prominent in deeper zones and were 
frequently binucleated (Fig. 5C). Because 
abnormal cytokinesis could also contribute to the 
reduced cell density, the binucleation rate of tibial 
plateau chondrocytes was quantified (Fig. 5D). 
The percentage of binucleated chondrocytes 
increased with age from 0.89% (1 month) to 
1.62% (4 months) and to 2.19% (10 months) in 
control, whereas in mutant the binucleation rate 
was 5% at 1 month and it increased to 7.66% and 
10.57% by the age of 4 and 10 months, 
respectively. Assessing cell death by TUNEL 
assay, we observed no difference in the apoptotic 
rates at 4 and 12 months, however, the percentage 
of TUNEL-positive chondrocytes was 
significantly higher at 7 months in the mutants 
(Fig. 5F).  
The expression of collagen X and collagen 
VI is altered in the mutant AC. IHC showed that 
most ECM molecules including aggrecan and 
collagen type II were normally expressed and 
deposited in the mutant tibial plateau cartilage (not 
shown). In contrast, collagen X, which is produced 
by hypertrophic chondrocytes and present in the 
calcified zone of the AC, displayed an abnormal 
staining pattern (Fig. 6A). In controls, collagen X 
was detectable below the tidemark at a distance of 
6-7 cell layers from the surface, while in β1fl/fl-
Prx1cre+ AC collagen X appeared at a distance of 
2-3 cell layers, consistent with the reduced depth 
of the uncalcified cartilage. Occasionally, mutant 
 5
cells in the uncalcified zone displayed strong 
collagen X deposition suggesting premature 
differentiation of β1fl/fl-Prx1cre+ chondrocytes. 
Furthermore, collagen VI was detectable in the 
PM of all control cells in the uncalcifed zones but 
it was apparently missing at certain locations 
around mutant chondrocytes (Fig. 6B).  
The lack of β1 integrin on chondrocytes 
does not lead to detectable changes in articular 
cartilage metabolism. To assess the expression of 
matrix degrading enzymes, first the mRNA levels 
of Mmp2, Mmp8; Mmp9 and Mmp13 were 
examined by semiquantitative RT-PCR at four 
months of age. In three independent experiments, 
we found comparable levels of MMP mRNAs in 
control and β1fl/fl-Prx1cre+ mice (Fig. 7A). Next, 
we performed immunostaining for MMP-1, MMP-
2, MMP-3, MMP-9, MMP-13, ADAMTS-4 and 
ADAMTS-5.  In general, the expression of MMPs 
was low or undetectable in the AC, and no 
significant differences were observed between 
mutant and control samples at 4, 7 and 12 months 
of age (Fig. 7B and not shown). ADAMTS-5 and 
ADAMTS-4 were evident around chondrocytes in 
the non-mineralized AC and their expression was 
indistinguishable between control and β1fl/fl-
Prx1cre+ mice (Figure 7B and not shown). To 
further examine matrix catabolism, collagen and 
aggrecan degradation products were investigated 
on tissue sections by IHC (Fig. 7C). The aggrecan 
neoepitope G1-IPEN341 (generated by MMPs) was 
predominantly detectable in the calcified zone, 
whereas the G1-TEGE373 (generated by 
aggrecanases) was abundant in the pericellular 
matrix of chondrocytes in the uncalcified zones. 
We noticed no changes in the amount of degraded 
aggrecan in β1fl/fl-Prx1cre+ mice compared to 
controls at 7 and 12 months. Similarly, there was 
no detectable difference in type II collagen 
degradation in situ judged by the C1,2C polyclonal 
antibody which recognizes the Col2-3/4Cshort 
neoepitope upon cleavage by collagenases such as 
MMP13 (Fig. 7C). Finally, body fluid samples 
were investigated by ELISA assays to detect type 
II collagen degradation (C2C and CTX-II) or 
synthesis (CPII) products. Again, no statistically 
significant differences were found between mutant 
and control samples (Fig. 7, D-F). 
  β1 integrin null chondrocytes display 
normal activation of MAP kinases. Signaling 
pathways via MAPKs are activated by 
extracellular stimuli and may play important role 
in joint destruction by regulating the expression of 
proinflammatory cytokines and MMPs (31). To 
check the activity of “classical” MAPKs in β1-
deficient AC chondrocytes, we performed IHC 
using antibodies that specifically recognize the 
phosphorylated forms of ERK-1/2, p38 and JNK. 
At 1 month of age, numerous femoral head AC 
chondrocytes stained positive and we observed no 
obvious differences in activation of MAPKs 
between controls and mutants (Fig. 8A). Next, 
femoral head articular cartilage was removed from 
control and mutant mice, cultured in serum free 
medium with or without the central, cell binding 
fragment of fibronectin (FnIII7-10). After 4 days 
in culture, the explants were investigated for ERK 
phosphorylation and MMP-13 expression by IHC 
(Fig. 8B). In untreated samples, no ERK activation 
and MMP-13 deposition were observed in the 
articular cartilage. In contrast, both control and 
mutant articular cartilage that received Fn-f 
exhibited comparable ERK phosphorylation and 
MMP-13 expression. This data indicates that 
FnIII7-10 fragments could stimulate MMP-13 
expression via MAP kinase activation in the 
absence of the major Fn binding integrin α5β1. 
Finally, we analyzed the activation of the focal 
adhesion kinase (FAK), a central player of  
integrin signaling pathways, by using an antibody 
that recognizes the auto-phosphorylated Tyr397 
residue. In agreement with previous results on 
growth plate chondrocytes (10), mutant AC 
chondrocytes at 2 weeks of age showed 
moderately decreased immunostaining compared 
to controls (not shown).   
Histopathological changes of the synovial 
tissue. Mid-sagittal sections through the 
developing knee joint at embryonic day 16 showed 
poorly differentiated synovium, collateral and 
cruciate ligaments in β1fl/fl-Prx1cre+ mice 
compared with controls (Fig. 9A). In newborns, 
the control synovium was compact and the joint 
ligaments were well-developed, whereas in 
mutants the synovial tissue had a loose-
appearance, the cruciate ligament was 
disorganized and the collateral ligament was 
thinned (not shown). At 2 weeks, the control 
synovium was composed of a narrow lining layer 
and a large adipose compartment. The mutant 
synovium showed fibrosis with extensive collagen 
deposits, revealed by strong birefringence under 
polarization microscopy (Fig. 9, B and C). At 1 
month, SO-stained sections through the 
nonarticular area of the control joints showed non-
cartilaginous surfaces of the tibia and the femur 
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interconnected by the cruciate ligaments, whereas 
the intercondylar surface of the mutant tibia was 
still cartilaginous (Fig. 9D). In mutant, the fibrotic 
synovial tissue invaded the joint space and began 
to undergo chondrogenic differentiation revealed 
by PG deposits and by 7 months of age, the joint 
cavity was frequently filled with chondrophytes 
(Fig. 9, D and E). IHC at 2 weeks demonstrated 
increased numbers of PCNA-positive cells in the 
mutant synovium (Fig. 9F). In contrast to 
cartilage, increased phosphorylation of FAK was 
observed in the β1fl/fl-Prx1cre+ synovial tissue 
(Fig. 9G). 
 
DISCUSSION 
 
Previous in vivo studies in mice revealed that the 
loss of β1 integrins on chondrocytes results in 
severe growth plate defects and perinatal lethality 
(10), whereas ablation of the α1β1 integrin leads to 
accelerated knee OA (25). Here we report the 
generation of β1fl/fl-Prx1cre+ mice and demonstrate 
that targeting β1 integrin in limb skeletal precursor 
cells leads to a complex knee joint phenotype 
characterized by multiple AC and synovial 
abnormalities but is not accompanied by altered 
cartilage metabolism.   
Histology of the knee joints revealed 
increased AC depth and a reduced ratio of 
uncalcified/calcified cartilage thicknesses in 
mutant mice compared to controls. This 
phenomenon might be the consequence of 
abnormal secondary ossification and subchondral 
bone formation. Since the articular cartilage and 
the underlying subchondral bone together provide 
the joint with its normal biomechanical properties, 
it is possible that the increased thickness of the 
calcified zone in mutant mice is due to a 
physiological compensation of the reduced 
subchondral bone mass to adopt mechanical 
loading. Supporting this hypothesis, it was 
recently reported that C57Bl/6 mice with a thin 
subchondral plate exhibit a higher 
calcified/uncalcified ratio in the AC than 
C3H/HEJ mice, which have a thick subchondral 
plate (32). At the molecular level, the increased 
calcified thickness of the β1fl/fl-Prx1cre+ AC was 
also apparent from the expression of collagen X, a 
hypertrophic chondrocyte marker which is 
normally deposited below the tidemark (1). 
Several previous studies have indicated an 
inductive role of β1 integrins in hypertrophic 
differentiation. Signaling via α1β1 and α5β1 
integrins was required for hypertrophy of cultured 
AC chondrocytes induced by transglutaminases 
(33, 34), β1 integrin-blocking antibody impaired 
chondrocyte hypertrophy and collagen X 
deposition in sternal organ culture (35) and miss-
expression of α5β1 integrin in embryonic chick 
legs resulted in joint fusion and initiation of the 
hypertrophic differentiation program (13). Finally, 
we have demonstrated that hypertrophic 
differentiation is delayed in β1fl/fl-Col2cre+ growth 
plate and epiphyseal cartilages (10). Here we show 
that collagen X demarcates a broader calcified 
zone in β1fl/fl-Prx1cre+ knee joints and appears in 
cells above the tidemark, suggesting that β1 
integrin signaling may actually prevent terminal 
differentiation of AC chondrocytes. This implies 
that integrins have a complex role in chondrocyte 
hypertrophy, which obviously depends on the 
tissue context.  
β1fl/fl-Prx1cre+ AC displays several 
abnormalities, which are reminiscent of those 
found previously in the growth plate of the β1fl/fl-
Col2a1cre mice (10). In the normal growth plate, 
chondrocytes are flattened in the proliferative zone 
where they arrange into distinct vertical columns 
(36), whereas in the normal AC, flat chondrocytes 
are apparent in the superficial zone and column-
like, vertical alignment of chondrocytes can be 
observed in the radial and calcified zones of the 
condyles (37). The growth plate of β1fl/fl-
Col2a1cre mice has rounded proliferative 
chondrocytes that are unable to form vertical 
columns due to a migratory block following 
cytokinesis (10). Similarly, β1fl/fl-Prx1cre+ 
chondrocytes were rounded in the superficial zone 
and were not aligned into columns in deeper 
regions resulting in a more isotropic cell 
distribution compared to the normal, structural 
anisotropy seen in the control AC. The inability of 
β1 integrin-deficient chondrocytes to form 
organized structures in cartilage can be explained, 
by the impaired adhesion and by the disruption of 
the F-actin and the normal matrix architecture. It 
has been shown that administration of anti-β1 
integrin blocking antibody to chicken sternum 
organ culture disrupts the cortical actin network 
and reduces chondrocyte-matrix interactions 
revealed by fewer collagen fibrils and filopodia-
like cell projections in the PM (35). Interestingly, 
our electron microscopic analysis of β1fl/fl-
Prx1cre+ AC revealed an enlarged PM 
compartment with unusually thick collagen fibrils 
closely associated with the plasma membrane and 
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with large number of long microvilli. The normal 
PM consists of proteins that bind to β1 integrins 
such as collagens II, VI and fibronectin (1, 6). The 
observation that β1 integrin-deficiency result in 
abnormalities of the collagen II network and 
deposition of collagen VI suggest that β1 integrins 
are pivotal organizers of the collagenous 
architecture of the matrix. Defects in pericellular 
collagen assembly could directly affect the size of 
the compartment leading to its expansion as 
observed around β1fl/fl-Prx1cre+ chondrocytes. The 
elongation of the cell processes are probably due 
to the altered pericellular environment as 
suggested in a recent study demonstrating 
multiple, elongated microvilli in human OA 
femoral head cartilage (38).  
Finally, both growth plate and AC β1-null 
chondrocytes exhibit proliferation defect, frequent 
binucleation and increased apoptosis. As the 
current view suggests that AC growth is primarily 
achieved by apposition from the surface (39), the 
depletion of proliferative chondrocytes in this 
region could be the primary cause of reduced 
cellularity seen in the β1fl/fl-Prx1cre+ mice. 
Binucleation, caused by cytokinesis failure, cell 
fusion or amitosis, is relatively common in 
auricular and articular chondrocytes (40). Since β1 
integrins are localized in the cleavage furrow (10) 
and adhesion-mediated pulling forces are required 
to separate daughter cells (41), it is likely that the 
high binucleation rate in β1-integrin-null 
chondrocytes is due to impaired cytokinesis. β1fl/fl-
Prx1cre+ AC also displays slightly elevated 
numbers of apoptotic chondrocytes at 7 months of 
age. The lack of massive cell death in the mutant 
AC suggests that other integrins (e.g αvβ3) or non-
integrin surface receptors may also support cell 
survival and partially prevent chondrocyte 
apoptosis in the absence of β1 integrins. 
 Despite the AC abnormalities, histology 
and histochemistry did not indicate increased 
proteoglygan depletion and cartilage erosion in the 
mutant AC compared to control mice. These 
results were corroborated with the normal 
expression of MMP and ADAMTS proteases and 
their degradation products implying that β1 
integrins are apparently dispensable for overall 
cartilage metabolism in vivo. Mice lacking the 
major, chondrocyte-specific collagen binding 
integrin α10β1 have no obvious AC abnormalities 
(11) further supporting the view that β1 integrins 
are less important for cartilage homeostasis.   
However, these observations are in contrast with 
the phenotype of the α1β1 integrin–deficient mice 
that display precocious PG loss and severe 
cartilage lesions associated with elevated levels of 
MMP-2 and MMP-3 (25). In normal joints, α1 
integrin expression is low, whereas in OA 
cartilage α1 is significantly up-regulated (14) 
suggesting that this particular integrin heterodimer 
might be required for cartilage matrix remodeling 
at the damaged regions. Our finding, however, 
clearly show that the loss of all β1 heterodimers on 
chondrocytes does not phenocopy the AC 
abnormalities of the α1-null mice. Could this 
contradiction be accounted to the abnormal gait 
and reduced mobility of β1fl/fl-Prx1cre+ mice?  The 
fact that we did not notice significantly reduced 
mobility of mutant mice until 8 months of age, 
whereas α1 knockout mice develop severe AC 
degeneration as early as 4 months, argues against 
the possibility that reduced joint usage would 
prevent physical activity-induced cartilage damage 
in β1fl/fl-Prx1cre+ mice. Alternatively, the lack of  
β1 integrin heterodimers may attenuate AC 
destruction. Several studies indicate that integrins 
are involved in the regulation of MMPs expression 
in response to matrix degradation fragments in AC 
chondrocytes. First, the 110-140 kDa cell-binding 
and the 29 kDa, amino-terminal heparin-binding 
FN-fs are both capable of interacting with α5β1 
integrin, and upregulate MMP-3 and/or MMP-13 
via activation of the ERK1/2, p38 and JNK 
MAPKs (18, 20). Second, engagement of α2β1 or 
α5β1 integrins by adhesion-blocking antibodies on 
human AC chondrocytes increases ERK1/2, p38 
and JNK phosphorylation and blocking antibody 
to α5β1 stimulates gelatinase production (22). 
These studies implicate β1 integrins, particularly 
α2β1 and α5β1, as active participants in matrix 
degradation and their absence may lower MMPs 
expression. However, the phosphorylation  of 
MAPKs  was apparently indistinguishable 
between β1fl/fl-Prx1cre+ and control ACs 
indicating that β1 integrins are either not required 
for MAPKs activation per se or their lack can be 
efficiently compensated via signaling through 
β3/β5 integrins or growth factor receptors. More 
surprisingly, we found that FnIII7-10 fragments in 
explant culture were able to activate ERK and 
upregulate MMP-13 expression in both control 
and β1 integrin-deficient femoral heads. Since not 
only α5β1 but also αvβ3 and αvβ5 integrins are
 8
capable to bind FnIII7-10 (42), it is likely that Fn-
fs-induced cartilage degradation is a complex 
process involving signaling through several 
integrin heterodimers.  
Synovial changes including hyperplasia 
and inflammation are often characteristics of OA 
joints and, via production of various cytokines and 
proteinases, synovitis likely contributes to 
cartilage destruction (43). β1fl/fl-Prx1cre+ mice 
display synovial fibrosis accompanied by frequent 
chondrification but the mutant synovial tissue 
shows no clear sign of inflammatory infiltrates, 
suggesting that the observed alterations are 
unlikely to be linked to immunological processes. 
Recent findings indicate that synovial-lining cells 
in OA patients display enhanced activation of 
FAK (44) that may lead to increased cell 
proliferation and/or migration. Indeed, and in 
contrast to chondrocytes, we detected upregulation 
of phospho-FAK expression in mutant synovial 
tissue. Since FAK is tyrosine phosphorylated in 
response to αvβ3 integrin ligation in osteoclasts 
(45), it is tempting to speculate that β1-deficient 
synovial fibroblasts may over-use αvβ3-mediated 
signaling pathways resulting in altered FAK 
activation. However, the precise mechanism how 
altered cell-matrix interactions and integrin 
signaling contribute to the synovial pathology of 
β1fl/fl-Prx1cre+ mice remains to be elucidated.  
Taken together, our study indicates that β1 
integins are pivotal for joint development 
regulating structural organization, differentiation 
and growth of the AC and the synovium. The lack 
of β1 integrins in the AC, however, has no obvious 
impact on cartilage homeostasis, excluding β1-
integrin signaling as a good candidate for 
intervention in degenerative cartilage diseases. 
Owing to the complex phenotype of β1fl/fl-
Prx1cre+ joints, however, the generation of a 
transgenic line with AC-specific deletion is 
required to precisely define the role of β1 integrin-
mediated chondrocyte-ECM interactions in AC 
destruction.
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Figure 1.  Deletion of the β1 integrin gene in mice using the Prx1-cre transgenic line. A, X-gal 
staining of a forelimb section from  β1fl/fl-Prx1cre+ E18.5 embryo shows cre activity in cartilaginous 
and bony tissues of the elbow and in muscle fibroblasts (h, humerus; r, radius; u, ulna). B, Distal 
epiphysis of the humerus exhibits cre activity in all chondrocytes (blue) of the presumptive articular 
cartilage (ac), while in the growth plate (gp) some chondrocytes (red) are negative. C and D, X-gal 
staining demonstrates cre activity in the forming synovium (sy, C) and in the vessels (v, D). E and F, 
β1 integrin immunostaining  at 1 month of age demonstrates the absence of β1 integrin on articular 
cartilage chondrocytes of mutant tibia (ti, E) and on synoviocytes of the synovium (sy, F). The bars 
on F indicate the intimal/subintimal layers of the synovium. G, X-ray of the hindlimb at 16 months 
indicates short bones, joint space narrowing and blood vessel calcification (arrows) in mutants. 
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Figure 2. Comparison of the articular cartilage from the knee joints of control and β1fl/fl-
Prx1cre+ mice. A-D, Photomicrographs of hematoxylin-eosin-stained sections (Ti, tibia). A, In 
newborn (NB), both control and mutant articular cartilage (ac) chondrocytes are rounded and exhibit 
isotropic distribution pattern (ec, epiphyseal cartilage; gp, growth plate). B, At 1 month (1m), β1fl/fl-
Prx1cre+ joints show a delay in the formation of the secondary ossification centre (so) and display 
flat tibial surface. C, Closer view from (B) indicates fewer chondrocytes, a broad, cell-free superficial 
layer (upper-right inset) and the lack of column-like structures (upper-left inset) in mutant AC. 
Subchondral bone (sb) does not form in the mutant tibia at this age. D, Micrographs demonstrate 
surface irregularities (arrows) of control and mutant articular cartilage at 7 months of age. 
Chondrocyte columns are missing and less subchondral bone forms in mutants. E and F, 
Photomicrographs of Safranin orange-Fast green-stained sections through the medial tibial plateau. At 
1 month (E), chondrocyte clustering, structural disorganization and the lack of tidemark are 
characteristic for the mutant articular cartilage. In control, the tidemark (arrowheads) separates the 
calcified zone (cz) from the upper uncalcified region. At 7 months (F), the mutant articular cartilage 
is thicker with expanded calcified and reduced uncalcified zones. Note the enlarged pericellular 
matrix staining around mutant chondrocytes (ellipses) in the calcified zone. G, Quantification of the 
articular cartilage (AC) thickness. H, Quantification of the ratio of uncalcified and calcified zones. 
The total AC thicknesses were set as 1.  
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Figure 3. Quantification of the histopathological changes of the knee. A, Total score indicates 
increased severity of joint histopathology in mutants at 4 and 7 months of age. By 12 months, the 
difference between controls and mutants are not significant (ns). Open symbols denote female mice 
and filled symbols denote male mice. B, Quantification of cartilage erosion reveals no significant 
difference in articular cartilage destruction between controls and mutants.  
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Figure 4.  Electron and confocal microscopy of articular cartilage from control and β1fl/fl-
Prx1cre+ mice. A, Representative electron micrographs of the cartilage surface (superficial zone) 
reveal additional disorganized layers of collagen fibrils (double arrow) in the mutant sample. The 
superficial chondrocytes are more rounded and extend long microvilli into the matrix (arrows). In the 
lower radial zone, the mutant cartilage displays frequent binucleation, an enlarged pericellular matrix 
compartment (PM) and large collagen bundles near the chondrocyte surface (ellipse). B, Confocal 
micrographs of sections stained for phalloidin (to visualize actin, green) and DAPI (to visualize 
nuclei, blue) from tibial plateau of 11-month-old mice demonstrate a reduced and irregular cortical 
actin network in β1fl/fl-Prx1cre+ chondrocytes. The dashed lines demarcate the surface of the articular 
cartilage. The insets show magnified images of control and mutant chondrocytes. 
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Figure 5. Chondrocyte cellularity, proliferation and survival in control and β1fl/fl-Prx1cre+ 
articular cartilage. A, Quantification of cell density at the tibial plateau demonstrates fewer 
chondrocytes per unit area in mutant than in control. B, Percentage of PCNA-positive cells. Note the 
moderatly reduced proliferation rate in mutant at 2 weeks of age. C, PCNA immunostaining reveals 
the depletion of proliferative chondrocytes close to the articular surface compared with controls. 
Arrows indicate binucleated, PCNA-positive mutant chondrocytes in deeper regions of the articular 
cartilage. D, Diagram showing the percentage of binucleated chondrocytes in control and mutant 
articular cartilage. E, Percentage of apoptotic chondrocytes throughout the uncalcified articular 
cartilage. 
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Figure 6. Abnormal deposition of collagens X and VI in the mutant articular cartilage. A, At 7 
months, collagen X, a marker of the calcified zone (cz), appears closer to the cell surface in mutant 
compared with control. The arrow indicates mutant cells in the uncalcified zone depositing collagen 
X into the matrix. B, Collagen VI is abundant in the pericellular matrix of control chondrocytes in the 
uncalcified zone. However, areas (boxes) with mutant chondrocytes in the uncalcified zone are 
devoid of immunoreactivity. 
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Figure 7. Characterization of articular cartilage metabolism. A, Representative RT-PCR analysis 
at 4 months of age indicates that the levels of MMP mRNAs are comparable in control and mutant 
articular cartilage samples. B, Immunohistochemistry at 7 months reveals no changes in the 
deposition of MMP-13, MMP-3 and ADAMTS-5 in mutants compared with controls.  C, 
Immunohistochemistry at 7 months demonstrates that the degradation neoepitopes for collagen II 
(C1,2C) and aggrecan (G1-IPEN341 and G1-TEGE373) are exposed similarly in mutant and control. D-
F, At 7 months, comparable levels of collagen degradation (C2C, CTX-II) and synthesis (CPII) 
products were found in body fluids of control and β1fl/fl-Prx1cre+ mice. 
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Figure 8. Normal activation of MAP kinases in the mutant articular cartilage . A, 
Immunostaining for phospho-ERK1/2 (P-ERK), phospho-p38 (P-p38) and phospho-JNK (P-JNK) 
shows no detectable difference in the activation of MAP kinases in control and mutant femoral head 
chondrocytes at 1 month of age. B, Fn-f stimulation of ERK activation and MMP-13 expression in 
femoral head explant culture. At day 0 (d0), ERK is phosphorylated in many control and mutant 
chondrocytes. MMP-13 staining is visible only in the centre of secondary ossification (so) but not in 
the articular cartilage (ac) of control samples. Due to the delay of terminal hypertrophic chondrocyte 
differentiation, mutant explants show only restricted MMP-13 deposition in the area of secondary 
ossification. At day 4 (d4), both control and β1fl/fl-Prx1cre+ samples treated with Fn-f show ERK 
reactivation and MMP-13 expression in the articular cartilage. 
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Figure 9. Synovial abnormalities in β1fl/fl-Prx1cre+ mice. A and B, Photomicrographs of 
hematoxylin-eosin-stained (HE) mid-sagittal sections of the knee joints. A, Looser appearance of the 
developing synovial tissue (st) and the delayed formation of the cruciate ligament (cl) were observed 
in 16-day-old mutant embryo (E16). Also note the thinner collateral ligament (c) in mutant. B, At 2 
weeks (2w), the control synovium consists of a thin lining layer (arrows) and a large adipose (a) 
tissue. In mutant, the lining is hyperplastic with large vessels and the amount of adipose tissue is 
reduced. C, Picrosirius staining followed by polarization microscopy of the boxed areas in (B) reveals 
fibrosis of the mutant synovium as shown by the strongly birefringent collagen deposits (white 
arrows). D and E, Photomicrographs of Safranin orange-Fast green (SO)-stained sections.  D, At 1 
month, the intercondylar tibial surface is cartilaginous in the mutant and covered by the synovial 
tissue showing sign of chondrification (asterisk). E, By 7 months, extensive chondrification 
(asterisks) is observed in the joint space and in the synovial lining (arrows) of mutant. F, Increased 
numbers of PCNA-positive synovial cells are visible in the mutant. G, Increased phosphorylation of 
FAK was evident in fibroblast-like cells of the mutant synovium.     
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Early detection of aging cartilage and
osteoarthritis in mice and patient samples
using atomic force microscopy
Martin Stolz1*, Riccardo Gottardi2, Roberto Raiteri2, Sylvie Miot3, Ivan Martin3, Raphae¨l Imer4,
Urs Staufer4,5, Aurelia Raducanu6, Marcel Du¨ggelin7, Werner Baschong1,8, A. U. Daniels9,
Niklaus F. Friederich10, Attila Aszodi6 and Ueli Aebi1
The pathological changes in osteoarthritis—a degenerative joint disease prevalent among older people—start at the
molecular scale and spread to the higher levels of the architecture of articular cartilage to cause progressive and
irreversible structural and functional damage. At present, there are no treatments to cure or attenuate the degradation of
cartilage. Early detection and the ability to monitor the progression of osteoarthritis are therefore important for
developing effective therapies. Here, we show that indentation-type atomic force microscopy can monitor age-related
morphological and biomechanical changes in the hips of normal and osteoarthritic mice. Early damage in the cartilage of
osteoarthritic patients undergoing hip or knee replacements could similarly be detected using this method. Changes due to
aging and osteoarthritis are clearly depicted at the nanometre scale well before morphological changes can be observed
using current diagnostic methods. Indentation-type atomic force microscopy may potentially be developed into a minimally
invasive arthroscopic tool to diagnose the early onset of osteoarthritis in situ.
A
rticular cartilage is a highly specialized load-bearing tissue
that provides low-friction, wear-resistant diarthrodial joint
surfaces. The physiological functions of articular cartilage
depend on the precise interplay of the molecules that compose its
extracellular matrix. Proteoglycans embedded in a meshwork of
heterotypic types II/IX/XI collagen ﬁbrils are the two principal
supramolecular matrix components that are responsible for the
unique biomechanical properties of articular cartilage. The mesh-
work of collagen ﬁbrils provides tensile strength to the tissue.
Aggrecan, the major proteoglycan in cartilage, has a high density
of ﬁxed negative charges owing to its anionic glycosaminoglycan
side chains. This in turn draws water into the tissue and generates
an osmotic swelling pressure that is counteracted by the tense col-
lagen meshwork. Thus, collagens and proteoglycans create a
hydrated tissue that resists compressive loads. Age-related
changes in the composition and/or structure of the proteoglycans
and collagens affect the mechanical quality of the articular carti-
lage and may lead to osteoarthritic degradation. Although the
aetiology of osteoarthritis is largely unknown, its onset is charac-
terized by the imbalance between catabolic and anabolic processes,
favouring matrix degradation. This degradation process starts with
proteoglycan depletion followed by degradation of collagen II,
which, in turn, causes mechanical failure and ultimately complete
erosion of the articular cartilage. Hence, any method to diagnose
the onset of osteoarthritis must detect the early changes in the
articular cartilage’s proteoglycan gel before signiﬁcant changes in
its collagen matrix occur1,2.
Diagnosis of osteoarthritis generally relies on radiography or
arthroscopic evaluation of the joint surface, which only detect
macroscopic damage to the articular cartilage. Magnetic resonance
imaging (MRI) has been proposed as a promising non-invasive
method for early detection of osteoarthritis3–5. Unfortunately, the
underlying physical effect is too weak to detect changes at molecular
resolution6. In addition, the different orientations of collagen ﬁbrils
in distinct cartilage zones, as well as the heterogeneous distribution
of the chondrocytes within the articular cartilage exclude MRI from
providing bulk precision measurements that could be compared to a
normal reference7. Osteoarthritis-speciﬁc biomarkers in body ﬂuids
would allow assessment of the disease8,9, but their levels can signiﬁ-
cantly vary owing to physical activity or food consumption, so the
interpretation of results often leads to incorrect conclusions.
Invasive millimetre-scale methods assess mechanical properties
in situ using ultrasound and micro-mechanical devices, but they
lack the sensitivity and resolution to detect changes of stiffness at
the early stage of osteoarthritis10. Similarly, a lack of sensitive tools
also limits our understanding of the pathogenesis of the disease.
We have previously compared the capability of indentation-type
atomic force microscopy (IT-AFM) to image the surface of porcine
articular cartilage and measure its compressive stiffness at the
micrometre and nanometre scales11. We found that only
nanometre-sized tips resolved the ﬁne structural details such as
individual collagen ﬁbrils, in both imaging and indentation mode.
Importantly, enzymatic digestion of cartilage proteoglycans had
little effect on the microstiffness, but yielded clear stiffening at the
1M.E. Mu¨ller Institute for Structural Biology, Biozentrum University of Basel, Switzerland, 2Department of Biophysical and Electronic Engineering, University
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nanometre scale. Based on these observations we hypothesized that
nanoscale IT-AFM may be used to monitor subtle structural and
mechanical changes of articular cartilage that occur during aging
and at the onset of osteoarthritis11.
Articular cartilage of normal mice changes with age
For validation of the IT-AFM method in a biologically relevant
model system, in this study we ﬁrst recorded age-dependent
morphological and biomechanical alterations of the articular
cartilage surface in the femoral heads of C57BL/6 mice at 1, 10
and 19 months of age. In all experimental groups the articular
cartilage surface was apparently smooth and intact on histological
sections (see Supplementary Information, Fig. S1). Scanning
electron microscopy (SEM) following enzymatic digestion of
proteoglycans (see Methods) revealed an indistinguishable
collagen ﬁbril meshwork to a depth of 0.25 mm with ﬁbril
diameters of d1 month ¼ 30.5+3.6 nm, d10 months ¼ 31.5+4.8 nm
and d19 months ¼ 30.1+3.8 nm in all age groups. In contrast,
AFM imaging of the native articular cartilage surface in near-
physiological buffer revealed an age-dependent thickening of the
collagen ﬁbrils (Fig. 1a–c), sometimes with grain-like structures dec-
orating the ﬁbrils (Fig. 1b). The apparent diameter of the ﬁbrils
increased from d1 month ¼ 52+5 nm, to d10 months¼ 170+64 nm,
to d19 months ¼ 812+172 nm (n ¼ 15 ﬁbrils each). This phenom-
enon may be caused by the deposition of short proteoglycan
fragments onto the collagen ﬁbrils, and/or by ﬁbril bundling as a
consequence of the reduced interﬁbrillar glycosaminoglycan
content. Because SEM revealed neither thickened nor bundled
collagen ﬁbrils, it is conceivable that the exhaustive enzymatic
treatment during SEM sample preparation removed the proteo-
glycans from the bundled collagen ﬁbrils, thereby allowing their
dissociation. Taken together, AFM imaging by nanometre-sized
tips of normal mouse articular cartilage demonstrates an
age-dependent thickening of the collagen ﬁbrils, which most likely
represents a physiological rather than a pathological process.
Next, we measured the stiffness (dynamic elastic modulus, E) of
aging articular cartilage by IT-AFM at both the micrometre and
nanometre scales. Whereas the microstiffness did not change with
age and remained at 2.3+0.4 MPa (Fig. 1d), the corresponding
nanostiffness was two orders of magnitude lower compared to the
microstiffness (Fig. 1e,f ). Most importantly, the nanostiffness
increased with age from Enano ¼ 22.3+1.5 kPa (at 1 month), to
Enano ¼ 36.8+10.7 kPa (at 10 months), to Enano ¼ 50.9+4.7 kPa
(at 19 months) (Fig. 1f). To examine whether the observed age-
dependent stiffening of the mouse articular cartilage correlates
with its glycosaminoglycan content, the glycosaminoglycan/DNA
ratio of the samples was determined after mechanical testing. We
found that the glycosaminoglycan/DNA ratio decreased with
age from C1 month ¼ 10.0+4.1 (n ¼ 24), to C10 month ¼ 4.3+3.6
(n ¼ 13), to C19 month ¼ 1.6+0.6 (n ¼ 29) (Fig. 1f ). Taken
together, our data document an age-dependent increase of the
articular cartilage’s nanostiffness with a concomitant decrease in
its glycosaminoglycan/DNA ratio.
Monitoring osteoarthritis and aging in knockout mice
Mice deﬁcient in type IX collagen (Col9a12/2) develop
osteoarthritis-like changes in their knee joints that begin with chon-
drocyte clustering at 3 months, followed by proteoglycan depletion
and collagen II degradation at 6 months, and severe articular carti-
lage destruction at 9–12 months12,13. The pathomechanism in
Col9a12/2 knockout mice is characterized by the activation and
enhanced expression of the collagen-binding membrane protein
discoidin domain receptor 2 (DDR2), which upregulates the
expression of matrix metalloproteinase-13 (MMP-13), leading to
an increased production of collagen II degradation fragments12.
To test the efﬁcacy of IT-AFM to monitor the progression of
osteoarthritis in this animal model, articular cartilage from
femoral heads of Col9a12/2 knockout mice were analysed at
various ages. Although the histology revealed no obvious changes
of Col9a12/2 articular cartilage at 1 month, it yielded a higher
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Figure 1 | Surface imaging and indentation tests for articular cartilage of normal mice at various ages. a–c, AFM surface topography of articular cartilage
imaged in buffer solution (scale bars, 1 mm). Nanometre-sized AFM tips resolved the individual collagen ﬁbrils. Collagen ﬁbrils of older mice appear thicker
(circles). Micrometre (d) and nanometre (e,f) scale AFM indentation tests of articular cartilage from aging C57BL/6 mice (n ¼ 15 per group). d,e, Average
unloading curves for the different mice ages; for a qualitative comparison of the different curves the linear ﬁt of the upper 50% of the curve was also plotted.
Microstiffness values (d) were not affected by age: Emicro¼ 2.3+0.4 MPa (1 month), Emicro ¼ 2.3+0.4 MPa (10 months) and Emicro¼ 2.3+0.4 MPa
(19 months). f, Nanostiffness increases on average from Enano¼ 22.3+1.5 kPa (1 month; black), to Enano ¼ 36.8+10.7 kPa (10 months; green), to
Enano ¼ 50.9+4.7 kPa (19 months; red). The linear ﬁt (dashed line) shows increased nanostiffness with age. The pink curve reveals the concomitant loss of
glycosaminoglycans measured by biochemical analysis. A positive correlation (r¼ 0.86) between nanostiffness and age of mice was detected (P, 0.001).
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chondrocyte density at 3 months, and a roughening of the articular
cartilage surface at 6 and 12 months compared to the articular car-
tilage of wild-type control mice (see Supplementary Information,
Fig. S2a–d). SEM of proteoglycan extracted articular cartilage
(see Methods) revealed an intact, regular collagen ﬁbril meshwork
in 6- and 12-month-old control and in 6-month-old knockout
mice (see Supplementary Information, Fig. S2e,f ). In contrast,
12-month-old Col9a12/2 articular cartilage after the same treat-
ment for SEM inspection exhibited severe disruption of the
collagen ﬁbril meshwork together with bundling and tangling of
the ﬁbrils (see Supplementary Information, Fig. S2f). The collagen
damage was accompanied by increased levels of DDR2, MMP-13
and collagen II degradation fragment staining at 12 months
(see Supplementary Information, Fig. S2 g–l). These observations
indicate that the femoral heads of the knockout mice develop an
osteoarthritis-like phenotype by 6 months of age, with severe
structural changes by 12 months.
AFM imaging of the AC surface of seven femoral heads obtained
from 1-month-old Col9a12/2 knockout mice yielded four samples
with a collagen ﬁbril meshwork similar to wild-type controls
(Fig. 2a,b), one with intermediate ﬁbril thickening (Fig. 2c), and two
with substantial ﬁbril thickening (Fig. 2d). The average diameter of
the ﬁbrils varied from ‘normal’ (d1month ¼ 52+8 nm), to ‘intermedi-
ate’ (d1month ¼ 73+25 nm), to ‘thickened’ (d1month ¼ 183+68 nm)
(Fig. 3a). As expected, ﬁbril thickening correlated with an increase
of the articular cartilage’s nanostiffness from E ¼ 22.3+1.5 kPa
for wild-type and ‘normal’ knockout mice, to E ¼ 25.5+1.1 kPa
for ‘intermediate’, and E ¼ 27.7+1.1 kPa for ‘thickened’ knockout
mice (Figs 2f and 3c), whereas the corresponding microstiffnesses
appeared unchanged (Fig. 2e). These ﬁndings suggest that early
osteoarthritis-like changes in the femoral articular cartilage of
knockout mice, while only detectable at the nanometre scale, may
begin as early as one month of age.
In contrast to SEM imaging of the collagen meshwork (in which
proteoglycans have been extracted) of aging and osteoarthritis
(Fig. 4a–d; see also Supplementary Information, Fig. S2e,f ),
AFM imaging of native articular cartilage revealed an age-
dependent increase of the average ﬁbril thickness in both
wild-type control and Col9a12/2 knockout 3-month-old mice
(Fig. 3a). Accordingly, ﬁbrils of wild-type mice exhibited an
average diameter of d3 months ¼ 53+7 nm, d6months ¼ 61+7 nm
and d12months ¼ 292+122 nm, whereas ﬁbrils of knockout
mice had an average diameter of d3months ¼ 616+190 nm,
d6 months ¼ 665+197 nm and d12months¼ 989+231 nm (Fig. 3a),
indicating a pronounced and drastically accelerated ﬁbril thickening
in the Col9a12/2 mice compared to wild-type mice. As we could
not detect a signiﬁcant difference in the glycosaminoglycan/DNA
ratio between age-matched wild-type and knockout samples (data
not shown), the underlying molecular mechanism remains elusive.
It is conceivable that the lack of collagen IX, which is covalently
bound to the collagen II ﬁbril surface and mediates interactions
between the collagen ﬁbrils and other components of the extracellular
matrix14, may alter the molecular architecture and thus the mechan-
ical properties (that is, the stiffness) of the articular cartilage. Indeed,
aggregated and/or fused collagen ﬁbrils have been reported in the
tectorial membrane of the inner ear of Col9a12/2 mice15.
Next, we assessed the stiffness of articular cartilage from 3-, 6- and
12-month-old wild-type and knockout mice. At 3 months, two of ﬁve
knockout mice exhibited a nanostiffness identical to that of wild-type
mice (Enano¼ 22.3+1.5 kPa; Fig. 3c), whereas three knockout
mice revealed an increased nanostiffness of Enano¼ 29.5+4.4 kPa
(n ¼ 5) (Fig. 3c). At 6 months, the nanostiffness increased signiﬁ-
cantly to an average value of Enano¼ 38.9+3.4 kPa in knockout
mice (n ¼ 6) compared to Enano ¼ 23.5+1.9 kPa in wild-type mice
(Fig. 3c). Somewhat unexpectedly, by 12 months, the average nano-
stiffness of the wild-type mice increased to Enano¼ 41.1+2.9 kPa
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Figure 2 | Surface imaging and indentation tests for articular cartilage of wild-type control and Col9a12/2 knockout mice at 1 month of age. a–d, AFM
surface topography of the articular cartilage (scale bars, 1 mm). Circles indicate individual collagen ﬁbrils with different thicknesses. Wild-type controls (a)
and 4 of 7 Col9a12/2 knockout mice (b) showed no structural differences in the collagen meshwork (normal). One Col9a12/2 articular cartilage (c) showed
the onset of protein deposition along the ﬁbrils (intermediate). Two Col9a12/2 knockout mice (d) exhibited a clear thickening of collagen ﬁbrils (thickened).
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(Fig. 3c), whereas the nanostiffness of the knockout mice (n ¼ 5)
decreased to an average value of Enano ¼ 20.8+3.4 kPa. The large
differences of nanostiffness between knockout mice in each age
group most likely reﬂect the time differences of disease onset in indi-
vidual animals. In contrast to the nanostiffness, the microstiffness at 3
and 6 months did not change and remained at 2.3+0.4 MPa for both
the knockout and the wild-type mice (Fig. 3b). At 12 months, when
the destruction of the collagen meshwork became visible by SEM
(see Supplementary Information, Fig. S2f), microscale indentation
also detected a softening of the knockout articular cartilage surface
to an average value of Emicro ¼ 1.6+0.4 MPa (n¼ 5) (Fig. 3b).
Interestingly, the two 12-month-old knockout mice exhibiting the
lowest microstiffness of Emicro ¼ 1.4+0.2 MPa (Fig. 3b) also exhibited
the lowest nanostiffness of Enano¼ 17.2+2.8 kPa (Fig. 3c).
Taken together, collagen IX deﬁciency had no effect at the
micrometre scale until 6 months of age, but at the nanometre scale
signiﬁcant structural ( ﬁbril thickness) and functional (nanostiffness)
changes were induced upon progression from 1 to 12 months of age.
Importantly, AFM imaging and nanometre-scale IT-AFM can
monitor the early onset of osteoarthritis before histology, molecular
markers and micrometre scale IT-AFM detect the disease.
Measuring cartilage stiffness of osteoarthritic patients
In order to establish IT-AFM for clinical practice, we examined
articular cartilage biopsies obtained from seven osteoarthritis
patients (Table 1; patients 1–7, age 62–96 years) undergoing total
hip or knee replacement. The macroscopic changes of the samples
were evaluated using the Outerbridge scale system16,17, which
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a, Quantiﬁcation of the ﬁbril thickness. Arabic numerals denote the number of mice analysed; n, i and t refer to ‘normal’, ‘intermediate’ and ‘thickened’ groups
as outlined in Fig. 2. At 1 month, compared to wild-type mice (52+5 nm), the average ﬁbril thickness in knockout mice were higher. Four of seven (blue
number) showed a mean ﬁbril thickness of 52+8 nm, one (green number) mouse showed a thickness of 73+25 nm and two (red number) knockout mice
had 183+68 nm. Similarly, at 3 months, knockout mice showed higher ﬁbril thickness: two of ﬁve mice had a mean value of 56+5 nm, whereas three had
616+190 nm. At 6 months, the average ﬁbril thickness increased from 61+7 nm in the wild-type to 665+197 nm in the knockout mice, and at 12 months,
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at all ages. In knockout mice, microstiffness was comparable to the wild-type until 6 months, and decreased at 12 months as follows: two of ﬁve mice had a
mean value of Emicro¼ 1.4+0.2 MPa, and three had Emicro¼ 1.7+0.4 MPa. c, Quantifying nanostiffness. Average nanostiffness for the wild-type control mice
remained constant up to 6 months (Enano/3 months¼ 22.3+1.5 kPa and Enano/6 months ¼ 23.5+1.9 kPa) but increased to Enano¼ 41.1+2.9 kPa at 12 months
(normal aging). In young knockout mice, nanostiffness increased from an average of Enano¼ 25.2+2.3 kPa (1 month; average calculated from four of seven
mice (blue number) Emean¼ 22.3+1.5 kPa, one mouse (green number) E¼ 25.5+1.1 kPa, two mice (red number) Emean¼ 27.7+1.1 kPa) to
Enano ¼ 29.5+4.4 kPa (3 months; average, two of ﬁve mice Emean¼ 22.3+1.5 kPa, three mice Emean ¼ 29.5+4.4 kPa; compared to 22.2+1.1 kPa for controls)
and Enano¼ 38.9+3.4 kPa (6 months; average: two of six mice Emean¼ 33.4+2.5 kPa, one mouse E¼ 37.3+1.7 kPa, three mice Emean¼ 43.7+1.8 kPa),
suggesting the loss of normal biomechanical function of the articular cartilage. By 12 months, the average nanostiffness decreased to Enano¼ 20.8+3.4 kPa
due to disruption of the collagen meshwork (average: two of ﬁve mice Emean¼ 17.2+2.8 kPa, three mice Emean¼ 24.4+2.8 kPa).
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classiﬁes articular cartilage degeneration into grades with increasing
osteoarthritis severity. Grade 0 represents normal cartilage, grade 1
describes articular cartilage with softening and superﬁcial lesions,
grade 2 refers to partial-thickness defects with ﬁssures down to
,50% of the cartilage depth, grade 3 describes severe damage
with ﬁssuring reaching the subchondral bone, and grade 4 refers
to fully exposed subchondral bone with no signiﬁcant articular car-
tilage left. SEM imaging of articular cartilage obtained from a
77-year-old osteoarthritis patient (Table 1; patient 6) revealed a
normal collagen meshwork organization in samples of grade 0
and 1 (Fig. 4a,b respectively), collagen ﬁbril tangling in grade 2
(Fig. 4c), and extensive meshwork disintegration and ﬁbril splitting
in grade 3 samples (Fig. 4d). The micro- and nanostiffness of
samples from the same 77-year-old osteoarthritis patient were
then examined by IT-AFM. Microstiffness values were on the
order of 2 MPa (Fig. 4e; Emicro ¼ 2.3+0.3 MPa) for all grades, in
agreement with previously reported values obtained by convention-
al micrometre- and millimetre-size indenters11. In contrast, when
the IT-AFM measurements of the same biopsies were performed
at the nanometre scale, the corresponding nanostiffness values
decreased from 83 kPa for grade 0 articular cartilage to 5.6 kPa for
grade 3 osteoarthritis cartilage (Fig. 4f). In agreement with this
ﬁnding, analyses of samples from other osteoarthritis patients con-
ﬁrmed the increasing softening of articular cartilage with progres-
sing osteoarthritis at a given age (Table 1 and Fig. 4g). Most
signiﬁcantly, in all seven patients, changes occurring in grades 1
and 2 osteoarthritis cartilage could only be detected at the nano-
metre scale but not by micrometre indentation. We note that
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softening of grade 3 osteoarthritis cartilage was occasionally also
detectable at the micrometre scale (data not shown).
The nanostiffness values of grade 0 cartilage from three individ-
uals without osteoarthritis (age 38, 41 and 50 years) were in the
same average range as those from osteoarthritis patients between
62 and 71 years of age (Fig. 4g). In contrast, we observed a pro-
nounced, age-dependent increase in nanostiffness of ‘healthy’
grade 0 specimens after the age of 71 years from 15.3+3.5 to
142+29 kPa (Fig. 4g and Table 1). This increase in nanostiffness
may be due to the gradual loss of the glycosaminoglycans with
age1,2,18–22, resulting in lower electrostatic repulsive forces between
the glycosaminoglycan chains and consequently in a dehydration
of the proteoglycan gel. As a consequence, the AFM probe measures
the stiffness of the evidently intact collagen meshwork in an age-
dependent fashion23.
Our data also imply that morphological and biomechanical
changes occurring in articular cartilage during normal aging are dis-
tinct from the pathological changes observed during osteoarthritis
progression. Although the nanostiffness of normal (that is,
Outerbridge scale 0) human articular cartilage increases signiﬁ-
cantly with age (Fig. 4g: osteoarthritis grade 0), the age-dependent
nanostiffening is counteracted in osteoarthritis-afﬂicted articular
cartilage (Fig. 4g: osteoarthritis grades 1, 2 and 3). The increasing
cartilage softening observed in osteoarthritis is due to the progress-
ive disintegration of the collagen meshwork (Fig. 4d) and clearly has
a dominant negative effect on the age-dependent increase in the
nanostiffness of normal human articular cartilage. This phenom-
enon is most pronounced in the two oldest patients (age 77 and
96 years, Fig. 4g and Table 1).
Conclusions
The ability to detect early changes in the structure and mechanical
properties of normal aging and osteoarthritic articular cartilage in
mice and patients, using AFM at the nanometre scale, has opened
up the exciting prospect of using a simple nanodevice as a potential
clinical tool. Towards this challenge, transgenic mice (that is,
Col9a12/2 knockout mice) mimicking an osteoarthritis-like phe-
notype have played a crucial role, not only to scrutinize this novel
diagnostics modality ex vivo, but also to serve as a powerful
animal model for unravelling the molecular mechanism underlying
osteoarthritis. The next obvious step is to move this simple, yet
effective nanotool from the bench into the clinic, that is, to
develop a user-friendly in situ IT-AFM setup that allows for
direct arthroscopic inspection of, for example, a human knee
joint24,25. Such nanotools will expand considerably the range of
minimally invasive surgical interventions and allow direct inspec-
tion of articular cartilage structure and biomechanics in health
and disease. In addition to its value in pre-symptomatic diagnostics
of osteoarthritis, nanostiffness may also serve as a sensitive disease
marker in the course of developing novel therapeutic modalities
to halt progression of osteoarthritis or curing the disease. Last, but
not least, IT-AFM may be used for quality control to validate
in situ the outcome of articular cartilage repair procedures
(for example, autologous chondrocyte or engineered cartilage
implantation).
Methods
Preparation of mouse articular cartilage specimens. C57BL/6 and Col9a12/2
knockout mice on C57BL/6 background were used in this study. The animals had
been provided with standard nutrition and physical environment in the animal
facility. For the experiments, mice were killed at various ages and femoral heads were
excised using a razor blade. The specimens were cleaned and stored in ice-cold
phosphate-buffered saline (PBS, pH 7.0) supplemented with a protease inhibitor
cocktail (Complete, Boehringer Mannheim) and 0.01% NaN3. The mechanical
testing was started within 1 h after disarticulating the hips and ended within two
days. Mechanical properties of the articular cartilage remained constant during this
time period.
Histology and immunohistochemistry. Femoral heads harvested from C57BL/6
and Col9a12/2 knockout mice were ﬁxed in 4% paraformaldehyde (PFA) in PBS,
decalciﬁed in 10% EDTA–PBS and processed for parafﬁn embedding. Serial
sections (6 mm) were taken through the entire femoral head and stained with
Toluidine Blue or Safranin Orange-Fast Green to assess articular cartilage
histomorphology and glycosaminoglycan content. Immunohistochemistry was
conducted on hyaluronidase-treated sections using the Vectastain ABC Elite kit
(Vector Laboratories) and 3,30-diaminobenzidine (Sigma) as chromogenic substrate.
Primary antibodies against the following antigens were applied: discoidin domain
receptor 2, matrix metalloproteinase-13 and C1,2C collagen II fragment. For
detailed histological and immunohistochemical procedures see the Supplementary
Information, Methods.
Human articular cartilage specimens. Articular cartilage was obtained from seven
patients undergoing total knee or hip arthroplasty. The samples were graded
independently by two experienced clinicians using the Outerbridge classiﬁcation
system16,17. From each area presenting a clear Outerbridge grade from 0 to 3, three
adjacent osteochondral plugs were obtained using a biopsy punch with inside
diameter of 2 mm. Each punch or ‘plug explant’ consisted of a full-thickness
articular cartilage fragment and the underlying subchondral bone. The plugs were
transferred into PBS and kept on ice until the measurement. For each individual
plug, force maps were taken at ﬁve different locations.
IT-AFM measurements. Samples were prepared as described previously11. Brieﬂy,
for the analysis of the cartilage samples by IT-AFM, mouse femoral heads or human
cartilage specimens were glued onto a round Teﬂon disk with Histoacryl (B. Braun
Surgical GmbH). The mounted specimens were kept in ice-cold PBS until use.
Stiffness (dynamic elastic modulus, E) measurements of articular cartilage
samples were performed as described previously11. Brieﬂy, we recorded load–
displacement curves at a given sample site during both loading and unloading. An
individual set of data consisted of 1,024 load–displacement curves, 512 data points
each. The load–displacement curves on the mouse femoral heads were recorded at
two different trigger deﬂections (that is, maximum applied loads) for the two types
of indenter tips: at 30 nm for the sharp pyramidal tips (200-mm-long silicon nitride
cantilevers, nominal cantilever spring constant k ¼ 0.06 N m21; Veeco, Santa
Barbara, CA) corresponding to an applied load of 1.8 nN and a maximum
indentation of 100–600 nm, and at 150 nm for the microspheres (k ¼ 10 N m21)
corresponding to an applied load of 1.5 mN and a maximum indentation of
1 mm. Microstiffness measurements on the human articular cartilage were
performed by using spherical tips exhibiting a typical diameter of d ¼ 15 mm
(k ¼ 12 N m21). Therefore, a trigger deﬂection of 250 nm corresponded to an
applied load of 3 mN and resulted in an indentation of 2 mm. Microstiffness was
determined using a model for curve ﬁtting, whereas nanostiffness was calculated
using a reference curve as described earlier11. Both approaches include a ﬁt of the
Table 1 | Nanostiffness determined from cartilage biopsies from seven osteoarthritis patients with grade 0–3 cartilage
(Outerbridge scale).
Enano (kPa)
Patient Age of patient (years) Grade 0 Grade 1 Grade 2 Grade 3
1 62 25.0+5.4 10.6+2.2 4.8+1.1 3.4+0.7
2 64 15.3+3.5 6.9+1.6 4.5+1.6 2.2+0.5
3 68 16.8+3.5 13.8+3.0 9.0+1.9 3.4+0.7
4 71 25.8+5.6 15.6+3.4 5.4+1.3 2.2+0.5
5 74 n.a. 22.5+5.0 4.0+0.9 2.5+0.7
6 77 83.0+17.2 23.2+4.9 9.8+2.1 5.6+1.2
7 96 142.0+29.0 51.0+11.0 16.1+3.5 6.9+1.6
n.a.—not available; knee joint exhibited only higher grades of OA cartilage
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upper 50% of the curve as indicated in Fig. 1d,e. The stiffnesses were probed at 3 Hz,
that is, close to human gait. After the indentation testing, articular cartilage
topography was imaged by contact mode AFM at a scanning rate of 0.7 lines s21.
Scanning electron microscopy. Proteoglycans were extracted from articular
cartilage specimens in 100 mM Soerensen’s phosphate buffer (pH 7.2) containing
1 mg ml21 bovine hyaluronidase (type I, Sigma), 1 mg ml21 trypsin (type I, Sigma)
and 0.01% NaN3 at 37 8C for 3 days
26. Specimens were then ﬁxed with 2.5%
glutaraldehyde in PBS for 2.5 h at room temperature, rinsed in water and dehydrated
in graded ethanol series. After critical point drying, samples were sputter-coated
with 3–5 nm platinum and examined by SEM (Hitachi S-4800 FEG), operated at
1.5–5 kV accelerating voltage. Areas corresponding to the joint surface were selected
for imaging, choosing ﬂat, uniform parts.
Glycosaminoglycan quantiﬁcation.Mouse femoral heads were digested with 0.5 ml
proteinase K solution (1 mg ml21 proteinase K, 1 mM iodoacetamide and
10 mg ml21 pepstatin-A in 50 mM Tris/1 mM EDTA buffer, pH 7.4) at 56 8C for
15 h. Glycosaminoglycan content was measured spectrophotometrically after
reaction with dimethylmethylene blue27 using puriﬁed chondroitin sulphate as a
reference standard. The glycosaminoglycan content was compared to the DNA
content, which was measured by the CyQUANT cell proliferation assay kit
(Molecular Probes), with calf thymus DNA as a standard.
Statistical analysis. Data are given as mean+standard deviation (s.d.). The linear
correlations were determined by regression analysis and correlation coefﬁcient using
SPSS 15 (SPSS) and Origin 7.5 (OriginLab), respectively. If not mentioned explicitly,
statistical signiﬁcance was set at P  0.05.
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Spermatogonial stem cells (SSCs) provide the foun-
dation for spermatogenesis. In a manner comparable
to hematopoietic stem cell transplantation, SSCs
colonize the niche of recipient testes and reinitiate
spermatogenesis following microinjection into the
seminiferous tubules. However, little is known about
the homing mechanism of SSCs. Here we examined
the role of adhesion molecules in SSC homing. SSCs
isolated from mice carrying loxP-tagged b1-integrin
alleles were ablated for b1-integrin expression by
in vitro adenoviral cre transduction. The b1-integrin
mutant SSCs showed significantly reduced ability
to recolonize recipient testes in vivo and to attach
to laminin molecules in vitro. In contrast, genetic
ablation of E-cadherin did not impair homing, and
E-cadherin mutant SSCs completed normal sper-
matogenesis. In addition, the deletion of b1-integrin
on Sertoli cells reduced SSC homing. These results
identify b1-integrin as an essential adhesion receptor
for SSC homing and its association with laminin is
critical in multiple steps of SSC homing.
INTRODUCTION
One of the distinct features of stem cells is their migration and
repopulation of niches, where they undergo self-renewal division
(Laird et al., 2008). Of the self-renewing systems, the homing
mechanisms of hematopoietic stem cells (HSCs) have been
best characterized.HSCsaredefinedashavingboth thecapacity
for self-renewal and the ability to differentiate into all mature
hematopoietic lineages after migration into niches. After damage
by radiation or chemicals that destroy endogenous stem cells,
transplanted HSCs can find and actively migrate into empty
niches and quickly regenerate hematopoiesis, a process that
can be exploited to study HSCs and repopulation. Although the
molecular mechanism underlying HSC homing remained long
unknown, a large number of molecules, including cell-adhesion
molecules and their ligands, extracellular matrix (ECM) compo-Cenents, and chemokines, have been identified to be involved in
the homing process (Lapidot et al., 2005).
The spermatogenic system is the only other self-renewing tis-
sue for which a functional transplantation technique is available
(Brinster and Zimmermann, 1994). When spermatogonial stem
cells (SSCs) are microinjected into the seminiferous tubules of
infertile testes, SSCs migrate into the niche, where they reinitiate
and maintain spermatogenesis for a long period of time. While it
is well known that primordial germ cells (PGCs), from which
SSCs develop, migrate into genital ridges during fetal develop-
ment (Molyneaux andWylie, 2004; Raz, 2004), the microinjection
of SSCs now demonstrates that postnatal SSCs retain the ability
to migrate into the niche. Unlike bone marrow, which is com-
posed of multiple cell types, the composition of the germline
niche is relatively simple; the only somatic cell type that directly
interacts with SSCs are the Sertoli cells (de Rooij and Russell,
2000; Meistrich and van Beek, 1993). They support spermato-
genesis and also form a blood testis barrier (BTB) that is consti-
tuted by specific tight junctions between adjacent cells. Trans-
planted SSCs attach to Sertoli cells and, by passing through
the BTB, migrate from the adluminal side of the seminiferous
tubules to the niche site on the basement membrane. Approxi-
mately 10% of transplanted SSCs can accomplish this process,
while the remaining cells disappear within 2 to 3 weeks (Nagano
et al., 1999). SSCs are the only cell type to achieve reconstitution
and long-term spermatogenesis; the rest of the cells disappear
because they do not have self-renewing capabilities. Thus,
SSCs exhibit strongmigratory activity into their niche in amanner
similar to HSCs. However, very little is known about the homing
mechanisms of SSCs or whether stem cells of the two different
self-renewing tissues share the common molecular machinery
for homing.
In this study, we analyzed the roles of adhesion molecules in
theSSChoming. SSCsexpressmembers of the integrin andcad-
herin family of adhesion molecules, both of which play important
roles in HSC homing. We previously found that SSCs preferen-
tially attach to laminin and express both a6- and b1-integrins
that are components of the laminin receptor (Shinohara et al.,
1999). Another study showed thatSSCsalso expressE-cadherin,
which is expressed in a very small population of undifferentiated
spermatogonia (Tokuda et al., 2007). Using adenovirusmediated
gene delivery systems, SSCs or Sertoli cells from mutant micell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc. 533
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transduced with cre to delete the loxP-tagged alleles. Germ cell
transplantation technique was subsequently used to functionally
assess the effect of the b1-integrin or E-cadherin genes in SSC
homing.
RESULTS
Expression of b1-Integrin and E-Cadherin on SSCs
To examine the expression of integrin and cadherin family of
adhesion molecules on SSCs, we used cultured spermatogonia,
germline stem (GS) cells, which are highly enriched with SSCs
(Kanatsu-Shinohara et al., 2003). To avoid contamination of
somatic cells, GS cells on laminin-coated dishes were used for
analysis. Reverse transcription polymerase chain reaction
(RT-PCR) analyses indicated the expression of most b-integrin
subunits (i.e., b1-, b2-, b3-, b4-, b5-, and b7-integrins) and
Figure 1. Expression of b-Integrin and Cadherin
Family Molecules in SSCs
(A) RT-PCR analysis of b-integrin and cadherin gene
expression.
(B) Real-time PCR analysis. Expression was normalized to
HPRT expression.
(C) Reduced expression of E-cadherin in the absence of
GDNF, as assessed by real-time PCR analysis. Expression
was normalized to HPRT expression. Asterisk denotes
significant difference from the control (mean ± SEM,
n = 3, p < 0.01).
(D) Inhibition of GS cell attachment to laminin by Ha2/5.
Asterisks denote significant differences from the control
(mean ± SEM, n = 5, p < 0.01).
(E) Inhibition of GS cell colonization by neutralizing
antibodies. No significant effect was observed (mean ±
SEM, n = 11 to 12).
(F–I) Effects of neutralizing antibodies on colony formation.
Addition of Ha2/5 (F) or ECCD1 (H) did not show significant
effect on GS cells. On the other hand, while typical ES-like
EG cell colonies were observed in the absence of neutral-
izing antibody (G), ECCD1 prevented EG cell colony
development (I). Bar, 200 mm (F–I).
cadherins (i.e., E-, N-, and P-cadherins) (Fig-
ure 1A). However, we were unable to detect
expression of the b6- and b8-integrins. We next
quantified the expression levels of these tran-
scripts using real-time PCR (Figure 1B). Of the
several integrin molecules, b1- and b5-integrins
were dominantly expressed in GS cells. E-cad-
herin was expressed at higher levels than
N- and P-cadherin.
Because adhesionmolecules are dynamically
regulated in HSCs by mitogenic signals (Wilson
et al., 2004), we examined whether the expres-
sion of these molecules is regulated by glial
cell line-derived neurotrophic factor (GDNF),
a critical regulator of self-renewal division of
SSCs (Meng et al., 2000). Real-time PCR analy-
ses showed that expression of the E-cadherin is
downregulated to50%when they are cultured
in the absence of GDNF (Figure 1C). In contrast,
the expression of b1- and b5-integrins did not change signifi-
cantly. These results suggest that expression of integrin and
cadherin adhesion molecules are regulated differentially.
To examine the function of these molecules, we initially used
neutralizing antibodies. Neutralizing antibodies against b1-integ-
rin (Ha2/5) or E-cadherin (ECCD1) inhibited colony formation of
embryonic germ (EG) cells or binding of GS cells to laminin,
respectively (Figures 1D and 1F–1I). However, addition of anti-
b5-integrin neutralizing antibody did not have any effect, indicat-
ing that b1-integrin plays a major role in laminin binding. Both
Ha2/5 and ECCD1 had no effects on GS cell colony morphology
or proliferation. We also tested their effect in vivo. Because HSC
homing can be blocked when bone marrow cells are preincu-
bated with neutralizing antibodies against cell surface antigens
(Lapidot et al., 2005; Laird et al., 2008),Ha2/5orECCD1werepre-
incubated with enhanced green fluorescence protein (EGFP)-
expressing GS cells, and the cells were then microinjected into534 Cell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc.
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lack endogenous spermatogenesis because of mutations in the
c-kit receptor (Geissler et al., 1988). Two experiments were per-
formed, and recipients were transplanted with 2 3 104 GS cells.
However, no evidence of impaired colonization was found (Fig-
ure 1E). The combination of these antibodies also did not show
any impact on colonization.
Analysis of b1-Integrin and E-Cadherin Function
in SSCs Using Conditional Knockout Mice
Although our results suggested that neither b1-integrin nor
E-cadherin is involved in SSC homing, the techniques used in
the HSC studies may not be applicable to SSCs because of
differences in the anatomical structures of the migratory paths
and the kinetics of the homing processes. We therefore took
advantage of the cre/lox technology to remove both these genes
individually in SSCs derived from conditional knockout animals
(Figures 2A and 2B). The cre-mediated gene ablationwas carried
out with a recombinant, cre-expressing adenovirus (AxCANCre).
We previously showed that exposure of testis cells in vitro to
AxCANCre results in the deletion of the target genes in SSCs
(Figure 2C) (Takehashi et al., 2007).
In the first set of experiments, we used mice carrying a
b1-integrin gene flanked by loxP sites (b1-integrin floxed mice)
(Figure 2A) (Brakebusch et al., 2002). In this mouse strain, the
excision of the floxed b1-integrin gene can be confirmed by the
activation of a reporter LacZ gene, which was inserted down-
stream of the b1-integrin locus. The reporter is activated after
the excision of the b1-integrin allele by cre. Using this mouse
strain, heterozygous floxed animals were bred to produce mice
homozygous for the b1-integrin floxed allele. Heterozygous
floxed animals were used as controls. Testis cells from both
homozygous and heterozygous animals were collected from
10- to 14-day-old pups, which are enriched with SSCs because
of the lack of differentiating germ cells (Shinohara et al., 2001).
The cells were exposed to AxCANCre overnight and then were
recovered for transplantation (Figure 2C). After trypsinization,
48%–77% of the input cells could be recovered. The adenovirus
treatment resulted in the loss of the b1-integrin gene at an effi-
ciency of 49.0 ± 4.1% (mean ± SEM, n = 3; Figure 2A). Three
experiments were performed, and 1.5 3 105 testis cells were
transplanted into 30 testes.
Three months after transplantation, recipient mice were sacri-
ficed, and the testes were stained with 5-bromo-4-chloro-3-
indolyl b-D-galactoside (X-gal). Recipient testes that received
mutant cells had a significantly smaller number of colonies than
did testes that received control cells (Figures 3A, 3B, and 3G).
BecauseW testes do not have differentiating germ cells, all sper-
matogenesis in the recipient testes originated from the trans-
planted donor cells (Shinohara et al., 2001). We also evaluated
the homing efficiency by counting the number of seminiferous
tubules containing spermatogenesis by histology. Overall,
whereas testes with mutant donor cells showed spermatogene-
sis in 13 of 757 tubules (1.7%), those that received control
transplants exhibited spermatogenesis in 187 of 602 tubules
(31.1%); this difference was statistically significant (Figure 3H).
Figure 2. Functional Analysis of Homing
Molecules by Adenoviral Transduction
(A and B) Conditional mutant mice used in the
experiments. LacZ gene expression begins after
cre-mediated gene deletion in b1-integrin mutant
mice. Southern blots of deletion efficiency. Geno-
mic DNA was digested with PstI (A) or EcoR V (B)
and hybridized with a LacZ (A)- or E-cadherin
(B)-specific probe, respectively. P, PstI; E, EcoRV.
(C) Diagram of the experimental procedure to test
gene functions in SSCs. Testis cells from condi-
tional mutant mice were dissociated and infected
in vitro by AxCANCre. Cre-mediated deletion
removed the target genes, and LacZ gene expres-
sion was initiated under the b1-integrin or ROSA26
promoters in b1-integrin or E-cadherin mutant
cells, respectively. The cells were transplanted
into recipient testes for assessing the SSC activity.
The level of donor cell colonization was evaluated
by counting LacZ-positive colony numbers or
tubules with spermatogenesis.
(D) A diagram of the experimental procedure to
test gene functions in Sertoli cells. The b1-integrin
floxed mice were treated with busulfan to remove
endogenous spermatogenesis. One month after
busulfan injection, AxCANCre was microinjected
into the testes. Donor cells from EGFP transgenic
mice were transplanted after 2 weeks. The level of
donor cell colonization was evaluated by counting
the number of colonies under UV light.Cell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc. 535
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those from mutant males (Figures 3A and 3B), suggesting that
b1-integrin mutant cells did not differentiate efficiently. In agree-
ment with this result, although control cells could complete
normal spermatogenesis, very few differentiated germ cells
were found in the recipients that received mutant donor cells
(Figures 3E and 3F).
SSChoming involves several steps: attachment toSertoli cells,
passage through the BTB, migration into the germline niche, and
attachment to the basement membrane (Nagano et al., 1999). To
examine which of these processes are affected, we analyzed the
pattern of donor cell colonization at early time points (Figure 4A).
Both control andmutant cells produced chains of spermatogonia
on the basement membrane at 1 week after transplantation
(Figure 4B, inset), indicating that the mutant cells were able to
migrate through BTB and proliferate on basement membrane.
Figure 3. ReducedColonizing Ability of b1-Integrin
Mutant Cells
(A–D) Appearance of recipient testes following transplan-
tation of AxCANCre-infected control (A and C) or b1-integ-
rin (B) or E-cadherin (D) mutant testis cells. Blue tubules
represent the colonization of donor stem cells that were in-
fected by AxCANCre adenovirus. Weakly stained colonies
were found in the recipient testis (arrows), suggesting that
the cells differentiated poorly.
(E and F) Histological appearance of recipient testes that
received AxCANCre-infected testis cells from control (E)
or b1-integrin mutant (F) mice. Note the reduced sper-
matogenesis in the mutant cells.
(G) Colony count. The loss of b1-integrin induced a signif-
icant reduction. Asterisks denote significant differences
from the control (mean ± SEM, n = 18 to 26, p < 0.01 for
b1-integrin; n = 9 to 10, p = 0.41 for E-cadherin).
(H) Evaluation of spermatogenesis in the recipient testes.
The values represent the percentage of tubules with
spermatogenesis in each testis. Asterisks denote signifi-
cant difference from control (mean ± SEM, n = 4 to 6,
p < 0.01). The total number of tubules from four to eight
different recipient testes was counted.
(I) Appearance of pup recipient testes that received
AxCANCre-infected control (left) or b1-integrin mutant
(right) testis cells. Note the larger size of the recipient
testes that received control cells (left), due to enhanced
colonization in the immature testis.
(J and K) Histological appearance of pup recipient testes
that received AxCANCre-infected control (J) or b1-integrin
mutant (K) testis cells.
(L) Weight and evaluation of spermatogenesis in the pup
recipient testes. Asterisks denote significant differences
from the control (mean ± SEM, n = 8 to 9, p < 0.01 for testis
weight; n = 7–10 for histology). Bars: 1 mm, (A)–(D) and (I);
100 mm, (E), (F), (J), and (K). Stain, X-gal followed by
hematoxylin and eosin (E, F, J, and K).
However, when the recipient testes were
analyzed at 3 weeks after transplantation, only
control cells remained on the basement mem-
brane (Figure 4B). By 6 weeks after transplanta-
tion, most of the mutant cells disappeared from
the testis. In contrast, no significant effects on
colonization were observed with neutralizing
antibodies (Figure 4C).
To further examine the mechanism of homing defect, we next
used 5- to 10-day-old immatureW pups as recipients (Shinohara
et al., 2001). At this stage, recipient testes lack the BTB, which
forms at approximately days 12–14 after birth (de Rooij and
Russell, 2000). Three experiments were performed, and a total
of 12 testes were transplanted with 63 104 testis cells that were
exposed to AxCANCre. Testis cells lacking b1-integrin showed
a significantly reduced colonization (Figure 3I), while transplanta-
tion of control cells resulted in extensive colonization at 3months
after transplantation. Some haploid cells were found, but we
were unable to observe complete spermatogenesis (Figures 3J
and 3K). A total of 373 of 584 tubules (63.9%) showed spermato-
genesis with control cells, but only 63 of 1203 (5.2%) tubules
showed spermatogenesis with mutant cells. Decreased coloni-
zation was also evident by the low testicular weight of mutant
cell recipients (Figure 3L).536 Cell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc.
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lished GS cells from 7-day-old homozygous b1-integrin floxed
mice. The established GS cells were exposed to AxCANCre to
generate GS cells lacking b1-integrin. The growth rate of the
mutant GS cells was comparable to that of control cells on
mouse embryonic fibroblasts (MEFs). Additionally, there were
no significant changes in colony morphology or size (Figure 5A).
However, when the mutant cells were transferred on different
kinds of ECM molecules, they showed reduced ability to bind
to laminin (Figure 5B). The number of cells that attached was
significantly smaller than that of control cells as early as 30 min
after incubation (Figure 5C). Interestingly, the mutant cells could
attach to poly L-lysine, an artificial substrate that can mediate
b1-integrin independent attachment (Figure 5B).
We also analyzed the role of E-cadherin in SSC homing.
Preliminary experiments using a dominant-negative E-cadherin
construct did not show any effect on GS cell colony proliferation
or homing (data not shown). We therefore used a conditional
knockout mouse line for the E-cadherin gene (Figure 2B)
Figure 4. Colonization of Recipient Seminiferous
Tubules by Donor Cells
(A) Appearance of the recipient testis that received cre-treated
testis cells from homozygous and heterozygous (control)
animals. Although many clusters of blue cells were initially ob-
served (arrows), very few colonies were found in the recipient
testis that received homozygous donor cells after 6 weeks. In
contrast, heterozygous control cells proliferated tomake germ
cell colonies (arrowheads). The intense blue color in the colony
at 3 months represents extensive differentiation of SSCs.
(B) Colonization of seminiferous tubules at 3 weeks after trans-
plantation. Control cells made networks of spermaotgonia,
whereas homozygous cells produced blue cell clusters. Note
the greater distance between the blue cells and the outlines
of the tubules in recipient with mutant cells, which suggested
that they are not on the basement membrane. Inset shows
chains of control and mutant spermatogonia in the tubule at
1 week after transplantation, suggesting that the cells were
proliferating.
(C) Effect of neutralizing antibodies. Heterozygous donor cells
were transplanted with indicated antibodies, and the recipient
testes were analyzed at 1 week after transplantation. Bars:
500 mm, (A) and (C); 200 mm, (B).
(Boussadia et al., 2002). The E-cadherin mutant
mouse strain was crossed with a ROSA26 reporter
mouse strain (R26R) to visualize the mutant SSCs
(Soriano, 1999). Heterozygous floxed animals were
used as controls. Testis cells were collected from
the homozygous mutant and control mouse and
exposed to AxCANCre. After overnight incubation,
41%–75% of the input cells were recovered.
Southern blots indicated that 35.7 ± 4.6% (mean ±
SEM, n = 3) of the floxed allele was deleted from
the E-cadherin gene locus (Figure 2B). Three
experiments were performed, and 1.5 3 105 testis
cells were transplanted into 18 recipient testes.
Analysis of the recipient testes showed that both
mutant and control cells could extensively colonize
the seminiferous tubules (Figures 3C and 3D), and
there was no significant difference in colony
numbers (Figure 3G). Histological analysis also showed compa-
rable numbers of seminiferous tubules with spermatogenesis
(Figure 3H). Overall, the control and mutant cells produced
spermatogenesis in 148 of 367 (40.3%) and 188 of 413 (45.5%)
tubules, respectively. No apparent differentiating defects were
observed. Moreover, we also did not find any differences at
1–3 weeks after transplantation (data not shown), suggesting
that E-cadherin is not involved in migration in the initial phase
of colonization.
Analysis of b1-Integrin and E-Cadherin Function
in Sertoli Cells Using Conditional Knockout Mice
Because b1-integrin is also expressed in Sertoli cells (Yan et al.,
2006), we hypothesized that b1-integrin on Sertoli cells may
affect SSC homing. We examined this hypothesis by taking
advantage of the in situ infection of Sertoli cells by adenovirus
(Figure 2D) (Kanatsu-Shinohara et al., 2002). Wild-type (WT) or
conditional b1-integrin knockout mice were injected with busul-
fan to deplete endogenous spermatogenesis. After 1 month,Cell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc. 537
Cell Stem Cell
Homing of Spermatogonial Stem Cellsboth types of mice were injected with AxCANCre. Exposure to
AxCANCre resulted in the deletion of the b1-integrin gene
throughout the whole testis, as visualized by X-gal staining (Fig-
ure 6A). Histological analyses showed that the deletion occurred
in 71.5 ± 6.4% of the seminiferous tubules (mean ± SEM, n = 6),
and 19.3 ± 1.6% of Sertoli cells in each tubule expressed LacZ
gene (mean ± SEM, n = 31) (Figure 6B).
Twoweeks after AxCANCre exposure, 13 106 testis cells from
adult EGFP transgenic mice C57BL/6 Tg14(act-EGFP)OsbY01
(designated as Green) were microinjected into the seminiferous
tubules of both control and b1-integrin mutant mice. When the
recipient testes were analyzed 2 months after transplantation,
b1-integrin mutant recipient testes had a smaller number of
EGFP-expressing colonies compared with control recipients,
suggesting that the loss of b1-integrin decreased the seeding
or maintenance of stem cells in recipient testis (Figures 6C, 6D,
and6H).However, someEGFP+cells overlapped in LacZ-stained
areas (Figures 6E and 6F). Despite fewer colonies, those that
did develop in the testes did not show any particular abnormali-
ties, and the cells were able to differentiate at least beyond
the spermatocyte stage after histological analyses, as indicated
by synaptonemal complex protein 3 (SYCP3) expression (Fig-
ure 6G). In contrast, although the number of colonies decreased
in E-cadherin mutants, the difference was not significant
(Figure 6I).
Figure 5. Reduced Laminin Binding of b1-Integrin Mutant GS Cells
(A) b1-integrin mutant GS cells. The cells retained a typical morula-like
appearance.
(B) Adherence of b1-integrin mutant GS cells to ECM substrates. GS cells
were plated on ECM-coated dishes for 30 min. Asterisk denotes significant
difference from the control (mean ± SEM, n = 5, p < 0.01). LN, laminin; FN,
fibronectin; Col, collagen; PLL, poly L-lysine.
(C) Reduced laminin binding of mutant GS cells. The differences between
control and mutant cells were significant at all time points for both adherent
and floating cells (mean ± SEM, n = 5, p < 0.01). Bar, 200 mm (A).
Figure 6. Evaluation of b1-Integrin Function in Sertoli Cells
(A and B)Wholemount (A) and histology (B) of recipient testes fromAxCANCre-
injected b1-integrin floxed mice. Injection of AxCANCre induced the loss of the
b1-integrin gene, as evidenced by LacZ expression. Inset shows whole mount
of cre-treated control recipient testis.
(C and D) Appearance of AxCANCre-injected control (C) and homozygous
b1-integrin floxed (D) recipient testes that received EGFP-positive donor cells.
(E and F) Colonization of donor cells. EGFP-expressing cells are found among
LacZ-expressing Sertoli cells (arrows).
(G) Spermatogenesis in the recipient testis. SYCP3-positive (red) meiotic cells
were observed.
(H and I) Colony count. The number of colonies in b1-integrin mutants was
reduced in recipient testes that received AxCANCre injection (H), whereas
those in E-cadherin mutants did not decrease significantly (I). The results are
from two experiments. Asterisks denote significant differences from the
control (mean ± SEM, n = 14 to 17, p < 0.01). Bars: 200 mm, (A), (E), and (F);
1 mm, (C) and (D); 50 mm, (B) and (G).538 Cell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc.
Cell Stem Cell
Homing of Spermatogonial Stem CellsDISCUSSION
Although the discovery of the homing activity of SSCs was sur-
prising, the mechanism of SSC homing has been long unknown
due, at least in part, to the lack of appropriate techniques for the
genetic manipulation of SSCs. We took advantage of adenovirus
to analyze the involvement of adhesion molecules in SSC hom-
ing. Although SSCs were thought to be refractory to adenovirus
infection, adenovirus can transduce SSCs in vitro (Takehashi
et al., 2007). An additional advantage of adenovirus is that it
also infects Sertoli cells (Kanatsu-Shinohara et al., 2002). Be-
cause Sertoli cells are mitotically quiescent and constitute only
2% of the total testis cells in the adult (Bellve´, 1993), their role
in spermatogenesis has been difficult to analyze despite the
relatively simple niche structure. Our study demonstrates that
adenovirus exposure to SSCs in vitro and the infection of Sertoli
cells in vivo are both useful methods by which to analyze gene
function in stem cells and their microenvironment.
The integrin family, which comprises various ECM receptors,
plays important roles in stem cell biology. In particular, b1-integ-
rin is involved not only in HSC homing to the fetal liver or bone
marrow, but also in the proliferation of neural stem cells (Hirsch
et al., 1996; Ptocnik et al., 2000; Leone et al., 2005; Campos
et al., 2004). In germline cells, PGCs, precursor of SSCs, require
b1-integrin tomigrate into the genital ridges during fetal develop-
ment (Anderson et al., 1999). Through the analysis of chimeras
between b1-integrin-deficient embryos with WT embryos, it
was found that b1-integrin-deficient PGCs enter the germline
but fail to efficiently colonize the genital ridges. Conversely, the
function of b1-integrin in postnatal germ cells remained elusive,
even though its expression was demonstrated on SSCs (Shino-
hara et al., 1999). However, the decreased colony formation from
the b1-integrin mutant SSCs now indicates that b1-integrin plays
an important role in the SSC biology.
A major problem in studying SSC homing is that it is difficult to
track SSCs immediately after transplantation. This is because
the concentration of SSCs is very low in the testis cell suspen-
sion, and no SSC-specific markers have been identified. Stem
cells could be identified retrospectively only by their ability to
self-renew. During the first several weeks after transplantation,
germ cell colonies cannot be defined because SSCs proliferate
very slowly. In addition, numerous transplanted cells remain in
the seminiferous tubules, which prevents direct identification of
prospective SSC colonies. However, cells that failed to reach
the nichemay undergo apoptosis or are phagocytosed by Sertoli
cells and disappear after 1 month. Colonies derived from SSCs
can be defined at least 6 weeks after transplantation.
Although these problems make it difficult to study the homing
mechanism, our results suggested strongly that b1-integrin is
involved in the first several weeks of SSC colonization. First,
we detected a homing defect in immature pup recipient testis,
which lacks the BTB. Because SSC homing is enhanced in
pup recipients, passage through the BTB is thought to be the
most critical step in SSC homing (Shinohara et al., 2001). How-
ever, the homing defect of b1-integrin mutant cells was still
prevalent, suggesting that b1-integrin is not involved in passage
through BTB. Second, b1-integrin mutant GS cells have an
impaired ability to attach to laminin in vitro. In addition, while
WT GS cells attach to laminin preferentially compared withCfibronectin or collagen (Shinohara et al., 1999), anti-b1-integrin
antibody specifically inhibited the attachment of WT cells in this
study. Third, mutant cells retained proliferative activity both
in vivo and in vitro. The mutant cells proliferated to make chains
of spermatogonia at 1 week after transplantation in vivo,
although it is unclear whether they originated from SSCs. More-
over, mutant GS cells could proliferate for a long term in vitro.
Fourth, by 3 weeks after transplantation, most mutant cells de-
tached from the basement membrane. These results suggest
that initial phase of colony establishment is affected by b1-integ-
rin loss. Therefore, a likely scenario is that transplanted mutant
SSCs respond to a chemotactic signal and migrate from the
adluminal to the basal compartment of the seminiferous tubules
through the BTB, but migration to niche or retention on the base-
ment membrane is abrogated because of a decreased ability to
bind to laminin (Figure 7).
Although our results indicate the importance of b1-integrin in
SSChoming, thismoleculemay also be involved in other aspects
of spermatogenesis. In our study, we did not observe gross ab-
normalities in b1-integrin mutant GS cells in vitro or in the germ
cell colony in vivo, suggesting that they have normal potential
for spermatogenesis. Moreover, the cells were undergoing dif-
ferentiation because meiotic cells were observed in the recipient
testes after transplantation of mutant cells. However, we were
not able to detect complete spermatogenesis from the mutant
cells, which suggested that the cells are not differentiating
efficiently. One possibility is the direct involvement of b1-integrin
in SSC differentiation. In fact, ligand binding by b1-integrin can
influence differentiation of keratinocytes (Levy et al., 2000). Alter-
natively, inefficient differentiation may be caused indirectly by
low SSC seeding. The degree of commitment of cells to the
differentiation pathway may be influenced by the stem cell
and seminiferous tubule conditions (Nagano et al., 1999). Partic-
ularly, in case of low level of colonization, initiation of SSC
Figure 7. Potential Roles of b1-Integrin in SSC Homing
The b1-integrin is potentially involved in three distinct steps of SSC homing. Its
expression on Sertoli cells may facilitate the attachment of SSCs or migration
through the tight junction, whereas b1-integrin on SSCs may mediate their
attachment to the basement membrane. The role of cadherin is yet to be
determined.ell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Inc. 539
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SSC expansion. Indeed, SSCs transplanted in pup testis differ-
entiate more quickly than in adult testis because of enhanced
colonization (Shinohara et al., 2001). Considering that many ab-
normalities, such as missing layers of germ cells, were observed
during the first several months after transplantation (Parreira
et al., 1998), it remains unclear whether b1-integrin is involved
in SSC differentiation. Strikingly, previous studies on HSCs
showed that, although HSC homing depends on b1-integrin after
transplantation, hematopoiesis proceeded normally in the
absence of b1-integrin when the gene was inactivated in HSCs
within the bone marrow (Brakebusch et al., 2002). Long time
follow-up of the transplants is therefore necessary to determine
the effect of b1-integrin loss in spermatogenic differentiation.
We also showed that SSC homing was impaired when the
b1-integrin of Sertoli cells was ablated in the recipient testes.
This suggests that b1-integrin on Sertoli cells plays a role in
SSC homing. Although Sertoli cells may have been exposed to
the virus only transiently due to the flow of seminiferous tubule
fluid in vivo, the cre-mediated deletion occurred evenly in the
testis, and LacZ staining showed that 72% of the seminiferous
tubules were infected with the virus. However, the deletion was
modest compared with SSCs, and only 19% of the Sertoli cells
showed LacZ expression. Some germ cell colonies developed
in areas with LacZ staining, which suggested that the cells might
be heterozygous for the integrin expression in these areas. Alter-
natively, several Sertoli cellsmay cooperate to facilitate transport
of SSCs to the basement membrane. More dramatic inhibition
would occur in the complete absence of b1-integrin, which may
be achieved using higher virus titer or injection into immature
pups.
The involvement of Sertoli cells in SSC homing suggests that
stem cell homing in the testis may operate in a different manner
from that in the bone marrow. While active chemotaxis of stem
cells alone may explain SSC homing, it was also proposed that
Sertoli cells may play a major role. In this model, Sertoli cells
actively sort transplanted SSCs and position them within the
epithelium, using their unique cytoskeltal elements and cell con-
figurations that enable such movements (Russell et al., 1996).
Unlike normal epithelium, in which b1-integrin is usually present
in the cell matrix, the b1-integrin of Sertoli cells is restricted to
definite sites of intercellular contact, colocalizing with actin
bundles at apical and basal ectoplasmic specialization (ES),
a testis-specific, actin-based hybrid for anchoring and forming
tight junctions (Yan et al., 2006). Although the ligand for b1-integ-
rin at the ES is unknown, laminin expressed on germ cells may be
a candidate (Yan et al., 2006). Because SSCs also express lam-
inin (Kanatsu-Shinohara et al., 2006), b1-integrin on Sertoli cells
may be used to capture transplanted SSCs. Alternatively, b1-
integrin on Sertoli cells may be used for the transport of SSCs
through the BTB. Reduced immunoreactive b1-integrin expres-
sion around the BTB in the seminiferous epithelium coincides
with the migration of spermatocytes across this barrier, which
suggests that Sertoli cells regulate germ cell movement during
passage through the BTB (Salanova et al., 1995). Therefore, it
is possible that SSCs take advantage of this distinct physiolog-
ical activity of Sertoli cells to migrate into the niche. Although it
remains to be determined whether SSCs exert chemotactic ac-
tivity or Sertoli cells coordinate the homing process, b1-integrin540 Cell Stem Cell 3, 533–542, November 6, 2008 ª2008 Elsevier Ion both germ cells and Sertoli cells is a key molecule in SSC
homing, and accurate measurement of integrin protein levels in
both SSCs and Sertoli cells will clarify how laminin- b1-integrin
interactions coordinate different steps of SSC homing.
On the other hand, E-cadherin has been considered the prime
candidate for stem-cell-niche interaction because it is specifi-
cally expressed to a higher extent on smaller populations of
spermatogonia than is b1-integrin (Wu et al., 1993). This was
also suggested by the fact that, in Drosophila, cadherin interac-
tion is necessary to sustain undifferentiated stem cells (Song
et al., 2002; Yamashita et al., 2003). Therefore, we had good
reason to believe that cadherin also plays a similar role in mam-
malian spermatogenesis. In fact, E-cadherin has several impor-
tant functions in mouse germline development. The addition of
neutralizing antibody inhibits PGC formation from epiblasts
and inhibits the migration and condensation of PGCs to the
genital ridges (Bendel-Stenzel et al., 2000; Okamura et al.,
2003; Di Carlo andDe Felici, 2000). Based on these experiments,
we expected that the loss of E-cadherinwould have adetrimental
effect on the homing or maintenance of SSCs. However, we
found no significant effect of E-cadherin by using the neutralizing
antibody, by a dominant-negative construct, or by genetic abla-
tion. Although other family members of the cadherin genes may
compensate for the loss of the E-cadherin, these results suggest
that E-cadherin in the SSCs plays a lesser role than that in the
PGCs. Interestingly, although Drosophila stem cells interact
with somatic supporting cells by homophilic E-cadherin interac-
tions, E-cadherin expression is not found in mammalian Sertoli
cells (Tokuda et al., 2007). Perhaps, cadherin molecules on
SSCs have a different role in the mammalian testis.
One of the important tasks in the future will be to identify the
a-subunits that are involved in SSC homing. Of 18 a-subunits,
several have been identified in the testes, including a1, a3, a4,
a5, a6, and a9 (Yan et al., 2006). In addition, the search for other
homing molecules also needs to be continued. The adenoviral
gene delivery system may prove useful in such functional analy-
ses because very few cre-expressing transgenic lines are avail-
able for analysis of the spermatogonia stage and breeding
requiresmore time and larger numbers of animals. The biological
significance of SSC migration awaits further study, but the iden-
tification of homing molecules is practically important because
the low homing efficiency of SSCs has long been one of the prob-
lems in germ cell transplantation. Not all recipients become
fertile despite successful germ cell transplantation. However,
the manipulation of homing molecules by genetic or chemical
methods may help to improve the colonization efficiency. Thus,
the identification of the SSC homing machinery will not only
reveal common principles of stem cell systems, but also will be
important for practical SSC applications in medicine and
biotechnology.
EXPERIMENTAL PROCEDURES
Animals
The generation of conditional b1-integrin or E-cadherin mutant mice was
described previously (Brakebusch et al., 2002; Boussadia et al., 2002). For
experiments using b1-integrin mutant mice, b1-integrin flox/flox and flox/WT
littermates were used. For experiments using E-cadherin mutant mice, E-cad-
herin flox/flox males were crossed with homozygous R26R female mice to
produce E-cadherin flox/WT offspring (both from The Jackson Laboratory,nc.
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spring. We also used Green mice (a gift from Dr. M. Okabe, Osaka University)
andWmice (Japan SLC, Shizuoka, Japan) for transplantation. All animals were
maintained in a C57BL/6 background for transplantation studies, except that
b1-integrin flox/flox mouse was backcrossed to the ICR background for GS
cell derivation.
Cell Culture and Adhesion Assay
Testes cells were collected from 10- to 14-day-old pups, and single-cell
suspensions were obtained using a two-step enzymatic dissociation (Bellve´,
1993). The cells were cultured on mitomycin C-treated MEFs in StemPro-34
SFM (Invitrogen, Carlsbad, CA), supplemented as described (Kanatsu-Shino-
hara et al., 2003). For in vitro infection by the AxCANCre (RIKEN BRC,
Tsukuba, Japan), 1 3 106 testis cells were plated in a 6-well plate (9.5 cm2),
whereas 3 3 105 GS cells were plated in a 12-well plate (3.8 cm2). The cells
were incubated overnight, and the virus was removed the next day. The titer
of the virus was 2 3 106 plaque forming units (pfu)/ml.
GS cells were established according to a standard protocol, using newborn
Green mice (backcrossed to the DBA/2 background) or 7 day-old WT or b1-in-
tegrin flox/flox mice in ICR background. GS cells were maintained on MEFs or
laminin (Kanatsu-Shinohara et al., 2003, 2005). EG cells were cultured in
Dulbecco’s modified Eagles’ medium supplemented with 15% fetal calf
serum, 5 3 105 M 2-mercaptoethanol, and 103 units/ml ESGRO (Invitrogen,
Carlsbad, CA). For antibody treatment, the cells were incubated with 20 mg/ml
Ha2/5 (BD Biosciences, Lenexa, KS) or 200 mg/ml ECCD1 (Takara Bio Inc.,
Ohtsu, Japan).
Adhesion assay was performed as described previously with slight modifi-
cations (Kanatsu-Shinohara et al., 2006). In brief, cre-treated GS cells from
wild-type and b1-integrin flox/flox mice were plated on ECM-coated dishes
at a density of 2.53 105 cells per 3.8 cm2. The dishes were coated with laminin
(20 mg/ml), fibronectin (100 mg/ml), poly L-lysine (0.002%) (all from Sigma,
St. Louis, MO), and collagen type I (2.4 mg/ml; Nitta gelatin, Osaka, Japan).
For blocking experiments, cells were plated at a density of 3 3 105 cells per
3.8 cm2 in the presence of 20 mg/ml anti-b1-integrin (Ha2/5), anti-b3-integrin
(2C9.G2; BD Biosciences), or anti-b5-integrin (KN52; eBioscience, San Diego,
CA) antibodies. Data were analyzed using Student’s t test.
Transplantation
Germ cell transplantation was performed via the efferent duct, filling 75%–
85% of the seminiferous tubules in each testis. Approximately 2 or 3 ml could
be introduced into Wmice that were 5–10 days or 4 weeks old, respectively. In
experiments using neutralizing antibodies, donor cells were incubated with
200 mg/ml Ha2/5 or ECCD1 for 1 hr on ice and transplanted into the testis.
To delete genes in Sertoli cells, b1-integrin and E-cadherin mutants, or WT/
WT animals, were treated with busulfan (44 mg/kg) at 4 weeks of age to
destroy endogenous spermatogenesis. Four weeks after the treatment, both
mutant and wild-type animals were injected with AxCANCre (2 3 106 pfu/ml).
Approximately 10 ml of the donor cell suspension was injected into the seminif-
erous tubules of a busulfan-treated recipient, and donor cells from 8-week-old
Greenmice were microinjected 2 weeks after AxCANCre injection. The Institu-
tional Animal Care and Use Committee of Kyoto University approved the
animal experimentation protocols.
Analysis of Recipient Testes
The recipient testes were recovered at indicated time points after donor cell
transplantation and analyzed by staining for the LacZ gene product, b-galac-
tosidase, with X-gal (Wako Pure Chemical Industries, Osaka, Japan) (Nagano
et al., 1999). In experiments using Green mice, colonization was evaluated by
fluorescence under UV light. Germ cell clusters longer than 0.1 mm were
considered as colonies.
For histological evaluation of the recipient testes, the testes were fixed with
10% neutral-buffered formalin and processed for paraffin sectioning. Two
histological sections were made from each recipient testis with an interval of
12 mm. All sections were stained with hematoxylin and eosin. The number
of tubule cross-sections showing spermatogenesis, defined as the presence
of multiple layers of germ cells in the entire circumference of the seminiferous
tubule, was recorded for one section from each testis. Deletion efficiency in
Sertoli cells was evaluated by counting the number of tubules with LacZCexpression. For immunohistochemistry, cryosections of the testes fixed in
4% paraformaldehyde were stained using anti-SYCP3 antibody (Chuma and
Nakatsuji, 2001) and Alexa 488-conjugated anti-rabbit immunoglobulin G
antibody (Molecular Probes, Eugene, USA). The slides were counterstained
with Hoechst 33258 (Sigma). Statistical analysis was conducted using the
Student’s t test.
DNA Analysis
DNA transfer and hybridization were performed as described previously (Take-
hashi et al., 2007). To estimate cre-mediated deletion in b1-integrin mutant
mice, full-length LacZ cDNA was used as a probe. For E-cadherin mutant
mice, a 936-bp fragment in the exon 11-intron 11 region was amplified by
PCR using the primers 50-TGAGATGGACAGAGAAGACGC-30 and 50-GCCTT
AATCAAGTTGGTGTGG-30. The PCR product was digested by EcoRI to
produce a 250 bp fragment, which was used as a hybridization probe. Band
intensity was quantified using NIH image 1.63 software.
Analysis of Gene Expression
First-strand cDNA was synthesized using Superscript II (Invitrogen) for RT-
PCR. To quantify mRNA expression using real-time PCR, comparisons were
made by normalizing the expression to that of hypoxanthine phosphorybosyl
transferase (HPRT) using Step One Plus Real-Time PCR System and Power-
SYBR Green PCR Master mix (Roche Applied Science, Mannheim, Germany).
The PCR conditions were 95C for 10 min, followed by 40 cycles of 95C for
15 s, 60C for 60 s, and 72C for 12 s.
PCR was carried out using the following primers (50-ATCGTGCATGTTGTG
GAGAC-30and 50-CTGCTGTGAGCTTGGTGTTG-30 for b1-integrin, 50-GGTAT
GACGCTGCAGACTATCC-30 and 50-CAGTACGACACCTACCACGG-30 for
b2-integrin, 50-TGGCAAGTACTGTGAGTGCG-30 and 50-TCCAGTCCGAGTC
ACACACG-30 for b3-integrin, 50-GCCTACGAGGTCTGCTATGG-30 and 50-CG
CCTTAACCGTGTATCGG-30 for b4-integrin, 50-GCCAAGATGGCATATCTTAC
C-30 and 50-TGCAATTGTAGGCGACTTCC-30 for b5-integrin, 50-TGGAATATC
CAACTATCGGCC-30 and 50-ACCGCAGTTCTTCATAAGCG-30 for b6-integrin,
50-GAGGTCACACATTCTGTGCG-30 and 50-TCTCTCTCGAAGGCTTGAGC-30
for b7-integrin, 50-AAGGATCCACAATCAGTGC-30 and 50-CCAATATGACTCT
CACAGACG-30 for b8-integrin, 50-ACCGATTCAAGAAGCTGGC-30 and 50-AC
CATCCTAACACAGACAGTCC-30 for E-cadherin, 50-CATGCTGAGCCACAGT
ACC-30 and 50-CGCTACTGGAGGAGTTGAGG-30 for N-cadherin, 50-GGACCA
GGACTATGACATCACC-30 and 50-TGTTGGCAGCCTTCAGG-30 for P-cad-
herin, and 50-GCTGGTGAAAAGGACCTCT-30 and 50-CACAGGACTAGAACA
CCTGC-30 for HPRT).
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